Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Rhosin | 1173671-63-0 | C20H18N6O | 358.4 | |
Rhombifoline | 529-78-2 | C15H20N2O | 244.33 | |
Rhoifolin | 17306-46-6 | C27H30O14 | 578.52 | Rhoifolin |
Rhodotorulic acid | 18928-00-2 | C14H24N4O6 | 344.36 | RHODOTORULICACID; 18928-00-2; EINECS242-681-9; NSC143096; BRN0965705; (2S-cis)-N,N'-((3,6-Dioxopiperazine-2,5-diyl)di-3,1-propanediyl)bis(N-hydroxyacetamide) |
Rhodium, tri-m-carbonylnonacarbonyltetra-,tetrahedro | 19584-30-6 | C12O12 Rh4 | 747.74 | TETRARHODIUM DODECACARBONYL; DODECACARBONYLTETRARHODIUM; DODECACARBONYLTETRARHODIUM (0); tri-mu-carbonylnonacarbonyl-tetrahedro-tetrarhodium; Tetrarhodiumdodecacarbonyl,min.98%; Tetrarhodium dodecacarbonyl, min. 98% |
rhodium(iii) sulfate solution | 10489-46-0 | 494 | RHODIUM SULFATE; RHODIUM(III) SULFATE; rhodium(iii)sulfatesolution; sulfuricacid,rhodium(3++)salt(3:2); dirhodium trisulphate; Rhodium plating solution | |
Rhodamine 575 | 25152-49-2 | C26H26N2O3 | 414.51 | 2-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]-benzoic acid; Rhodamine 19 |
Rhodamine 110 bis-(L-aspartic acid amide) trifluoroacetic acid salt | 220846-63-9 | C32H26F6N4O13 | 788.57 | Rh110-2(Asp) |
Rhodamine 101 inner salt | 116450-56-7 | C32H30N2O3 | 490.6 | Rhodamine 640; 9-(2-carboxyphenyl)-2,3,6,7,12,13,16,17-octahydro-1H,5H,11H,15H-xantheno[2,3,4-ij:5,6,7-i'j']diquinolizin-18-ium, inner salt |
Rhodamin 116 perchlorate | 62669-77-6 | C22H19ClN2O7 | 458.85 | 2-(6-(methylamino)-3-(methylimino)-3h-xanthen-9-yl)benzoicacidmonoperchlora; 2-(6-(methylamino)-3-(methylimino)-3h-xanthen-9-yl)-benzoicacimonoperch; 9-(2-carboxyphenyl)-3,6-bis(methylamino)xanthyliumperchlorate; lorate; rh116; rhodamine116; RHODAMIN 116 |
Rhamnocitrin | 569-92-6 | C16H12O6 | 300.27 | 4H-1-Benzopyran-4-one, 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-;7-Methylkaempferol;Kaempferol 7-methyl ether |
Rhamnetin | 90-19-7 | C16H12O7 | 316.3 | rhamnetin; 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one |
RHIZOCARPIC ACID | 18463-11-1 | C28H23NO6 | 469.49 | RHIZOCARPIC ACID; N-[Phenyl(2,5-dihydro-3-hydroxy-5-oxo-4-phenylfuran-2-ylidene)acetyl]-L-phenylalanine methyl ester; REBAUDIOSIDE B(RG) |
rhEPO | 113427-24-0 | C42H73NO16 | 848.02612;g/mol | (4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-[(2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4R,5S,6R)-5-[(2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-7-(2-hydroxyethyl)-5-methox |
Rheothik 80-11 | 27119-07-9 | C7H13NO4S | 0 | 2-ACRYLAMIDO-2-METHYL-1-PROPANESULFONIC ACID POLYMER; POLY(2-ACRYLAMIDO-2-METHYL-1-PROPANESULFONIC ACID); POLY(2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID); 1-Propanesulfonicacid,2-methyl-2-[(1-oxo-2-propenyl)amino]-,homopolymer; 2-methyl-2-[(1-oxo-2-prope |
Rhenium,bromopentacarbonyl-, (OC-6-22)- (9CI) | 14220-21-4 | C5Br O5 Re | 406.16 | BROMOPENTACARBONYLRHENIUM; RHENIUM PENTACARBONYL BROMIDE; PENTACARBONYLBROMORHENIUM (I); Re(CO)5Br; Rhenium, bromopentacarbonyl-, (OC-6-22)-; Rhenium,bromopentacarbonyl-(OC-6-22)- |
Rhenium, methyltrioxo-,(T-4)- (9CI) | 70197-13-6 | CH3 O3 Re | 249.24 | Rhenium,methyltrioxo-,(T-4)-; MTO; METHYLTRIOXORHENIUM; METHYLTRIOXORHENIUM(7); METHYLTRIOXORHENIUM(VII); METHYLRHENIUM TRIOXIDE; METHYLRHENIUM TRIOXIDE(VII); Methylrhenium(VII) trioxide |
Rhamnazin | 552-54-5 | C17H14O7 | 330.29 | 3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxychromen-4-one |
RH1 | 221635-42-3 | C12H14N2O3 | 234.255 | 2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-; NSC 697726; RH 1 |
RGX-104 hydrochloride | 610318-03-1 | C34H34Cl2F3NO3 | 632.54 | RGX-104; 2-[3-[(3R)-3-[[2-Chloro-3-(trifluoromethyl)phenyl]methyl-(2,2-diphenylethyl)amino]butoxy]phenyl]acetic acid hydrochloride |
RGW2938 | 111786-07-3 | C13H14N4O2 | 258.28 | |
RGW 611 | 6497-78-5 | C9H14N4O3 | 226.236 | 4-(2-(4-nitro-1H-imidazol-1-yl)ethyl)morpholine |
RGFP966 | 1396841-57-8 | C21H19FN4O | 362.4 | |
RGFP966 | 1357389-11-7 | C21H19FN4O | 362.4 | RGFP966; RGFP 966; RGFP-966 |
RGD (Arg-Gly-Asp) Peptides | 99896-85-2 | C12H22N6O6 | 346.34 | |
RGB-286638 Free base | 784210-88-4 | C29H35N7O4 | 545.63 | 1-[3-[4-[[4-(2-methoxyethyl)piperazin-1-yl]methyl]phenyl]-4-oxo-1H-indeno[1,2-c]pyrazol-5-yl]-3-morpholin-4-ylurea; RGB 286638; RGB286638 |
RGB-286638 | 784210-87-3 | C29H37Cl2N7O4 | 618.55 | |
RG7834 | 2072057-17-9 | C22H27NO6 | 401.45 | RO 7020322; (6S)-6-Isopropyl-10-methoxy-9-(3-methoxypropoxy)-2-oxo-6,7-dihydro-2h-pyrido[2,1-a]isoquinoline-3-carboxylic acid |
RG7800 | 1449598-06-4 | C24H28N6O | 416.52 | RO 6885247; 2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-(1-methylpiperidin-4-yl)-4H-pyrido[1,2-a]pyrimidin-4-one |
RG7129 | 1628077-06-4 | RG-7129; RO-5508887 | ||
RG7090 | 802906-73-6 | C18H13ClFN3 | 325.77 | Basimglurant; CTEP Derivative |
RG3039 | 1005504-62-0 | C21H23Cl2N5O | 432.35 | RG-3039;PF06687859;PF-06687859;5-((1-(2,6-dichlorobenzyl)piperidin-4-yl)methoxy)quinazoline-2,4-diamine;5-[[1-[(2,6-dichlorophenyl)methyl]piperidin-4-yl]methoxy]quinazoline-2,4-diamine |
RG2833 | 1215493-56-3 | C20H25N3O2 | 339.43 | RGFP 109; N-[6-(2-Aminophenylamino)-6-oxohexyl]-4-methylbenzamide |
RG14620 | 136831-49-7 | C14H8Cl2N2 | 275.13 | (E)-3-(3,5-dichlorophenyl)-2-pyridin-3-ylprop-2-enenitrile; RG 14620; RG14620; RG-14620; TYRPHOSTIN RG 14620 |
RG13022 | 136831-48-6 | C16H14N2O2 | 266.29 | 3-(3,4-dimethoxyphenyl)-2-pyridin-3-ylprop-2-enenitrile; RG 13022; RG-13022 |
RG108 | 48208-26-0 | C19H14N2O4 | 334.33 | N-Phthalyl-L-tryptophan; RG-108; (2S)-2-(1,3-dioxoisoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid |
RG 102240 | 162326-49-0 | C23H30N2O3 | 382.5 | 2-Ethyl-3-methoxybenzoic acid 2-(3,5-dimethylbenzoyl)-2-(1,1-dimethylethyl)hydrazide; GS-E; GS-E (ligand); RSL 1; RheoSwitch Ligand 1; RheoSwitch Ligand RSL 1 |
RFRP-1 (human) | 311309-25-8 | C67H101N19O14S | 1428.72 | MPHSFANLPLRF; MPHSFANLPLRF-NH2 |
RFRP 3 (human) | 311309-27-0 | C45H72N14O10 | 969.15 | VPNLPQRF |
R-Frovatriptan | 158747-02-5 | C14H19N3O | 243.33 | (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide |
RF 9 | 876310-60-0 | C26H38N6O3 | 482.62 | 2-Adamantanecarbonyl-Arg-Phe-NH2 |
Rezatomidine | 847829-38-3 | C13H16N2S | 232.35 | AGN 203818;(S)-4-(1-(2,3-dimethylphenyl)ethyl)-1,3-dihydro-2H-imidazole-2-thione |
Reynoutrin | 549-32-6 | C20H18O11 | 434.35 | Quercetin 3-beta-D-xylopyranoside; |
Reynosin | 28254-53-7 | C15H20O3 | 248.3 | Reysin |
Revexepride | 219984-49-3 | C21H32ClN3O4 | 425.95 | 4-amino-5-chloro-N-[[(3S,4S)-3-hydroxy-1-(3-methoxypropyl)piperidin-4-yl]methyl]-2,2-dimethyl-3H-1-benzofuran-7-carboxamide; revexepride; SSP-002358 |
Reversine | 656820-32-5 | C21H27N7O | 393.49 | |
Reversin 121 | 174630-04-7 | C34H47N3O9 | 641.8 | |
Reversan | 313397-13-6 | C26H27N5O2 | 441.52 | N-[3-(4-Morpholinyl)propyl]-5,7-diphenylpyrazolo[1,5-a]pyrimidine-3-carboxamide |
Reveromycin D | 144860-70-8 | C37H54O11 | 674.8 | |
Reveromycin C | 144860-69-5 | C37H54O11 | 674.8 | |
Reveromycin B | 144860-68-4 | C36H52O11 | 660.8 | |
Reveromycin A | 134615-37-5 | C36H52O11 | 660.8 | |
Revefenacin | 864750-70-9 | C35H43N5O4 | 597.76 | TD-4208; TD4208; TD 4208; GSK1160724; GSK-1160724; GSK 1160724 |
Revaprazan HCl | 178307-42-1 | C22H23N4F·HCl | 398.9041632 | 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine Hydrochloride; 5,6-Dimethyl-2-(4-fluorophenylamino)-4-(1-methyl- 1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine hydrochloride; Revaprazan Hydrochloride; SB 641257 |
REV 5901 | 101910-24-1 | C22H25NO2 | 335.4 | REV-5901; REV5901; 1-[3-(quinolin-2-ylmethoxy)phenyl]hexan-1-ol |
Retusin | 1245-15-4 | C19H18O7 | 358.34 | 2-(3,4-dimethoxyphenyl)-5-hydroxy-3,7-dimethoxychromen-4-one |
Retrorsine | 480-54-6 | C18H25NO6 | 351.39 | beta-Longilobine |
Retronecine | 480-85-3 | (1R,7aR)-7-Hydroxy- methyl-2,3,5,7a-tetra- hydro-1H-pyrrolizin-1-ol | ||
Retrobradykinin | 5991-13-9 | C50H73N15O11 | 1060.22 | RFPSFGPPR |
Retro-2 | 1429192-00-6 | C19H16N2OS | 320.4 | RN 1-001; 2,3-Dihydro-2-(5-methyl-2-thienyl)-3-phenyl-4(1H)-quinazolinone |
Retreversine | 1028332-91-3 | C21H27N7O | 393.5 | N2-Cyclohexyl-N6-[4-(4-morpholinyl)phenyl]-1H-purine-2,6-diamine |
RETRA hydrochloride | 1173023-52-3 | C11N11NO3S2.HCl | 305.8 | 2-[(4,5-Dihydro-2-thiazolyl)thio]-1-(3,4-dihydroxyphenyl)ethanone hydrochloride |
Retosiban | 820957-38-8 | C27H34N4O5 | 494.59 | GSK221149; (3R,6R)-6-((2S)-Butan-2-yl)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl- 1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl)piperazine-2,5-dione |
Resorufin pentyl ether | 87687-03-4 | C17H17NO3 | 283.32 | 7-(Pentyloxy)-3H-phenoxazin-3-one; 7-Pentoxyresorufin; 7-Pentoxyphenoxazone |
Resorufin methyl ether | 5725-89-3 | C13H9NO3 | 227.22 | MR |
Resorufin b-D-glucuronide sodium salt | 125440-91-7 | C18H14NNaO9 | 411.29 | 3H-Phenoxazine, b-D-glucopyranosiduronic acid |
Resorufin b-D-glucopyranoside | 101490-85-1 | C18H17NO8 | 375.33 | |
Resorufin b-D-cellobioside | 1000404-48-7 | C24H27NO13 | 537.47 | Resorufin cellobioside |
Rebaudioside G | 127345-21-5 | C38H60O18 | 804.87 | |
Resorufin a-D-mannopyranoside | 125440-92-8 | C18H17NO8 | 375.33 | |
Resorufin a-D-galactopyranoside | 1175532-13-4 | C18H17NO8 | 375.33 | |
Resorufin acetate | 1152-14-3 | C14H9NO4 | 255.2 | O-acetyl Resorufin; 7-(acetyloxy)-3H-phenoxazin-3-one |
Resorufin | 635-78-9 | C12H7NO3 | 213.19 | 7-Hydroxy-3H-phenoxazin-3-one, NSC 12097 |
Resorcinolnaphthalein | 41307-63-5 | C24H14O5 | 382.4 | NSC 354317 |
RESORCIN BLUE, PURE | 71939-12-3 | C24 H15 N O7 | 429.39 | RESORCIN BLUE, PURE; Resorcin blueC.I. 51400Lacmoid |
Resorantel | 20788-07-2 | C13H10BrNO3 | 308.13 | N-(4-bromophenyl)-2,6-dihydroxybenzamide |
Resminostat hydrochloride | 1187075-34-8 | C16H20ClN3O4S | 385.87 | RAS2410 hydrochloride; 4SC-201 hydrochloride; RAS 2410 hydrochloride; RAS-2410 hydrochloride |
Resminostat | 864814-88-0 | C16H19N3O4S | 349.405 | 4SC-201; RAS2410 |
reslizumab | 241473-69-8 | Cinqair | ||
Resistomycin | 20004-62-0 | C22H16O6 | 376.4 | Croceomycin, Geliomycin, Heliomycin, Itamycin, 11-98, A 3733A, X 340 |
Resistoflavine | 29706-96-5 | C22H16O7 | 392.4 | A 3733Y, resistoflavin |
Refametinib R enantiomer | 923032-38-6 | C19H20F3IN2O5S | 572.34 | BAY 869766 R enantiomer; RDEA119 R enantiomer |
Resiniferatoxin | 57444-62-9 | C37H40O9 | 628.70 | TRX; Reciniferatoxin |
Resiquimod | 144875-48-9 | C17H22N4O2 | 314.38 | R-848; R 848; R848; S 28463; S-28463; S28463; VML-600; VML600; VML 600; Resiquimod; 1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-C]quinolin-1-yl]-2-methylpropan-2-ol; Chebi:36706; 4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-et |
Resins, polyurethane | 9048-90-2 | |||
Resins, hydrocarbon (aliphatic) | 152698-66-3 | |||
Resins, alkyd | 63148-69-6 | 0 | ALKYD RESIN; Glycerophthalic resins; Including alkyd molding compounds; Phthalic alkyd resins; TERLON; Resins, alkyd | |
Resins, acrylic | 26300-51-6 | |||
Resin acids and Rosin acids, esters with triethylene glycol | 8050-25-7 | |||
RESIDUES (PETROLEUM), CATALYTIC REFORMER FRACTIONATOR | 64741-67-9 | |||
Remodelin hydrobromide | 1622921-15-6 | C15H15BrN4S | 363.28 | |
Remodelin | 949912-58-7 | C15H14N4S | 282.36 | |
Remimazolam benzenesulfonat | 1001415-66-2 | C27H25BrN4O5S | 597.48 | CN-7056; benzenesulfonate; methyl (S)-3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate benzenesulfonate |
Remifentanil Impurity 4 | 72996-78-2 | C16H22N2O3 | 290.37 | 4-[(1-Oxopropyl)phenylamino]-4-piperidinecarboxylic Acid Methyl Ester |
Remifentanil Impurity 1 ( RTF-02) | 938184-94-2 | C16H21N3O2 | 287.36 | |
Remeglurant | 1309783-00-3 | C17H15BrN4O | 371.24 | UNII-Y7H8880HMD;(R)-(6-bromopyrazolo[1,5-a]pyrimidin-2-yl)(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)methanone |
Remdesivir | 1809249-37-3 | C27H35N6O8P | 602.59 | GS-5734; 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate |
remazol brilliant violet 5R | 12226-38-9 | C20H16N3Na3O15S4 | 735.56 | REMAZOL BRILLIANT VIOLET 5R; REACTIVE VIOLET 5; CI 18097; C.I.ReactiveViloet5(18097); C.I.Reactiveviolet5; DiamiraBrilliantViolet5R |
Remacemide hydrochloride | 111686-79-4 | C17H20N2O.HCl | 304.82 | 2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide hydrochloride; PR-934423; PR934423 PR 934423; PR 934-423A; FPL 12924AA; Remacemide hydrochloride |
Relugolix | 737789-87-6 | C29H27F2N7O5S | 623.636 | TAK-385; TAK385; TAK 385 |
rel-trans-Methoprene Epoxide | 65277-96-5 | C19H34O4 | 326.47 | (2E)-rel-3-[(2R,3R)-3-(6-Methoxy-2,6-dimethylheptyl)-2-oxiranyl]-2-butenoic Acid 1-Methylethyl Ester; (2E)-rel-3-[(2R,3R)-3-(6-Methoxy-2,6-dimethylheptyl)oxiranyl]-2-butenoic Acid 1-Methylethyl Ester |
Relebactam | 1174018-99-5 | C12H20N4O6S | 348.38 | Relebactam; UNII-1OQF7TT3PF; 1OQF7TT3PF; CHEMBL3112741; MK-7655 |
Relamorelin | 661472-41-9 | C43H50N8O5S | 790.98 | BIM28131;BIM-28131;BIM-28163;BIM28163;RM131;RM-131;N-((R)-3-(benzo[b]thiophen-3-yl)-1-(((R)-1-(((S)-1-((4-carbamoylpiperidin-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)piperidine-3-carboxamide;4 |
Relacatib | 362505-84-8 | C27H32N4O6S | 540.635 | SB-462795; GSK-462795; D06634 |
rel-(8R,8'R)-dimethyl-(7S,7'R)-bis(3,4-methylenedioxyphenyl)tetrahydro-furan | 178740-32-4 | C20H20O5 | 340.4 | 5-[5-(1,3-benzodioxol-5-yl)-3,4-dimethyloxolan-2-yl]-1,3-benzodioxole |
Rehmapicroside | 104056-82-8 | C16H26O8 | ||
Rehmapicrogenin | 135447-39-1 | C10H16O3 | 184.23 | 3-hydroxy-2,6,6-trimethylcyclohexene-1-carboxylic acid |
Rehmaglutin D | 103744-84-9 | C9H13ClO4 | ||
Regrelor | 787548-03-2 | C22H25N6O8P | 532.45 | UNII-Q6C8TY6SW1; CHEMBL1162175; 787548-03-2; Regrelor [INN]; INS50589;[(2S,3aR,4R,6R,6aR)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl dihydrogen phosphate |
Regorafenib-13C-d3 | 2126178-55-8 | C2013CH12D3ClF4N4O3 | 486.83 | |
Regorafenib N-Oxide (M2 Metabolite) | 835621-11-9 | C21H15ClF4N4O4 | 498.82 | 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide |
Regorafenib monohydrate | 1019206-88-2 | C21H17ClF4N4O4 | 500.83 | BAY 73-4506 |
Regorafenib Impurity 6 | 1187945-05-6 | C20H12ClF4N3O4 | 469.78 | |
Regorafenib Hydrochloride | 835621-07-3 | C21H16Cl2F4N4O3 | 519.28 | BAY73-4506 hydrochloride |
Regorafenib D3 | 1255386-16-3 | C21H12ClD3F4N4O3 | 485.81 | |
Regorafenib | 755037-03-7 | C21H15ClF4N4O3 | 482.83 | Regorafenibum; Stivarga; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; BAY 73-4506; BAY 734506; BAY734506; BAY-734506 |
Reglan | 5581-45-3 | C14H26Cl3N3O3 | 390.73354;g/mol | 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide; hydrate; dihydrochloride; 5581-45-3; Metoclopramidedihydrochloridemonohydrate; Reglan(TN) |
Regiolone | 137494-04-3 | C10H10O3 | 178.18 | (-)-Isosclerone |
Regelidine | 114542-54-0 | C35H37NO8 | 599.7 | |
Regaloside E | 120601-66-3 | C18H24O10 | 400.38 | |
Regaloside C | 117591-85-2 | C18H24O11 | 416.4 | |
Regaloside B | 114420-67-6 | C20H26O11 | 442.4 | |
Regadenoson | 313348-27-5 | C15H18N8O5 | 390.35 | 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide CVT 3146 CVT-3146 CVT3146 Lexiscan regadenoson |
Refosporin | 63521-15-3 | C18H14Cl2N5NaO5S3 | 570.42500 | |
Refametinib | 923032-37-5 | C19H20F3IN2O5S | 572.338 | RDEA-119, BAY 86-9766, BAY 869766 |
Redued Var Blue 1 | 894-86-0 | C16H10N2Na2O2 | 308.24234 | Vat Blue 1, Reduced; disodium [2,2'-bi-1H-indole]-3,3'-diolate; Reduced Vat Blue 1; [2,2'-bi-1H-Indole]-3,3'-diol, disodium salt; 3,3'-Bis(sodiooxy)-2,2'-bi(1H-indole); 3,3'-Bis(sodiooxy)-2,2'-bi[1H-indole]; C.I.Reduced Vat Blue 1; disodium 2-(3-oxidanid |
Rediocide C | 677277-98-4 | C46H54O13 | 814.92 | |
Rebaudioside F | 438045-89-7 | C43H68O22 | 936.99 | (4a)-13-[(O-b-D-Glucopyranosyl-(1,3)-O-[b-D-glucopyranosyl-(1,2)]-b-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid b-D-glucopyranosyl ester; Reb F |
Rebaudioside E | 63279-14-1 | C44H70O23 | 967.01 | 13-[(O-b-D-Glucoopyranosyl-(1,2)-O-[b-D-glucopyranosyl)-oxy]-kaur-16-en-18-oic acid (4)-O-b-D-glucopyranosyl-deoxy-(1,2)-O-[b-D-glucopyranosyl ester; Reb E |
Rebaudioside D | 63279-13-0 | C50H80O28 | 1129.15 | (4a)-13-[(O-b-D-Glucopyranosyl-(1,2)-O-[b-D-glucopyranosyl-(1,3)]-b-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid 2-O-b-D-glucopyranosyl-b-D-glucopyranosyl ester; Reb D |
Rebaudioside C | 63550-99-2 | C44H70O22 | 951.01 | (4a)-13-[(O-6-Deoxy-a-L-mannopyranosyl-(1,2)-O-[b-D-glucopyranosyl-(1,3)]-b-D-glucopyranosyl)-oxy]-kaur-16-en-18-oic acid b-D-glucopyranosyl ester; Dulcoside B; Reb C |
Rebaudioside B | 58543-17-2 | C38H60O18 | 804.87 | 13-O-[b-D-Glucopyranosyl-(1,2)-b-D-glucopyranosyl-(1,3)-b-D-glucopyranoside]-16-kauren-19-oic acid; Stevioside A4; Reb B |
Rebaudioside A | 58543-16-1 | C44H70O23 | 967.01 | (4a)-13-[(2-O-b-D-Glucopyranosyl-3-O-b-D-glucopyranosyl-b-D-glucopyranosyl)-oxy]kaur-6-en-8-oic acid b-D-glucopyranosyl ester |
Rebastinib | 1020172-07-9 | C30H28FN7O3 | 553.598 | DCC-2036; 4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide |
Rebamipide impurity 2 | 94670-39-0 | C8H6ClNO2 | 183.59 | |
Rebamipide impurity 1 | 100342-53-8 | C18H15ClN2O2 | 326.79 | |
Rebamipide 3-Chloro Impurity | 90098-05-8 | C19H15ClN2O4 | 370.8 | |
Rebamipide 2-Chloro Impurity | 90098-06-9 | C19H15ClN2O4 | 370.8 | |
Rebamipide | 90098-04-7 | C19H15ClN2O4 | 370.79 | OPC-12759 |
ReAsH-EDT2 | 438226-89-2 | C16H13As2NO3S4 | 545.4 | Lumio Red; 4,6-bis(1,3,2-dithiarsolan-2-yl)-7-hydroxy-3H-phenoxazin-3-one |
Reactive Yellow 86 | 61951-86-8 | C18H14Cl2N8Na2O9S2 | 667.374 | REACTIVE YELLOW 86; C.I.Reactiveyellow86; procionyellow; ReactivebrilliantyellowX-7G; ReactiveflavineX-7G; Reactive Yellow M8G; practicalgrade |
Reactive Yellow 3 | 6539-67-9 | C21H17ClN8O7S2 | 592.999 | 3-[[2-(acetylamino)-4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]azo]naphthalene-1,5-disulphonic acid; C.I. Reactive yellow 3; C.I.Reactive Yellow 3(13254); Cibacron Yellow FR-A; Intracron Yellow FR-A; triazin-2-yl)amino]phenyl]azo]-; Reactive yel |
Reactive Yellow 15 | 12226-47-0 | 0 | REACTIVE YELLOW 15,CINO.YELLOW 15; C.I. Reactive Yellow 15; Diamira Yellow GR; Primazin Yellow GRL; Remazol Yellow GR; Benzactiv Yellow V-GR 133; Cavalite Yellow GR; Intracron Yellow VS-GR | |
QS-4 | 58186-01-9 | C13H16O6 | 268.27 | 6-(3-carboxypropyl)-2,3-diMethoxy-5-Methyl-1,4-benzoquinone |
Ramipril-d5 | 1132661-86-9 | C23H27D5N2O5 | 421.55 | (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-(phenyl-d5)propyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic Acid; Altace-d5; Cardace-d5; Delix-d5; HOE-498-d5; Pramace-d5; Ramace-d5; Unipril-d5; |
Ranolazine-D8 | 1092804-88-0 | C24H25D8N3O4 | 435.59 | N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide |
RB-90740 | 108307-65-9 | C20H22N6O | 362.437 | RB90740; RB 90740; RB-90740 |
RD 162 | 915087-27-3 | C22H16F4N4O2S | 476.45 | 4-[7-[4-cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide |
Ramipril Impurity 3 ((S,R,R)-2-Azabicyclo[3.3.0]octane-3-Carboxylic Acid Benzyl Ester) | 1279200-40-6 | C15H19NO2 | 245.32 | |
Ramipril Impurity 1 ((R,S,S)-2-Azabicyclo[3.3.0]octane-3-Carboxylic Acid Benzyl Ester) | 94498-85-8 | C15H19NO2 | 245.32 | |
Pyrocurzerenone | 20013-75-6 | C15H16O | 212.292 | 6,7-Dihydro-1,5,8-trimethylnaphtho[2,1-b]furan |
Pyrocoll | 484-73-1 | C10H6N2O2 | 186.17 | |
Pyrocincholic acid methyl ester | 107160-24-7 | C30H48O3 | ||
Pyrocatechol-4-ammoniumsul fonate | 61070-09-5 | C6H6NO5S | 0 | |
Pyrocatechol monoglucoside | 2400-71-7 | C12H16O7 | 272.25 | Pyrocatechol-O-beta-D-glucopyranoside;(2R,3S,4S,5R)-2-(HydroxyMethyl)-6-(2-hydroxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol |
Phortress | 328087-38-3 | C20H23FN4OS.2HCl | 459.41 | (2S)-2,6-Diamino-N-[4-(5-fluoro-2-benzothiazolyl)-2-methylphenyl]hexanamide dihydrochloride; Phortress; NSC-710305; NSC-710305; NSC-710305; 5F-DF-203-L-lysinamide; 5FDF 203Llysinamide |
Phenylephrine Bitartrate | 17162-39-9 | 317.29 | Phenylephrine Bitartrate | |
Prostaglandin B2 | 13367-85-6 | C20H30O4 | 334.5 | PGB2; (Z)-7-[2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoic acid |
Prostaglandin A3 | 36614-31-0 | C20H28O4 | 332.4 | PGA3; (Z)-7-[(1R)-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid |
Prostaglandin A2 methyl ester | 31753-19-2 | C21H32O4 | 348.5 | Medullin methyl ester; PGA2 methyl ester; 15S-Hydroxy-9-oxo-methyl ester-prosta-5Z,10,13E-trien-1-oic acid; Methyl (Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoate |
Prostaglandin A2 | 13345-50-1 | C20H30O4 | 334.46 | (5Z,13E,15S)-15-Hydroxy-9-oxoprosta-5,10,13-trien-1-oic Acid; 7-[2-(3-Hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl]-5-heptenoic Acid; (+)-Prostaglandin A2; (15S)-PGA2; 15(S)-Hydroxy-9-oxo-5-cis- 10,13-trans-prostatrienoic Acid; 15(S)-Hydroxy-9-oxo-5-cis-10 |
Prostaglandin A1 methyl ester | 26771-94-8 | C21H34O4 | 350.5 | PGA1 methyl ester; Methyl 7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate |
Pirprofen | 31793-07-4 | C13H14ClNO2 | 251.712 | |
Piroximone | 84490-12-0 | C11H11N3O2 | 217.22400 | |
Phenylethyl b-D-thiogalactopyranoside | 800376-82-3 | C14H20O5S | 300.37 | PETG; 2-Phenylethyl b-D-thiogalactoside |
Piroxicam impurity L | 118854-48-1 | C13H15NO5S | 297.33 | Isopropyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide; 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic Acid 1-Methylethyl Ester 1,1-Dioxide; 1-Methylethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide; NSC 64 |
Piroxicam Impurity J | 35511-15-0 | C11H11NO5S | 269.27 | Methyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide; 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic Acid Methyl Ester 1,1-Dioxide; Piroxicam Impurity J |
Piroxicam Impurity I | 76508-35-5 | C12H13NO5S | 283.31 | 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylic Acid 1-Methylethyl Ester 1,1-Dioxide; 1-Methylethyl 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide; NSC 642708 |
Piroxicam Impurity G | 35511-14-9 | C10H9NO5S | 255.25 | 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylic Acid Methyl Ester 1,1-Dioxide; Methyl 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide |
Piroxicam impurity F | 76508-37-7 | C12H13NO5S | 283.31 | 3-Oxo-1,2-benzisothiazole-2(3H)-acetic Acid 1-Methylethyl Ester 1,1-Dioxide; 1-Methylethyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate; Isopropyl 3-Oxo-1,2-benzisothiazole-2(3H)acetate 1,1-Dioxide |
Piroxicam Impurity D | 6639-62-9 | C10H9NO5S | 255.25 | 3-Oxo-1,2-benzoisothiazoline-2-acetic Acid Methyl Ester 1,1-Dioxide; Saccharin N-(2-Acetic Acid Methyl Ester); NSC 49216 |
Piroxicam Impurity C | 24683-25-8 | C10H10N2O4S | 254.27 | 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide |
Piroxicam Impurity B | 65897-46-3 | C14H11N3O4S | 317.33 | 4-Hydroxy-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide |
Pigment Yellow 13 | 5102-83-0 | C36H34Cl2N6O4 | 685.60 | YELLOW 13; 2,2'-[(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-3-oxo-butanamide; Pigment Yellow 12 (21090); 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-3-oxobutyramide]; 2,2'-[(3,3'-dichl |
Pigment Yellow 12 | 6358-85-6 | C32H26Cl2N6O4 | 629.50 | |
R-Carisbamate (RWJ-452399) | 194085-74-0 | C9H10ClNO3 | 215.64 | (1R)-1-(2-Chlorophenyl)-1,2-ethanediol 2-Carbamate; |
RC-3095 | 138147-78-1 | C58H80F3N15O11 | 1106.32 | RC3095 |
R-Butyryl Carnitine | 25576-40-3 | C11H21NO4 | 231.29 | |
Rbin-2 | 2032282-97-4 | C13H11BrN4S | 335.22 | 7-Bromo-2-(2-methyl-allylsulfanyl)-9H-1,3,4,9-tetraaza-fluorene |
Rbin-1 | 328023-11-6 | C13H12N4S | 256.33 | Ribozinoindole-1; 3-[(2-methylprop-2-en-1-yl)sulfanyl]-5H-[1,2,4]triazino[5,6-b]indole; 3-[(2-methyl-2-propenyl)sulfanyl]-5H-[1,2,4]triazino[5,6-b]indole |
RB394 | 1830320-32-5 | C21H22F3NO4 | 409.4 | RB-394; RB 394; 2-[[4-[[4-Methoxy-2-(trifluoromethyl)phenyl]methylcarbamoyl]phenyl]methyl]butanoic acid |
Razupenem | 426253-04-5 | C18H21N3O4S2 | 407.51 | PTZ601; (4R,5S,6S)-3-[[4-[(5S)-2,5-Dihydro-5-methyl-1H-pyrrol-3-yl]-2-thiazolyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
Razoxane | 21416-67-1 | C11H16N4O4 | 268.271 | Razoxane; Razoxin; 21416-67-1; 4,4'-Propylenebis(piperazine-2,6-dione); ICRF-159; Razoxana |
Razinodil | 30271-85-3 | C27H34N4O10 | 0 | Razinodil; 3,4,5-Trimethoxybenzoic acid 1-(morpholin-4-ylmethyl)-2-[6,7,8-trimethoxy-4-oxo-1,2,3-benzotriazin-3(4H)-yl]ethyl ester |
Raxatrigine | 934240-30-9 | C18H19FN2O2 | 314.35 | (2S,5R)-5-(4-((2-fluorobenzyl)oxy)phenyl)pyrrolidine-2-carboxamide; GSK1014802; GSK 1014802; GSK-1014802; CNV1014802; CNV-1014802; CNV 1014802; Raxatrigine |
Ravuconazole | 182760-06-1 | C22H17F2N5OS | 437.47 | 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile; BMS 207147; ER 30346 |
Ravidasvir HCl | 1303533-81-4 | C42H52Cl2N8O6 | 835.83 | PPI-668; PPI 668; PPI668; ASC16; ASC-16; ASC 16; BI238630; C5; Ravidasvir dihydrochloride;methyl N-[(2S)-1-{(2S)-2-[5-(6-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}naphthalen-2-yl)-1H-benzimidazol-2-yl]p |
Ravenine | 20105-22-0 | C15H17NO2 | 243.3 | 1-Methyl-4-[(3-methyl-2-buten-1-yl)oxy]-2(1H)-quinolinone |
Rauwolscine hydrochloride | 6211-32-1 | C21H27ClN2O3 | 390.9 | methyl (1S,15S,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride; alpha-Yohimbine hydrochloride; Fauwolscine, hydrochloride; alpha-Yohimbin hydrochloride; NSC 407307; Rauwolscine (hydrochloride); Me |
Rauvoyunine C | 1211543-01-9 | C32H36N2O9 | 592.7 | 11-Methoxyburnamine 17-O-3',4',5'-trimethoxybenzoate |
Rauvoyunine B | 1414883-82-1 | C23H26N2O6 | 426.5 | Rauvoyunine B |
Rauvoyunine A | 1414883-81-0 | C21H28N2O3 | 356.466 | |
Rauvovertine C | 2055073-74-8 | C20H23N3O | 321.424 | |
Rauvovertine B | 2055073-72-6 | C19H22N2O3 | 326.396 | 17-epi-Rauvovertine B; 10-Hydroxyperaksine |
Rauvovertine A | 2055073-75-9 | C19H22N2O3 | 326.396 | 17-epi-Rauvovertine A |
Rauvotetraphylline E | 1422506-53-3 | C20H18N2O3 | 334.4 | (4S,4aS,14aS)-1-carboxy-4-methyl-4a,5,14,14a-tetrahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizin-6-ium-13-ide |
Rauvotetraphylline D | 1422506-52-2 | C24H26N2O3 | 390.483 | |
Rauvotetraphylline C | 1422506-51-1 | C28H34N2O7 | 510.587 | |
Rauvotetraphylline B | 1422506-50-0 | C31H37N3O6 | 547.65 | |
Rauvotetraphylline A | 1422506-49-7 | C20H26N2O3 | 342.4 | (betaE,6S,8R,9S,10S)-beta-Ethylidene-6,7,8,9,10,11-hexahydro-2-hydroxy-9-(hydroxymethyl)-12-methyl-6,10-imino-5H-cyclooct[b]indole-8-ethano |
Raucaffricine | 31282-07-2 | C27H32N2O8 | 512.56 | (17R,19E,21alpha)-17-acetoxy-1,2,19,20-tetradehydro-1-demethylajmalan-21-yl beta-D-glucopyranoside |
Raubasine | 483-04-5 | C21H24N2O3 | 352.44 | Ajmalicine; methyl 19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate; methyl (19alpha)-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate |
Ratester | 854485-83-9 | C18H16ClNO8 | 409.77 | CHEMBL578372, SCHEMBL10186763 |
Raspberry ketone glucoside | 38963-94-9 | C16H22O7 | 326.34 | (4-Hydroxyphenyl)-2-butanone beta-D-glucoside; 4-[4-(b-D-Glucopyranosyloxy)phenyl]-2-butanone |
Raseglurant | 757950-09-7 | C15H13FN2 | 240.28 | ADX10059;2-[(3-Fluorophenyl)ethynyl]-4,6-dimethyl-3-pyridinamine |
Rasagiline-13C3 Mesylate | 1391052-18-8 | C9[13C]3H13N· CH4O3S | 270.32 | (1R)-2,3-Dihydro-N-2-propyn-1-yl-1H-inden-1-amine-13C3 Mesylate; (R)-2,3-Dihydro-N-2-Propynyl-1-indenamine-13C3 Mesylate; Agilect-13C3 ; Azilect-13C3 Mesylate; TVP-1012-13C3 Mesyalte |
Rasagiline Mesylate | 161735-79-1 | C12H13N.CH4O3S | 267.34 | TVP-1012; TVP 1012; TVP1012 |
Rasagiline 13C3 mesylate (racemic) | 1216757-55-9 | C12H13N.CH4O3S | 270.32 | Rac Rasagiline-13C3 Mesylate; Rasagiline 13C3 (mesylate racemic); Agilect-13C3; 1216757-55-9; Azilect-13C3 Mesylate; TVP-1012-13C3 Mesyalte |
Rasagiline | 136236-51-6 | C12H13N | 171.24 | Azilect, HSDB 7699, HSDB7699; HSDB-7699; Rasagiline, TV 1030, TV-1030; TV1030; (R)-2,3-DIHYDRO-N-2-PROPYNYL-1H-INDEN-1-AMINE;Rasagiline -13C3;Rasagiline;(R)-N-2-Propynyl-1-indanamine;1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R);1-Indanamine, N-2-prop |
Ras Inhibitory Peptide | 159088-48-9 | C53H91N19O11 | 1170.4 | |
RARECHEM AN KC 0156 | 90000-40-1 | C7H12N2 | 124.18 | RARECHEM AN KC 0156; 1-METHYL-2-(1H-PYRROL-2-YL)-ETHYLAMINE; 1H-Pyrrole-2-ethanamine, .alpha.-methyl- |
Raphin 1 | 2022961-17-5 | C8H8Cl2N4 | 231.08 | (2E)-2-[(2,3-Dichlorophenyl)methylene]hydrazinecarboximidamide |
Rapastinel | 117928-94-6 | C18H31N5O6 | 413.47 | Rapastinel; GLYX-13; GLYX 13; UNII-6A1X56B95E; GLYX-13 trifluoroacetate; TPPT-amide trifluoroacetate |
Rapanone | 573-40-0 | C19H30O4 | 322.44 | Ropanone,2,5-Dihydroxy-3-tridecyl-2,5-cyclohexadiene-1,4-dione |
Rapamycin-d3 (Sirolimus-d3) | 392711-19-2 | C51H76NO13D3 | 917.22 | (-)-Rapamycin-d3; AY 22989-d3; Antibiotic AY 22989-d3; Cypher-d3; NSC 226080-d3; RAPA-d3; RPM-d3; Rapammune-d3; Rapamune-d3; SIIA 9268A-d3; Sirolimus-d3; Wy 090217-d3 |
Rapamycin Impurity 3 | 157054-84-7 | C52H81NO13 | 928.22 | |
Rapamycin (Sirolimus) | 53123-88-9 | C51H79NO13 | 914.19 | (-)-Rapamycin; AY 22989; AY-22989; I-2190A; NSC 226080; RAPA; RAP; RPM; SLM; WY-090217 |
Ranolazine-d5 | 1092804-87-9 | C24H28N3O4D5 | 432.58 | |
Ranolazine Impurity C | 162712-35-8 | C14H22N2O3 | 266.34 | CVT-2513; CVT 2513; CVT2513; RS-88681; RS88681; RS 88681.1-Piperazineethanol, alpha-((2-methoxyphenoxy)methyl)- |
Ranolazine dihydrochloride | 95635-56-6 | C24H35Cl2N3O4 | 500.46 | |
Ranolazine Bis (N-Oxide) | 1246816-00-1 | C24H33N3O6 | 459.55 | N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide 1,4-Dioxide; |
Ranolazine | 95635-55-5 | C24H33N3O4 | 427.54 | CVT 303, RS 43285-003; CVT303, RS43285-003; CVT-303, RS-43285-003 |
Rankinidine | 106466-66-4 | C20H24N2O3 | 340.42 | Humantenine, 4-demethyl-; (7Z)-7-Ethylidene-1'-methoxyspiro[11-oxa-5-azatricyclo[6.3.1.04,9]dodecane-2,3'-indole]-2'-one |
Ranitidine-S-Oxide | 73851-70-4 | C13H22N4O4S | 330.41 | N-[2-[[[5-[(Dimethyamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine; USP Ranitidine Related Compound C; Ranitidine EP Impurity C |
Ranitidine N-Oxide | 73857-20-2 | C13H22N4O4S | 330.41 | N-[2-[[[5-[(Dimethyloxidoamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine; Ranitidine EP Impurity E; |
Ranitidine Impurity J | 1331637-48-9 | C11H22N6O4S2 | 366.46 | 1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1-diamine |
Ranitidine Impurity I | 207592-21-0 | C27H44N8O6S2 | 640.83 | N1,N5-Bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N1',N5'-dimethyl-2,4-dinitro-1,4-pentadiene-1,1,5,5-tetramine; Ranitidine Impurity I; Ranitidine Formaldehyde Adduct; Ranitidine EP Impurity I; |
Ranitidine Impurity H (N-Methylnitroacetamidel) | 72078-82-1 | C3H6N2O3 | 118.09 | N-Methyl-2-nitroacetamide; Ranitidine EP Impurity H; |
Ranitidine Impurity F HCl | 81074-81-9 | C8H13NO2 HCl | 191.66 | 5-[(Dimethylamino)methyl]-2-furanmethanol Hydrochloride; Ranitidine EP Impurity F; |
Ranitidine Hydrochloride | 71130-06-8 | C13H23ClN4O3S | 350.869 | |
Ranitidine hydrochloride | 66357-45-5 | C13H23ClN4O3S | 350.86 | Ranitidine HCl; Coleonol |
Ranitidine HCl | 66357-59-3 | C13H23ClN4O3S | 350.86 | Coleonol |
Ranitidine EP Impurity G | 112233-23-5 | 195.67 | 5,6-Dihydro-3-(methylamino)-2H-1,4-thiazin-2-one Oxime Monohydrochloride; Ranitidine Oxime Hydrochloride; Ranitidine EP Impurity G;5,6-Dihydro-3-(methylamino)-2H-1,4-thiazin-2-one Oxime Hydrochloride | |
Ranitidine d6 HCl | 1185238-09-8 | C13H16D6N4O3S.ClH | 356.86 | N-[2-[[[-5-[(Dimethylamino-d6)methyl)]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine Hydrochloride; AH 19065-d6; Azantac-d6; Melfax-d6; Raniben-d6; Ranidil-d6; Raniplex-d6; Zantac-d6; Zintac-d6; |
Ranitidine | 66357-35-5 | C13H22N4O3S | 314.40 | Raticina; Gastrosedol; (E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine |
Ranimustine | 58994-96-0 | C10H18ClN3O7 | 327.718 | Ranomustine. Cymer; Cymerin. MCNU |
Raniestat | 147254-64-6 | C17H11BrFN3O4 | 420.19 | (3R)-2'-[(4-bromo-2-fluorophenyl)methyl]spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5-tetrone Ranirestat AS-3201 CHEMBL334830 147254-64-6 SX-3202 Raniestat SX 3030 SX-3030 Ranirestat (JAN/INN) AC1L4BEU UNII-Z26P56GFTV Z26P56GFTV SC |
ranibizumab | 347396-82-1 | C2158H3282N562O681S12 | 48350 | Lucentis |
Randaiol | 87562-14-9 | C15H14O3 | 242.3 | 5-(2-Propenyl)-1,1'-biphenyl-2,2',5'-triol |
Ranaconitine | 1360-76-5 | C32H44N2O9 | 600.7 | |
Ramucirumab | 947687-13-0 | C6374H9864N1692O1996S46 | 143609.68 | Cyramza; Imc 1121b |
Ramosetron-d3 Hydrochloride | 1330266-04-0 | C17H15D3ClN3O | 318.82 | [1-(Methyl-d3)-1H-indol-3-yl][(6R)-4,5,6,7-tetrahydro-1H-benzimidazol-6-yl]methanone Hydrochloride; (-)-(R)-5-[(1-(Methyl-d3)-1H-indol-3-yl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole Monohydrochloride; (R)-(-)-Ramosetron-d3 Hydrochloride; Irribow-d3; |
Ramosetron Impurity 9 | 171967-71-8 | C17H13N3O2 | 291.31 | |
Ramosetron Impurity 4 | 171967-74-1 | C17H19N3O4 | 329.36 | |
Ramosetron Impurity 12 | 132036-42-1 | C12H17N3O | 219.29 | |
Ramiprilat | 87269-97-4 | C21H28N2O5 | 388.47 | (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic Acid; HOE 498 Diacid; Ramipril Diacid; Ramipril EP Impurity E; |
Ramiprilat-d5 | 1356837-92-7 | C21H23D5N2O5 | 393.49 | (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-Carboxy-3-(phenyl-d5)propyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic Acid; HOE 498 Diacid-d5; Ramipril Diacid-d5; |
Ramipril | 87333-19-5 | C23H32N2O5 | 416.51 | (2s-(1(r*(r*)),2-alpha,3a-beta,6a-beta))-henylpropyl)amino)-1-oxopropyl;cyclopenta(b)pyrrole-2-carboxylicacid,octahydro-1-(2-((1-(ethoxycarbonyl)-3-p;Tritace;Altace;Carasel;Ramace;(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propa |
Ramifenazone-d7 | 1330180-51-2 | 1,2-Dihydro-1,5-dimethyl-4-[(1-methylethyl-d7)amino]-2-phenyl-3H-pyrazol-3-one; | ||
Ramifenazone Hydrochloride | 18342-39-7 | C14H19N3O . HCl | 281.79 | 1,2-Dihydro-1,5-dimethyl-4-[(1-methylethyl)amino]-2-phenyl-3H-pyrazol-3-one Hydrochloride; 4-(Isopropylamino)antipyrine Hydrochloride; 1-Phenyl-2,3-dimethyl- 4-isopropylaminopyrazolone Hydrochloride; 4-(Isopropylamino)phenazone Hydrochloride; 4-Isopropyla |
Ramifenazone | 3615-24-5 | C14H19N3O | 245.32 | 1,5-dimethyl-2-phenyl-4-(propan-2-ylamino)pyrazol-3-one; 4-isopropylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one; 4-isopropylaminoantipyrine; isopropylaminophenazone; |
Ramelteon metabolite M-II (mixture of isomers) | 896736-21-3 | 275.34 | 2-Hydroxy-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-cyclopenta[e]benzofuran-8-yl]ethyl]-propanamide | |
ramelteon impurity F | 196597-17-8 | |||
ramelteon impurity E | 196597-16-7 | |||
ramelteon impurity D | 880152-61-4 | |||
Ramelteon | 196597-26-9 | C16H21NO2 | 259.34 | TAK-375; TAK 375; TAK375; Ramelteon. Brand name: Rozerem. |
Ramatroban | 116649-85-5 | C21H21FN2O4S | 416.47 | BAY u3405 |
Raltitrexed | 112887-68-0 | C21H22N4O6S | 458.49 | Tomudex; ZD1694; ZD-1694; ICI-D1694; (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid |
Raltegravir Potassium Salt | 871038-72-1 | C20H20FKN6O5 | 482.514 | MK-0518; MK 0518; MK0518; Raltegravir |
Raltegravir | 518048-05-0 | C20H21FN6O5 | 444.42 | Isentress; MK-0518; MK 0518; MK0518 |
Raloxifene-4' -glucuronide | 182507-22-8 | C34H35NO10S | 649.71 | 4-[6-Hydroxy-3-[4-2[2-(1-piperindinyl)ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic acid |
Raloxifene-d4-4'-glucuronide | 1279033-52-1 | C34H31NO10SD4 | 653.75 | 4-[6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy-d4]benzoyl]benzo[b]thien-2-yl]phenyl-D-c acid |
Raloxifene-d4 HCl | 1188263-47-9 | C28H23NO4SD4·HCl | 514.08 | Raloxifene-d4 Hydrochloride; Keoxifene-d4; Evista-d4; CTK8G2886; LY-139481-d4; [6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone-d4 Hydrochloride |
Raloxifene Impurity D | 177744-96-6 | C21H14O4S | 362.41 | [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl](4-hydroxyphenyl)methanone; LY 88074 |
Raloxifene Impurity C | 195454-31-0 | C28H27NO5S | 489.58 | [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-oxido-1-piperidinyl)ethoxy]phenyl]methanone; USP Raloxifene Related Compound C; Raloxifene EP Impurity C; Raloxifene N-Oxide |
Raloxifene Impurity B | 1391054-73-1 | C28H27NO4S | 473.6 | [6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-7-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; Raloxifene Impurity C; [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-7-yl](4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone;3-Des[4-(2-Piperidinyl)ethoxy]benzoyl- |
Raloxifene Impurity 6 (2-Ethyl-1-Benzothiophene) | 1196-81-2 | C10H10S | 162.26 | 2-Ethylbenzo[b]thiophene |
Raloxifene Impurity 3 | 84449-65-0 | C16H14O6S3 | 398.48 | 2-[4-[(Methylsulfonyl)oxy]phenyl]benzo[b]thien-6-yl methanesulfonate; 2-[4-[(Methylsulfonyl)oxy]phenyl]-benzo[b]thiophene-6-ol Methanesulfonate; Raloxifene Impurity; 2-(4-Hydroxyphenyl)benzo[b]thiophen-6-ol Bimesylate |
Raloxifene Impurity 2 | 63676-22-2 | C14H10O2S | 242.3 | 2-(4-Hydroxyphenyl)benzothiophene-6-ol |
Raloxifene Impurity 1 | 84449-85-4 | C30H31NO8S3 . HCl | 666.24 | [6-[(Methylsulfonyl)oxy]-2-[4-[(methylsulfonyl)oxy]phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone Hydrochloride;Raloxifene Dimesylate Hydrochloride |
Raloxifene hydrochloride | 82640-04-8 | C28H28ClNO4S | 510.045 | Evista; Keoxifene hydrochloride; [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride |
Ralinepag | 1187856-49-0 | C23H26ClNO5 | 431.91 | 2-[[4-[[(4-chlorophenyl)-phenylcarbamoyl]oxymethyl]cyclohexyl]methoxy]acetic acid,APD-811 |
Raloxifene 6,4-bis-b-D-glucuronide | 182507-20-6 | C40H43NO16S | 825.85 | |
Ralfinamide mesylate | 202825-45-4 | C17H19FN2O2.CH3SO3H | 398.45 | (2S)-2-[[[4-[(2-Fluorophenyl)methoxy]phenyl]methyl]amino]-propanamide methanesulfonate |
Ralfinamide | 133865-88-0 | C17H19FN2O2 | 302.347 | (2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide; ralfinamide; (S)-2-[[4-[(2-Fluorobenzyl)oxy]benzyl]amino]propanamide; (2S)-2-(4-(2-Fluorobenzyloxy)benzylamino)propanamide; Nw-1029; Ralfinamida; Ralfinamida [inn-spanish]; Ralfinamide [i |
Raffinose | 512-69-6 | C18H32O16 | 504.4 | Melitose; Gossypose |
Rafabegron | 244081-42-3 | C21H23ClN2O4 | 402.875 | 2-[[3-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxy-ethyl]amino]propyl]- 1H-indol-7-yl]oxy]acetic acid; TAK 677; TAK-677; TAK677; AD-9677; AD9677; AD 9677; AJ-9677; AJ-9677; AJ-9677; Rafabegron. |
RAF-709 | 1628838-42-5 | C28H29F3N4O4 | 542.5592 | N-(2-methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide; RAF709; RAF-709; RAF 709 |
RAF265 | 927880-90-8 | C24H16F6N6O | 518.41 | CHIR-265 |
Radotinib | 926037-48-1 | C27H21F3N8O | 530.515 | IY-5511; 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide |
Radiprodil | 496054-87-6 | C21H20FN3O4 | 397.40 | RGH-896; UCB-3491; 2-(4-((4-Fluorophenyl)methyl)piperidin-1-yl)-2-oxo-N-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)acetamide; |
Radicicol | 12772-57-5 | C18H17ClO6 | 364.78 | KF58332, (1AR,2Z,4E,14R,15AR)-8-CHLORO-1A,14,15,15A-TETRAHYDRO-9,11-DIHYDROXY-14-METHYL-6H-OXIRENO[E][2]BENZOXACYCLOTETRADECIN-6,12(7H)-DIONE; [1AS-(1AR*,2Z,4E,14*,15AR*)]-8-CHLORO-1A,14,15,15A-TETRAHYDRO-9,11-DIHYDROXY-14-METHYL-6H-OXIRENO[E][2]BENZOXACY |
Radezolid | 869884-78-6 | C22H23FN6O3 | 438.45 | RX-1741 |
Raddeanoside R8 | 124961-61-1 | C65H106O30 | 1367.53 | Hederacolchiside E |
Raddeanoside 20 | 335354-79-5 | C47H76O17 | 913.108 | (4aS,6aR,6aR,6bR,8aR,10S,12aR,14bS)-6a-(hydroxymethyl)-10-[(2S,3R,4S,5S)-4-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,2,6b,9,9,12a-hexamethyl-1,3,4, |
Raddeanin A | 89412-79-3 | C47H76O16 | 897.11 | Raddeanin(Anemodeanin) A; anemodeanin A; Raddeanin A; (3beta)-3-[(O-6-Deoxy-alpha-L-mannopyranosyl-(1-2)-O-beta-D-glucopyranosyl-(1-2)-alpha-L-arabinopyranosyl)oxy]olean-12-en-28-oic acid; Raddeanin R3; Raddeanoside R3; 2)-a-L-arabinopyranosyl)oxy]-, (3b) |
rac-trans-Ketoconazole | 83374-59-8 | C26H28Cl2N4O4 | 531.434 | (2R,4R)-Ketoconazole; 1-acetyl-4-(4-{[(2R,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine; Ketoconazole EP Impurity C |
rac-trans-7-Hydroxy-Pramipexole | 1246818-51-8 | C10H17N3OS | 227.33 | rel-(6S,7R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)-7-benzothiazolol |
rac-trans-5-Hydroxy-1,3-oxathiolane-2-carboxylic Acid | 147027-04-1 | C4H6O4S | 150.15 | (2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic Acid |
Rac-Trans-4-Hydroxy Tolvaptan | 926035-34-9 | C26H25ClN2O4 | 464.95 | |
rac-Tenofovir-D6 | 1020719-94-1 | C9H8D6N5O4P | 293.25 | 2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-d6-phosphonic Acid; 9-(2-Phosphonomethoxypropyl)adenine-d6 |
Rac-Sitagliptin | 823817-56-7 | C16H15F6N5O | 407.31 | 3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one |
rac-Silodosin | 160970-64-9 | C25H32F3N3O4 | 495.53 | |
Rac-Selenobiotin | 57956-29-3 | C10H16N2O3Se | 291.21 | Hexahydro-2-oxo-1H-selenolo[3,4-d]imidazole-4-pentanoic Acid |
rac-Propranolol-d7 | 98897-23-5 | C16H14D7NO2 | 266.34 | |
rac-Pregabalin Impurity III | 181289-15-6 | C9H17NO3 | 187.24 | |
Raclopride | 84225-95-6 | C15H20Cl2N2O3 | 347.24 | 3,5-Dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide; (-)-Raclopride; FLA 870; Raclopride |
rac-O-Desmethyl Venlafaxine-D6 | 1062605-69-9 | C16H19D6NO2 | 269.41 | |
rac-O-Desmethyl Venlafaxine-D10 | 1062607-49-1 | C16H15D10NO2 | 273.44 | 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl-D10)ethyl]phenol; DVS 233-D10; rac-O-Desvenlafaxine-D10; rac-O-Desmethylvenlafaxine-D10; Pristiq-D10; WY 45233-D10 |
Rac-Nebramine | 34051-04-2 | C14H30N2O5 | 306.41 | nebramine; Rac-Nebramine; 3'-Deoxyneamin; |
rac-Nebivolol HCl | 169293-50-9 | C22H25F2NO4. HCl | 441.91 | |
rac-N-Desmethyl Bedaquiline | 654654-76-9 | C31H29BrN2O2 | 541.5 | N-Monodesmethyl bedaquiline |
Rac-Monepantel | 851976-50-6 | C20H13F6N3O2S | 473.4 | N-[-1-Cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl]-4-[(trifluoromethyl)thio]benzamide; |
rac-Milnacipran Hydrochloride | 101152-94-7 | C15H22N2O.HCl | 282.81 | N/A |
rac-Methotrimeprazine Sulfoxide | 1188265-45-3 | C19H24N2O2S | 344.473 | Methotrimeprazine sulfoxide; 3-(2-methoxy-5-oxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine |
Rac-Luliconazole-E-Isomer | 101530-21-6 | C14H9Cl2N3S2 | 354.28 | |
rac-Lavandulol | 58461-27-1 | C10H18O | 154.253 | (+/-)-Lavandulol; 5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-ol; 4-Hexen-1-ol, 5-methyl-2-(1-methylethenyl)-; 2-Isopropenyl-5-methylhex-4-en-1-ol |
Quench 7 Carboxylic Acid Succinimidyl Ester | 304014-12-8 | C43H39ClN4O7S | 791.31 | |
rac-Kynurenine | 343-65-7 | C10H12N2O | 208.22 | 2-Amino-3-(2-aminobenzoyl)propionic acid, 2-Amino-4-(2-aminophenyl)-4-oxobutyric acid; DL-Kynurenine |
rac-Ketoprofen acyl-beta-D-glucuronide (mixture of isomers) | 76690-94-3 | C22H22O9 | 430.40 | 1-(3-Benzoly-a-methylbenzeneacetate)-b-D-glucopyranuronic acid; Ketoprofen Glucuronide |
rac-Ibuprofen Impurity G | 1391054-15-1 | C26H32O4 | 408.54 | Ibuprofen Dimer; (1RS,4RS)-7-(2-Methylrpopyl)1-[4-(2-methylpropyl)phenyl]-1,2,3,4-tetrahydronaphthalene-1,4-dicarboxylic Acid; Ibuprofen Impurity G |
rac-Glycerol 1-phosphate disodium salt hexahydrate | 34363-28-5 | C3H19Na2O12P | 324.13 | DL--Glycerophosphate disodium salt hexahydrate |
rac-Etodolac | 41340-25-4 | C17H21NO3 | 287.35 | Etodolac, AY 24,236, AY 24236, AY-24,236, AY-24236, AY24,236, AY24236, 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid; (RS)-Etodolic Acid; (+/-)-Etodolac; AY 24236; Eccoxolac; Edolan; Etodine; Etodolic Acid; Etogesic; Lodin XL; Lodine; NI |
rac-Eriodictyol | 4049-38-1 | C15H12O6 | 288.255 | (+/-)-Eriodictyol; MLS000877024; 5,7,3',4'-Tetrahydroxyflavanone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-4-one; SMR000440624; ST075648 |
Racemic-O-Desmethyl Rabeprazole Impurity | 117976-94-0 | C17H19N3O3S | 345.42 | |
Racemic Pregabalin (3-(Aminomethyl)-5-Methylhexanoic Acid) | 128013-69-4 | C8H17NO2 | 159.23 | 3-(Aminomethyl)-5-methylhexanoic Acid; rac-PD-144723; rac-CI-1008; (+/-)-Pregabalin; |
racemic-Monepantel Sulfone | 851976-52-8 | C20H13F6N3O4S | 505.39 | N-(2-Cyano-1-(5-cyano-2-(trifluoromethyl)phenoxy)propan-2-yl)-4-((trifluoromethyl)sulfonyl)benzamide; |
Racemic-Desmethyl Rabeprazole Sodium Salt | 117976-71-3 | C17H18N3O3S. Na | 367.41 | |
RACEMIC-4-HYDROXY[2,2]PARACYCLOPHANE | 157018-15-0 | C16H16O | 224.3 | RACEMIC-4-HYDROXY[2,2]PARACYCLOPHANE; RACEMIC-4,12-DIHYDROXY[2.2]PARACYCLOPHANE, MIN. 97%; racemic-4-Hydroxy[2.2]paracyclophane,min.97% |
RACEMIC-4,12-DIHYDROXY[2,2]PARACYCLOPHANE | 612492-27-0 | C16H16O2 | 240.3 | RACEMIC-4,12-DIHYDROXY[2,2]PARACYCLOPHANE; racemic-4,12-Dihydroxy[2.2]paracyclophane,min.97% |
Racemic Timolol Maleate | 57073-55-9 | C13H24N4O3S | 316.43 | 3-(3-(tert-Butylamino)-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole monomaleate; dl-Timolol maleate |
Racemic Sitagliptin-d4 xHCl | 1620233-77-3 | C16H11F6N5OD4·xHCl | 411.35 (free base) | |
Racemic Pazufloxacin Mesylate | 136905-87-8 | C16H15FN2O4.CH4O3S | 414.42 | |
rac-Ambrisentan | 713516-99-5 | C22H22N2O4 | 378.428 | (+/-)-Ambrisentan; Ambrisentan |
Rac-cis-Sertraline Hydrochloride | 79617-95-1 | C17H18Cl3N | 0 | cis racemic Setraline; rac-cis-Sertraline Hydrochloride |
Racemic Arimoclomol Maleate | 289893-24-9 | C14H20ClN3O3. C4H4O4 | 313.79 116.07 | N-[2-Hydroxy-3-(1-piperidinyl)propoxy]-3-Pyridinecarboximidoyl Chloride 1-Oxide (2Z)-2-Butenedioate Maleate |
Racemic Anabasine-d4 | 1020719-11-2 | C10H10N2D4 | 166.26 | (R,S)-Anatabine-2,4,5,6-d4; (+/-)-1,2,3,6-Tetrahydro-2,3'-bipyridine-d4; (+/-)-Anatabine-d4 |
Racecadotril Impurity H (Mixture of Diastereomers) | 141437-88-9 | C38H40N2O6S2 | 684.88 | N,N'-[Dithiobis[1-oxo-2-(phenylmethyl)-3,1-propanediyl]]bis-glycine Bis(phenylmethyl) Ester; Deacetyl Racecadotril Disulfide |
Racecadotril Impurity G | 81110-69-2 | C19H21NO3S | 343.45 | N-[2-(Mercaptomethyl)-1-oxo-3-phenylpropyl]-glycine Phenylmethyl Ester, Racecadotril Impurity G; Deacetyl Racecadotril |
Racecadotril Impurity F | 87428-99-7 | C19H19NO3 | 309.37 | N-[1-Oxo-2-(phenylmethyl)-2-propen-1-yl]glycine Phenylmethyl Ester; N-[1-Oxo-2-(phenylmethyl)-2-propenyl]glycine Phenylmethyl Ester; Racecadotril Impurity F; Benzyl[(2-benzylprop-2-enoyl)amino]acetate; 2-Des(acetylthiomethyl)-2-methylene Racecadotril |
Racecadotril Impurity D(Mixture of Diastereomers) | 123658-06-0 | C24H28N2O6S2 | 504.63 | N,N'-[Dithiobis[1-oxo-2-(phenylmethyl)-3,1-propanediyl]]bis-glycine;Thiorphan Disulfide |
Racecadotril Impurity C | 124735-06-4 | C14H17NO4S | 295.36 | (±)-N-[2-[(Acetylthio)methyl]-1-oxo-3-phenylpropyl]glycine; S-Acetylthiorphan, Racecadotril Impurity C;Hemiacetorphan |
Racecadotril Diacid Impurity | 141437-87-8 | C20H22O4S2 | 390.52 | |
Racecadotril | 81110-73-8 | C21H23NO4S | 385.48 | CS-514 Sodium; CS 514 Sodium; CS514 Sodium |
rac-Dobutamine-d6 HCl | 1246818-96-1 | C18H17NO3D6·HCl | 343.88 | 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl-d6]amino]ethyl]-1,2-benzenediol; DL-Dobutamine-d6 Hydrochloride |
rac-Dobutamine-d4 HCl | 1246815-74-6 | C18H19NO3D4·HCl | 341.87 | 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl-d4]-1,2-benzenediol; DL-Dobutamine-d4 Hydrochloride |
rac-Dimethylsilyl-bis-(2-methylindenyl)zirconium dichloride | 149342-08-5 | C22H22Cl2SiZr | 476.63 | RAC-DIMETHYLSILYLENEBIS(2-METHYL-1-INDENYL)ZIRCONIUM(IV) DICHLORIDE; MESO-DIMETHYLSILYLENEBIS(2-METHYL-1-INDENYL)ZIRCONIUM(IV) DICHLORIDE; rac-dimethylsilylbis(2-methyl-indenyl)zirconium(IV) dichloride; rac-Dimethylsilylbis(2-methylindenyl)zirconium dichl |
RAC-DIMETHYLSILYLBIS(1-INDENYL)ZIRCONIUM DICHLORIDE, MIN. 97% | 121009-93-6 | (CH3)2SI(C9H6)2ZRCL2 | 448.53 | |
rac-Dihydromethysticin | 3155-57-5 | C15H16O5 | 276.288 | DL-Dihydromethysticin; (+/-)-Dihydromethysticin |
rac-dehydrocostus lactone | 74299-48-2 | C15H18O2 | 230.307 | (+-)-dehydrocostus lactone; dehydrocostus lactone |
rac-Cotinine-d3 | 110952-70-0 | C10H9N2OD3 | 179.23 | (+/-)-1-(Methyl-d3)-5-(2-pyridinyl)-2-pyrrolidinone; (+/-)-Cotinine-d3 |
rac-columbianetin | 1147-29-1 | C14H14O4 | 246.26 | (+-)-columbianetin; 8-(2-hydroxypropan-2-yl)-8,9-dihydro-2H-furo[2,3-h]chromen-2-one; 8,9-dihydro-8-(1-hydroxy-1-methylethyl)-2H-furo[2,3-h]1-benzopyran-2-one; Columbianetin |
rac-Clopidogrel Hydrogen Sulfate | 135046-48-9 | C16H18ClNO6S2 | 419.9 | (±)-Methyl 2-(2-Chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate Hydrogen Sulfate; (±)-Clopidogrel Bisulfate; Clopidogrel Hemisulfate; Iscover; Myogrel ; Plavix; SR 25990C; Stroka |
rac-Clopidogrel Carboxylic Acid Hydrochloride | 1015247-88-7 | C15H15Cl2NO2S | 344.26 | |
rac-cis-Dorzolamide | 120279-37-0 | C10H16N2O4S3 | 324.44 | (4R,6S)-rel-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-Dioxide Monohydrochloride; cis-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-Dioxide Monohydrochloride |
rac-cis-Ambroxol | 107814-37-9 | C13H18Br2N2O | 378.108 | cis-4-[[(2-Amino-3,5-dibromophenyl)methyl]amino]cyclohexanol; Ambroxol EP Impurity D |
rac-cis-7-Hydroxy-Pramipexole | 1001648-71-0 | C10H17N3OS | 227.33 | (6S,7S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)-7-benzothiazolol |
rac-CCT 250863 | 1364269-06-6 | C24H25F3N4O2S | 490.54 | 4-[2-Amino-5-[4-[(dimethylamino)methyl]-2-thienyl]-3-pyridinyl]-2-[[(2Z)-4,4,4-trifluoro-1-methyl-2-buten-1-yl]oxy]benzamide |
Rac-7-Oxo-Pramipexole DiHCl (salt) | 1286047-33-3 | C10H15N3OS.2HCl | 261.77 | |
rac-5, 7--Dimethyltocol | 493-35-6 | C28H48O2 | 416.69 | 2,5,7-trimethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol |
rac-4-Hydroxy Propranolol HCl | 14133-90-5 | C16H21NO3. HCl | 311.81 | 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-1-naphthalenol Hydrochloride |
rac-4,11-Diethyl-9-hydroxycamptothecin | 130144-34-2 | C22H20N2O5 | 392.411 | |
rac-3-Hexadecanamido-2-methoxypropan-1-ol Phosphocholine Monohydrate | 163751-35-7 | 526.69 | 4-Hydroxy-7-methoxy-N,N,N-trimethyl-10-oxo-3,5-dioxa-9-aza-4-phosphapentacosan-1-aminium Inner Salt 4-Oxide Hydrate; (+/-)-4-Hydroxy-7-methoxy-N,N,N-trimethyl- 10-oxo-3,5-dioxa-9-aza-4-phosphapentacosan-1-aminium Inner Salt 4-Oxide Hydrate,cas 112989-00-1 | |
rac-2-Despiperidyl-2-amino Repaglinide | 874908-11-9 | C22H28N2O4 | 384.48 | 4-[2-[[1-(2-Aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic Acid; Repaglinide M1 Metabolite |
Rac1 Inhibitor W56 | 1095179-01-3 | C74H117N19O23S | 1671.93 | FLA 870; FLA-870; FLA870; Raclopride tartrate; MVDGKPVNLGLWDTAG |
Rac1 Inhibitor F56, control peptide | 1315378-77-8 | C72H116N18O23S | 1632.89 | MVDGKPVNLGLFDTAG |
rac Viloxazine-d5 Hydrochloride | 1276483-10-3 | C13H14NO3D5·HCl | 278.79 | (+/-)-2-[(o-Ethoxy-d5)phenoxymethyl]morpholine; Catatrol-d5; ICI 58834-d5; Vicilan-d5; Viloxazin-d5 Hydrochloride; Vivalan-d5; Vivarint-d5; Vivilan-d5 |
rac Viloxazine Hydrochloride | 35604-67-2 | C13H19NO3 HCl | 273.76 | (+/-)-2-(o-Ethoxyphenoxymethyl)morpholine; Catatrol; ICI 58834; Vicilan; Viloxazin Hydrochloride; Vivalan; Vivarint; Vivilan |
rac trans-4-Hydroxy Glyburide | 23155-04-6 | C23H28ClN3O6S | 510.01 | 5-Chloro-N-[2-[4-[[[[(4-hydroxycyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl)ethyl]-2-methoxy-benzamide, 4Hydroxyglibenclamide; 4-hydroxyglibenclamide; 5-Chloro-N-[2-[4-[[[[(4-Hydroxycyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl)ethyl]-2-methoxybenzam |
rac trans-10,11-Dihydro-10,11-dihydroxy Carbamazepine | 58955-93-4 | C15H14N2O3 | 270.28 | (10R,11R)-rel-10,11-Dihydro-10,11-dihydroxy-5H-dibenz[b,f]azepine-5-carbox-amide; Dihydrocarbamazepine-10,11-trans-diol; Carbamazepine-10,11-dihydrodiol; Carbamazepine-10,11-dihydro-10,11-diol; 10,11-Dihydroxycarbamazepine |
rac N'-Nitrosonornicotine | 80508-23-2 | C9H11N3O | 177.206 | NNN; 3-[(2R, S)-1-Nitroso-2-pyrrolidinyl]-pyridine; N-Nitroso-nornicotine; anti-N'-Nitrosonornicotine; syn-N'-Nitrosonornicotine; |
rac N-Desmethyl Tramadol-d3 Hydrochloride | 1261398-09-7 | C15H21D3ClNO2 | 288.83 | (1R,2R)-rel-1-(3-Methoxyphenyl)-2-[(methyl-d3-amino)methyl]-cyclohexanol Hydrochloride; cis-(+/-)-N-Demethyltramadol-d3 Hydrochloride; N-Monodesmethyltramadol-d3 Hydrochloride; Nortramadol-d3 Hydrochloride; |
rac N,O-didesmethyl venlafaxine b-D-glucuronide hydrochloride | 1021933-99-2 | C21H32ClNO8 | 461.93 | 4-[1-(1-Hydroxycyclohexyl)-2-(methylamino)ethyl]phenyl b-D-glucopyranosiduronic acid hydrochloride |
rac N-(2,3-Dihydroxypropyl)octadecanamide | 7336-25-6 | C21H43NO3 | 357.57 | (+/-)-3-Octadecanamido-1,2-propanediol; (+/-)-N-(2,3-Dihydroxypropyl)octadecanamide; |
rac Mono(ethylhexyl) Phthalate-d4 | 1276197-22-8 | Mono-2-ethylhexyl phthalate-D4 | ||
rac Mirabegron-d5 | 1215807-38-7 | C21H19D5N4O2S | 401.54 | 2-Amino-N-[4-[2[[2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-4-thiazoleacetamide-d5; 2-(2-Aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic Acid Anilide-d5; YM 178-d5; |
Rabeprazole Sodium Salt | 117976-90-6 | C18H20N3NaO3S | 381.42 | sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide;RABEPRAZOLESODIUM;117976-90-6;Pariet;Aciphex |
rac Metoprolol Hemi (+)-Tartrate | 56392-17-7 | 2C15H25NO3.C4H6O6 | 684.81 | CGP 2175E; CGP2175E; CGP-2175E |
rac Methyl Efavirenz | 353270-76-5 | C15H11ClF3NO2 | 329.7 | 6-Chloro-1,4-dihydro-4-[2-(2-methylcyclopropyl)ethynyl]-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; 6-Chloro-1,4-dihydro-4-[(2-methylcyclopropyl)ethynyl]-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one |
rac Efavirenz | 177530-93-7 | C14H9ClF3NO2 | 315.67 | 6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one |
Rac Dihydro Mebendazole | 60254-95-7 | C16H15N3O3 | 297.31 | [5-(Hydroxyphenylmethyl)-1H-benzimidazol-2-yl]carbamic Acid Methyl Ester; R 19167 |
rac Desmethyl Citalopram Hydrobromide | 1188264-72-3 | C19H20BrFN2O | 391.28 | 1-(4-Fluorophenyl)-1-(3-methylamino-propyl)-1,3-dihydro-isobenzofuran-5-carbonitrile Hydrobromide; 1-(3-Methylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide |
rac Desfluoro Citalopram Oxalate | 1093072-86-6 | C22H24N2O5 | 396.44 | 1-(3-Dimethylaminopropyl)-1-(phenyl)-5-phthalan-carbonitrile Oxalate |
rac Cycloserine-15N,d3 | 1219176-26-7 | C3H3N15NO2D3 | 106.1 | 4-Amino-3-isoxazolidinone-15N,d3; (+/-)-3-Oxoisooxazolidin-4-amine-15N,d3; DL-Cycloserine-15N,d3 |
Rac cotinine | 15569-85-4 | C10H12N2O | 176.22 | 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone; (+/-)-Cotinine; |
rac Cinacalcet HCl | 1025064-33-8 | C22H23ClF3N | 393.87 | |
rac Carbovir Diphosphate Triammonium Salt | 144606-03-1 | C11H15N5O8P2 | 407.21 | Diphosphoric Acid rel-Mono[[(1R,4S)-4-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl]methyl] Ester Triammonium Salt; Diphosphoric Acid cis-(±)-[4-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl]methyl Ester Triammonium Salt |
rac BHFF | 123557-91-5 | C17H21F3O3 | 330.34 | 5,7-Bis(1,1-dimethylethyl)-3-hydroxy-3(trifluoromethyl)-2(3H)-benzofuranone |
rac all-trans 3-Hydroxyretinol | 6890-93-3 | C20H30O2 | 302.45 | |
rac 8-Hydroxy Efavirenz | 205754-32-1 | C14H9ClF3NO3 | 331.68 | 6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one |
rac 5-Hydroxy Propentofylline | 56395-62-1 | C15H24N4O3 | 308.38 | |
rac 5,6-Dehydro Pregabalin | 1136478-30-2 | C8H15NO2 | 157.21 | 3-(Aminomethyl)-5-methyl-5-hexenoic Acid; 5,6-Dehydropregabalin |
rac 4-Desmethoxy-4-nitro Omeprazole | 317807-10-6 | C16H16N4O4S | 360.39 | 2-[[(3,5-Dimethyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole; 5-Methoxy-2-{(S)-[(4-nitro-3,5-dimethyl-pyridine-2-yl)methyl]sulfinyl}-1H-benzimidazole; |
rac 4,5-Dehydro Pregabalin | 216576-74-8 | C8H15NO2. CH2O2 | 157.21 | 3-(Aminomethyl)-5-methyl-4-hexenoic Acid; 4,5-Dehydropregabalin; |
rac 4-(3-Aminobutyl)phenol | 52846-75-0 | C10H15NO | 165.23 | 3-Amino-1-(4-hydroxyphenyl)butane; 4-(4'-Hydroxyphenyl)-2-aminobutane; Racemic 3-Amino-1-(4-hydroxyphenyl)butane; |
rac 1,2-Bis-palmitol-3-chloropropanediol-d5 | 1185057-55-9 | C35H62D5ClO4 | 0 | 3-Chloropropane-1,2-diol-d5 Dipalmiat; Hexadecanoic Acid 1,1[1-Chloromethyl)-1,2-ethanediyl-d5] Ester; rac 1,2-Bis-palmitol-3-chloropropanediol-d5; 3-Chloropropane-1,2-diol-d5 Dipalmiate; rac 1,2-Bis-palmitoyl-3-chloropropanediol-d5 |
rac 1,2-bis-Palmitol-3-chloropropanediol | 51930-97-3 | C35H67ClO4 | 587.363 | Hexadecanoic Acid 1,1'-[1-Chloromethyl)-1,2-ethanediyl] Ester; 3-Chloropropane-1,2-diol Dipalmiate; rac 1,2-Di-palmitoyl-3-chloropropanediol; 3-MCPD-1,2-dipalmitoyl ester |
rac (8-Hydroxyquinolin-3-yl)alanine Dihydrochloride | 1123191-88-7 | C12H14Cl2N2O3 | 305.155 | 2-Amino-3-(8-hydroxyquinolin-3-yl)propanoic Acid Dihydrochloride |
Rabeximod | 872178-65-9 | C22H24ClN5O | 409.92 | 2-(9-chloro-2,3-dimethyl-6H-indolo[2,3-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]acetamide;Rob 803 |
Rabeprazole-d4 | 934295-48-4 | C18H17N3O3SD4 | 363.47 | 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-4,5,6,7-d4; (±)-Rabeprazole-d4; 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-d4; 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]sulfi |
Rabeprazole Sulfone | 117976-47-3 | C18H21N3O4S | 375.45 | 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole; USP Rabeprazole Related Compound D; Rabeprazole EP Impurity A |
Rabeprazole Sulfide N-Oxide | 924663-40-1 | C18H21N3O3S | 359.45 | 2-[[[4-(3-Methoxypropoxy)-3-methyl-1-oxido-2-pyridinyl]methyl]thio]-1H-benzimidazole; |
Rabeprazole Sulfide | 117977-21-6 | C18H21N3O2S | 343.45 | 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]thio]-1H-benzimidazole; 2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]-methythio}-1H-benzimidazole; H 295/43; Rabeprazole Thioether; USP Rabeprazole Related Compound E; Rabeprazole EP Impurity B |
Rabeprazole N-Oxide | 924663-38-7 | C18H21N3O4S | 375.45 | 2-[[[4-(3-Methoxypropoxy)-3-methyl-1-oxido-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; 2-[[[1-Oxide-4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; Rabeprazole EP Impurity D |
2-((Z)-5-((E)-2-methyl-3-phenylallylidene)-2,4-dioxothiazolidin-3-yl)acetic acid | 794510-29-5 | C15H13NO4S | 303.3 | 2-[5-((2E)-2-methyl-3-phenylprop-2-enylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]a cetic acid |
Rabeprazole Impurity 1 | 1286104-27-5 | C14H11N3O3 | 269.26 | |
Rabeprazole | 117976-89-3 | C18H21N3O3S | 359.45 | Rabeprazole |
Rabdoternin F | 155977-87-0 | C21H30O7 | 394.46 | (1alpha,6beta,7alpha,14R,20S)-7,20-Epoxy-1,6,7,14-tetrahydroxy-20-methoxykaur-16-en-15-one |
Rabdosin C | 82460-75-1 | C22H30O7 | 406.47 | Rabdophyllin G; Isodonoiol |
Rabdoketone B | 174819-51-3 | C10H12O2 | 164.201 | 3-Methyl-1-(5-methyl-3-furyl)-2-buten-1-one |
RA190 | 1617495-03-0 | C28H23Cl5N2O2 | 596.76 | (3Z,5Z)-1-[(2S)-2-amino-3-phenylpropanoyl]-3,5-bis[(3,4-dichlorophenyl)methylidene]piperidin-4-one;hydrochloride; 3,5-bis(3,4-dichlorobenzylidene)-1-(S-2-amino-3-phenyl)-piperidin-4-one, HCl; RA190 |
RA 839 | 1832713-02-6 | C25H28N2O4S | 452.57 | (3S)-1-[4-[[(2,3,5,6-Tetramethylphenyl)sulfonyl]amino]-1-naphthalenyl]-3-pyrrolidinecarboxylic acid; RA-839; RA 839; RA839 |
R-96544 hydrochloride | 167144-80-1 | C22H29NO3.HCl | 391.94 | (2R,4R)-5-[2-[2-[2-(3-Methoxyphenyl)ethyl]phenoxy]ethyl]-1-methyl-3-pyrrolidinol hydrochloride |
Quinoxyfen | 124495-18-7 | C15H8Cl2FNO | 308.14 | 5,7-Dichloro-4-(4-fluorophenoxy)quinoline; Legend; |
R-8507 | 338773-13-0 | C16H8ClF3N4 | 348.7 | 1-(4-chlorophenyl)-4-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline |
R788 disodium hexahydrate | 914295-16-2 | C23H24FN6Na2O9P | 624.42 | Fostamatinib disodium hexahydrate |
R763 | 871357-89-0 | C24H30FN7O | 451.55 | AS703569 |
R-7128 | 940908-79-2 | C18H26FN3O6 | 399.41 | Mericitabine; PSI 6130 diisobutyrate |
R66905 | 110588-57-3 | C35H38F2N8O4 | 672.72 | 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-difluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; saperconazole |
R 121919 hydrochloride | 195055-66-4 | C22H32N6·HCl | 416.99 | 3-[6-(Dimethylamino)-4-methyl-3-pyridinyl]-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine hydrochloride |
QX 314 chloride | 5369-03-9 | C16H27N2OCl | 298.85 | N-(2,6-Dimethylphenylcarbamoylmethyl)triethylammonium chloride; N-Ethyllidocaine |
QX 314 bromide | 24003-58-5 | C16H27N2OBr | 343.31 | 2-[(2,6-Dimethylphenyl)amino]-N,N,N-triethyl-2-oxo-ethanaminium Bromide; Triethyl[(2,6-xylylcarbamoyl)methyl]-ammonium Bromide; 2-[(2,6-Dimethylphenyl)amino]-N,N,N-triethyl-2-oxo-ethanaminium Bromide; N-(2,6-Dimethylphenylcarbamoylmethyl)triethylammonium |
QX 222 | 5369-00-6 | C13H21ClN2O | 256.77 | 2-[(2,6-Dimethylphenyl)amino]-N,N,N-trimethyl-2-oxoethaniminium Chloride; Trimethyl[(2,6-xylylcarbamoyl)methyl]ammonium Chloride (8CI); 2-[(2,6-dimethylphenyl)amino]-N,N,N-trimethyl-2-oxo-ethanaminium Chloride (9CI); Trimethyl[(2,6-xylylcarbamoyl)methyl]a |
QWF | 126088-82-2 | C38H43N5O8 | 697.78 | Bgtcpo; N(alpha)-(N(alpha)-(N(alpha)-(tert-Butyloxycarbonyl)glutaminyl)-N(1)-formyl-tryptophyl)phenylalanine benzyl ester; Boc-gln-trp(cho)-phe-obzl |
QVD-OPH | 1135695-98-5 | C26H25F2N3O6 | 513.6 | (3S)-5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-pentanoic acid; QVD-OPH; Q-VD-OPH; Quinoline-Val-Asp-Difluorophenoxymethylketone. quinoline-val-asp(OMe)-CH2-OPH. |
Quisinostat | 875320-29-9 | C21H26N6O2 | 394.479 | JNJ-26481585; JNJ26481585; JNJ 26481585 |
Quipazine dimaleate | 150323-78-7 | C13H15N3.2C4H4O4 | 445.43 | 2-(1-Piperazinyl)quinoline dimaleate |
Quinupristin-Dalfopristin mesylate complex | 126602-89-9 | C54H71N9O13S2 (for quinupristin mesylate); C35H54N4O12S2 (for dalfopristin | 1905.2 | Synercid complex, Dalfopristin-Quinupristin complex |
Quinupristin mesylate | 120138-50-3 | C53H67N9O10S | 1022.23 | N-((6R,9S,10R,13S,15aS,18R,22S,24aS)-22-(4-(dimethylamino)benzyl)-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-18-((((S)-quinuclidin-3-yl)thio)methyl)docosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1]oxa[4,7,10,13,16]pentaazacyclononadecin-9-y |
Quinoxaline-5-sulfonyl chloride | 844646-88-4 | C8H5ClN2O2S | 228.6555 | |
Quinoxaline,2-bromo-7-chloro- | 89891-64-5 | C8H4 Br Cl N2 | ||
Quinoxaline, decahydro-1-methyl-, trans- (8CI,9CI) | 6335-62-2 | C9H18N2 | 154.25262 | |
QUINOXALINE, 2,3-DICHLORO-6-FLUORO- | 76089-04-8 | C8H3Cl2FN2 | 217.027 | |
Quinovin | 107870-05-3 | C36H56O9 | 632.8 | Cinchonaglycoside A |
Quinovic acid 3-O-rhamnoside | 104055-76-7 | C36H56O9 | 632.8 | Quinovic acid 3-O-alpha-L-rhaMnopyranoside |
Quinovic acid 3-O-glucoside | 79955-41-2 | C36H56O10 | 648.8 | Quinovic acid 3-O-beta-D-glucoside;Quinovic acid 3-O-glucoside |
Quinovic acid 3-O-(6-deoxyglucoside) 28-O-glucosyl ester | 124727-10-2 | C42H66O14 | 795.1 | |
Quinovic acid | 465-74-7 | C30H46O5 | 486.7 | (1S,2R,4aS,6aR,6aR,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a,6a-dicarboxylic acid |
Quinomycin A | 512-64-1 | C51H64N12O12S2 | 1101.3 | Echinomycin, Actinoleukin, 1491, 59266, X 948, X 53III |
QUININE SULFATE SALT MONOHYDRATE | 303137-00-0 | C20H28N2O7S | 440.51 | (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; sulfuricacid; hydrate; TCMDC-123939; QUININESULFATESALTMONOHYDRATE; 303137-00-0 |
Quinine hydrochloride dihydrate | 6119-47-7 | C20H29ClN2O4 | 396.91 | Quinine monohydrochloride dihydrate; Quinine (hydrochloride dihydrate); Cinchonan-9-ol, 6'-methoxy-, monohydrochloride, dihydrate, (8a,9R)- |
Quinine hydrochloride | 130-89-2 | C20H24N2O2.HCl | 360.88 | (R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)- 8-vinylquinuclidin-2-yl)methanol hydrochloride |
Quinine hemisulfate dihydrate | 6119-70-6 | C40H58N4O12S | 819 | Quinine sulfate hydrate(2:1:4) |
Quinine | 130-95-0 | C20H24N2O2 | 324.42 | (8-alpha,9r)-6'-methoxycinchonan-9-ol;(8S,9R)-6'-Methoxycinchonan-9-ol;( |
Quinidine N-Oxide | 70116-00-6 | C20H24N2O3 | 340.43 | (9S)-6'-Methoxycinchonan-9-ol 1-Oxide; Quinidine 1-Oxide; |
Quinagolide Metabolite 1 | 1049987-22-5 | C18H29N3O3S | 367.51 | |
Quindonium bromide | 130-81-4 | C16H20BrNO | 322.2401 | Quindonium bromide; Quindonium; Quindonium bromide [USAN:INN]; W-3366A; 1H-Benzo[A]cyclopenta[F]quinolizinium, 2,3,3A,5,6,11,12,12A-octahydro-8-hydroxy-, bromide; 2,3,3A,5,6,11,12,12A-Octahydro-8-hydroxy-1H-benzo[A]cyclopenta[F]quinolizinium bromide; 5H-B |
Quinagolide hydrochloride | 94424-50-7 | C20H34ClN3O3S | 432.02 | NORPROLAC, BRN 6074559; CV205-502. |
Quinagolide | 87056-78-8 | C20H33N3O3S | 395.57 | |
Quinacrine hydrochloride | 69-05-6 | C23H30ClN3O.2HCl | 472.88 | atabrine dihydrochloride; mepacrine dihydrochoride; SN 390 |
Quinacrine | 83-89-6 | C23H30ClN3O | 508.91 | 2-methoxy-6-chloro-9-diethylaminopentylaminoacridine; 3-chloro-7-methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine; 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxy-acridin; 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacrid |
Quinacainol | 86024-64-8 | C21H30N2O | 326.481 | |
Quin C1 | 786706-21-6 | C26H27N3O4 | 445.51 | 4-Butoxy-N-[1,4-dihydro-2-(4-methoxyphenyl)-4-oxo-3(2H)-quinazolinyl]benzamide |
Quillaic acid | 631-01-6 | C30H46O5 | 486.68 | Quillaja sapogenin |
Quetiapine-d8 Hemifumarate | 1185247-11-3 | C21H17D8N3O2S | 391.51 | |
Quetiapine-d8 Hemifumarate | 1031703-36-2 | C21H17D8N3O2S.C21H17D8N3O2S.C4H4O4 | 899.19 | 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol-d8 (2E)-2-Butenedioate; |
Quetiapine sulfoxide dihydrochloride | 329218-11-3 | C21H27Cl2N3O3S | 473.44 | 2-[2-[4-(11-oxobenzo[b][1,4]benzothiazepin-6-yl)piperazin-1-yl]ethoxy]ethanol;dihydrochloride 329218-11-3 Quetiapine sulfoxide (dihydrochloride) Ethanol, 2-[2-[4-(5-oxidodibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy]- ,dihydrochloride |
Quetiapine Sulfone | 329216-65-1 | C21H25N3O4S | 415.52 | |
Quetiapine Related Compound (Phenyl-2-(phenyl thio)phenyl carbamide) | 111974-73-3 | C19H15NO2S | 321.4 | N-[2-(Phenylthio)phenyl]carbamic Acid Phenyl Ester; Phenyl[2-phenylthio)phenyl]carbamate |
Quetiapine Impurtiy G (Dibenzo[b,f][1,4]thiazepine-11(10-H)-one) | 3159-07-7 | C13H9NOS | 227.29 | Quetiapine Impurity G, 10,11-Dihydro-11-oxodibenz[b,f][1,4]thiazepine; 10,11-Dihydrodibenzo[b,f][1,4]thiazepin-11-one; Dibenzo[b,f][1,4]thiazepine-11(10-H)-one; NSC 653252; Quetiapine EP Impurity G; Quetiapine Impurity G; Quetiapine USP-G |
Quetiapine Impurity W | 1800608-95-0 | C34H32N4O2S | 592.79 | O-Dibenzo[b,f][1,4]thiazepinyl Quetiapine |
Quetiapine Impurity U | 5786-26-5 | C13H10N2S | 226.3 | 11-Amino-dibenzo[b,f][1,4]thiazepine; NSC 651216; Dibenzo[b,f][1,4]thiazepin-11-amine |
Quetiapine Impurity T (Quetiapine Morpholine Impurity) | 5747-46-6 | C17H16N2OS | 296.39 | 11-(4-Morpholinyl)-dibenzo[b,f][1,4]thiazepine;11-Morpholino-dibenzo[b,f][1,4]thiazepine |
Quercetin-3-o-rutinose | 949926-49-2 | C27H30O16 | 610.5 | Osyritin; Globularicitrin; Violaquercitrin |
Quercetin-3-O-D-glucosyl]-(1-2)-L-rhamnoside | 143016-74-4 | C27H30O16 | ||
Quercetin-3-O-b-D-glucose-7-O-b-D-gentiobiosiden | 60778-02-1 | C33H40O22 | 788.66 | Quercetin-3-O-beta-D-glucose-7-O-beta-D-gentiobioside |
Quercetin pentamethyl ether | 1247-97-8 | C20H20O7 | 372.37 | Pentamethylquercetin; Penta-O-methylquercitin |
Quercetin dimer | 167276-19-9 | C30H18O14 | 602.47 | |
Quercetin Dihydrate | 6151-25-3 | C15H10O7 | 338.27 | |
Quercetin 7-O-b-D-glucuronide | 38934-20-2 | C21H18O13 | 478.36 | |
Quercetin 3-O-sophoroside-7-O-rhamnoside | 64828-40-6 | C33H40O21 | 772.66 | |
Quercetin 3,4'-dimethyl ether | 33429-83-3 | C17H14O7 | 330.3 | 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-methoxy-1-benzopyran-4-o ne;3',5,7-Trihydroxy-3,4'-dimethoxyflavone. |
Quercetin 3,3'-dimethyl ether | 4382-17-6 | C17H14O7 | 330.28 | 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-methoxychromen-4-one |
Quercetin | 117-39-5 | C15H10O7 | 302.238 | Sophoretin; Meletin; Xanthaurine; Quercetine; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one |
Quercetagitrin | 548-75-4 | C21H20O13 | 480.4 | Quercetagetin-7-O-glucoside |
Quercetagetin | 90-18-6 | C15H10O8 | 318.2 | 6-hydroxy Quercetin; NSC 115916; 3,3',4',5,6,7-Hexahydroxyflavone; 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxychromen-4-one |
Qingyangshengenin | 84745-94-8 | C28H36O8 | 500.6 | Quingyangshengenin |
QF0301B | 149247-12-1 | C23H28N2O2 | 364.48 | 3,4-Dihydro-2-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-1(2H)-naphthalenone |
Qc 1 | 403718-45-6 | C23H16F3N3O2S | 455.45 | 1,2,3,4-Tetrahydro-4-oxo-N-(phenylmethyl)-2-thioxo-3-[3-(trifluoromethyl)phenyl]-7-quinazolinecarboxamide; Qc1; Qc-1; Qc 1 |
Q94 hydrochloride | 1052076-77-3 | C21H17ClN2·HCl | 369.29 | 1-[(4-Chlorophenyl)methyl]-2-(phenylmethyl)-1H-benzimidazole hydrochloride; 2-benzyl-1-(4-chlorobenzyl)-1H-benzo[d]imidazole hydrochloride |
Q203 | 1334719-95-7 | C29H28ClF3N4O2 | 557.01 | 6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide; 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidin-1-yl)benzyl) imidazo(1,2-a)pyridine-3-carboxamide |
PZM21 | 1997387-43-5 | C19H27N3O2S | 361.5 | 1-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-thiophen-3-ylpropan-2-yl]urea |
PZ-II-029 | 164025-44-9 | C18H15N3O3 | 321.33 | 2,5-Dihydro-7-methoxy-2-(4-methoxyphenyl)-3H-pyrazolo[4,3-c]quinolin-3-one; PZ-II-029; PZII-029; PZ II-029; PZ-II029; PZII029; PZ II029 |
Pz-1 | 1800505-64-9 | C26H26N6O2 | 454.52 | N-(5-(Tert-Butyl)isoxazol-3-yl)-2-(4-(5-(1-methyl-1H-pyrazol-4-yl)-1H-benzo[d]imidazol-1-yl)phenyl)acetamide |
PYZD-4409 | 423148-78-1 | C14H7ClFN3O5 | 351.674 | PYZD-4409; PYZD 4409; PYZD4409. |
Pyrvinium Chloride | 548-84-5 | C26H28ClN3 | 382.52062;g/mol | PYRVINIUM; Pyrvinum; HSDB3178; UNII-6B9991FLU3; CHEBI:8687; Pyrviniumchloride |
PYRUVATE DEHYDROGENASE | 9014-20-4 | 0 | PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX; pyruvate dehydrogenase from*lactobacillus delbrue; PYRUVATE DEHYDROGENASE FROM*PORCINE HEAR T; PYRUVATE DEHYDROGENASE FROM*LACTOBACILLU S DELBRUECK; pyruvate dehydrogenase from lactobacillus delbruec | |
Pyrroside B | 116271-35-3 | C26H30O14 | 566.5 | |
Pyrrophenone | 341973-06-6 | C49H37F2N3O5S2 | 850 | N-[[(2S,4R)-1-[2-(2,4-Difluorobenzoyl)benzoyl]-4-tritylsulfanylpyrrolidin-2-yl]methyl]-4-[(E)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzamide |
Pyrroloquinoline quinone disodium salt | 122628-50-6 | C14H4N2Na2O8 | 374.17 | PYRROLOQUINOLINE QUINONE DISODIUM SALT;PQQ;METHOXATIN DISODIUM SALT;3-f)quinoline-2,7,9-tricarboxylicacid,4,5-dihydro-4,5-dioxo-1h-pyrrolo(di;disodium4,5-dihydro-4,5-dioxo-1h-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylat;PQQ, Pyrrolo-quinoline-quinone di |
Pyrrolo-dC CEP | 644962-92-5 | C42H50N5O7P | 767.85 | 3-[2-Deoxy-3-O-[2-cyanoethoxy(diisopropylamino)phosphino]-5-O-(4,4'-dimethoxytrityl)-beta-D-erythro-pentofuranosyl]-6-methyl-2,3-dihydro-7H-pyrrolo[2,3-d]pyrimidine-2-one |
Pyrrolobenzodiazepine (PBD) | 945490-09-5 | C14H14N2O3 | 258.28 | |
Pyrrolo[3,4-c]pyrrole, 1,2,3,4,5,6-hexahydro-2-methyl- (9CI) | 782417-97-4 | C7H12N2 | 124.18358 | Pyrrolo[3,4-c]pyrrole, 1,2,3,4,5,6-hexahydro-2-methyl- (9CI) |
Pyrrolo[2,3-b]indol-3a(1H)-ol,2,3,8,8a-tetrahydro-1-methyl-, (3aR,8aS)- | 101053-34-3 | C11H14 N2 O | 190.24200 | |
Pyrrolo[2,1-f][1,2,4]triazine-2,4(1H,3H)-dione | 918538-04-2 | C6H5N3O2 | 151.124 | |
Deoxyvasicinone | 530-53-0 | |||
Pyrithioxin dihydrochloride | 10049-83-9 | C16H20N2O4S2.2HCl | 441.38 | PYRITHIOXIN DIHYDROCHLORIDE;PYRITINOL DIHYDROCHLORIDE;PYRITINOL HYDROCHLORIDE;3,3'-(dithiodimethylene)bis(5-hydroxy-6-methyl-4-pyridinemethanodihydrochl;3,3'-dithiobis(methylene)bis(5-hydroxy-6-methyl-4-pyridinemethanol)dihydroch;3,3'-dithiodimethylenebi |
Pyrithioxin | 1098-97-1 | C16H20N2O4S2 | 368.47 | PYRITHIOXIN;PYRITHIOXINE;PYRITINOL;3,3'-(dithiobis(methylene))bis(5-hydroxy-6-methyl-4-pyridinemethano;3,3'-(dithiobis(methylene))bis(5-hydroxy-6-methyl-4-pyridinemethanol);3,3'-(dithiodimethylene)bis(5-hydroxy-6-methyl-4-pyridinemethano;biocefalin;bonol |
Pyrithiobac | 123342-93-8 | C13H11ClN2O4S | 326.76 | 2-Chloro-6-[(4,6-dimethoxy-2-pyrimidinyl)thio]benzoic acid; Pyrithiobac; Pyrithiobac [iso] |
Pyripyropene A | 147444-03-9 | C31H37NO10 | 583.6 | FO-1289A; PPPA |
Pyriproxyfen | 95737-68-1 | C20H19NO3 | 321.37 | Propiconazole; 2-[1-Methyl-2-(4-phenoxyphenoxy)ethoxy]pyridine; 2-((1-(4-Phenoxyphenoxy)propan-2-yl)oxy)pyridin |
Pyrintegrin | 1228445-38-2 | C23H25N5O3S | 451.54 | BCP19679; N-(cyclopropylmethyl)-4-[[4-(6-hydroxy-3,4-dihydro-2H-quinolin-1-yl)pyrimidin-2-yl]amino]benzenesulfonamide |
PYRIMITATE | 5221-49-8 | C11H20N3O3PS | 305.33 | ici29661; phosphorothioicacid,o-(2-(dimethylamino)-6-methyl-4-pyrimidinyl)o,o-diethyl; pyrimital; DIOTHYL; PYRIMITATE; Pyrimithate |
Pyrimidine-5-carboxamide | 40929-49-5 | C5H5N3O | 123.11 | 5-PYRIMIDINECARBOXAMIDE; 5-Pyrimidinecarboxamide (6CI, 7CI, 9CI); PYRIMIDINE-5-CARBOXAMIDE |
Pyrimidine-5-boronic acid hemihydrate | 696602-91-2 | C4H5BN2O2.0.5H2O | 132.91 (123.91anhy) | |
Pyrimidine-4-carbohydrazide | 39513-54-7 | C5H6N4O | 138.13 | Pyrimidine-4-carbohydrazide; 4-Pyrimidinecarboxylic acid hydrazide |
Pyrimidine-4,6-dicarbonitrile | 50844-89-8 | C6H2N4 | 130.10688 | pyrimidine-4,6-dicarbonitrile;Pyrimidine-4,6-dicarbonitrile;50844-89-8;4,6-PYRIMIDINEDICARBONITRILE;SCHEMBL3669699;CTK4J3245 |
Pyridoxine | 65-23-6 | C8H11NO3 | 2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine; 2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin; 2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine; 2-Picoline-4,5-dimethanol, 3-hydroxy-; 3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-; 3-hydroxy-2-picoline- | |
Pyridoxatin | 135529-30-5 | C15H21NO3 | 263.33 | Tolypocin; Pyridoxatine; (-)-Pyridoxatin; 3-[(1S,2R,4S,6R)-2-ethenyl-4,6-dimethylcyclohexyl]-1,4-dihydroxypyridin-2-one |
Pyridoxamine-5'-phosphate | 529-96-4 | C8H13N2O5P | 248.18 | |
Pyridoxamine dihydrochloride | 524-36-7 | C8H14Cl2N2O2 | 241.11 | Pyridoxamine 2HCl |
Pyridoxal-d5 5-Phosphate | 1246818-16-5 | C8H5D5NO6P | 252.17 | 3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinecarboxaldehyde-d5; Pyridoxal-d5 Phosphate; Pyridoxal-d5 5-(Dihydrogen Phosphate); 2-Methyl-3-hydroxy-4-formyl-5-pyridyl-methylphosphoric Acid-d5; 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde- |
Pyridoxal-5-Phosphate | 54-47-7 | C8H10NO6P | 247.15 | 3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinecarboxaldehyde; Pyridoxal Phosphate; Pyridoxal 5-(Dihydrogen Phosphate); 2-Methyl-3-hydroxy-4-formyl-5- pyridyl-methylphosphoric Acid; 3-Hydroxy-5-(hydroxymethyl)-2-methyl- isonicotinaldehyde 5-Phospha |
pyridoxal | 66-72-8 | C8H9NO3 | 167.16 | |
PuR | 660-33-4 | C10H12N4O4 | 262.2 | |
Pyridostigmine bromide | 101-26-8 | C9H13BrN2O2 | 261.12 | |
Pyridostatin TFA salt | 1472611-44-1 | C37H35F9N8O11 | 938.72 | 4-(2-aminoethoxy)-N2,N6-bis(4-(2-aminoethoxy)quinolin-2-yl)pyridine-2,6-dicarboxamide tris(2,2,2-trifluoroacetate); Pyridostatin; PDS; Pyridostatin TFA salt |
Pyridostatin pentahydrochloride | 1781882-65-2 | C31H32N8O5.5HCl | 778.94 | 4-(2-Aminoethoxy)N2,N6-bis[(4-(2-aminoethoxy)-2-quinolinyl]-2,6-pyridinecarboxamide pentahydrochloride |
Pyridostatin | 1085412-37-8 | C31H32N8O5 | 596.64 | RR-82 |
Pyridone 6 | 457081-03-7 | C18H16FN3O | 309.34 | JAK Inhibitor I; Merck-5; Merck 5; 4-tert-butyl-15-fluoro-3,5,10-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,14,16-heptaen-11-one |
Pyridomycin | 18791-21-4 | C27H32N4O8 | 540.6 | U24544, Antibiotic U24544, Erizomycin |
Pyridoclax | 1651890-44-6 | C29H22N4 | 426.52 | Pyridoclax; SCHEMBL17060301; CS-3777; KB-333747; B4901; 2-(5-methyl-6-pyridin-3-ylpyridin-3-yl)-3-[(E)-2-phenylethenyl]-5-pyridin-3-ylpyridine |
Pyrido[3,4-e]imidazo[1,5-a]pyrazin-4(5H)-one (9CI) | 240815-66-1 | C9H6N4O | 186.17014 | 240815-66-1; SCHEMBL4036186; CTK1A0343; ZINC39115187; KB-259549; Pyrido[3,4-e]imidazo[1,5-a]pyrazin-4-one |
Pyrido[3,4-d]pyrimidin-4(3H)-one,5,6,7,8-tetrahydro- | 859826-41-8 | C7H9 N3 O | 0 | 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(4aH)-one hydrochloride |
Pyrido[3,4-d]pyrimidin-4(1H)-one,2,3-dihydro-2-thioxo- | 412341-42-5 | C7H5 N3 O S | 179.2 | 2,3-DIHYDRO-2-THIOXO-PYRIDO[3,4-D]PYRIMIDIN-4(1H)-ONE |
Pyridinium,2-[2-[(5-bromo-2-pyridinyl)amino]ethenyl]-1-ethyl-6-methyl-, iodide (1:1) | 1463-95-2 | C15H17 Br N3 . I | 446.12405 | 2-[2-[(5-bromo-2-pyridyl)amino]vinyl]-1-ethyl-6-methylpyridinium iodide; QUATERNIUM-51; TAKANAL, QUATERNIUM-51; 2-[2-[(5-Bromopyridine-2-yl)amino]ethenyl]-1-ethyl-6-methylpyridinium·iodide; Kankohso 301; NK-343; Takanal |
Pyridinium,1-methyl-,chloride | 7680-73-1 | |||
Pyridinium,1-fluoro-4-methyl-2-sulfo-, inner salt | 147540-88-3 | C6H6 F N O3 S | 191.18 | DAIKIN MEC-02; N-FLUORO-4-METHYLPYRIDINIUM-2-SULFONATE; N-FLUORO-4-METHYLPYRIDINIUM-2-SULPHONATE |
Pyridine-3-sulfonamide | 2922-45-4 | C5H6N2O2S | 158.18 | pyridine-3-sulfonamide; 3-Pyridinesulfonamide; 2922-45-4; pyridine-3-sulfonicacidamide; NSC30572; 3-Pyridinesulphonamide |
Pyridine-3,4-diol | 10182-48-6 | C5H5NO2 | 111.10 | 3,4-pyridinediol; 3,4-DIHYDROXYPYRIDINE; 3,4-DIHYDROXYPYRIDINE 99%; Pyridine-3,4-diol |
PYRIDINE-2-CARBOXAMIC ACID | 31888-72-9 | C6H6N2O2 | 138.12404;g/mol | Picolinohydroxamicacid; 2-Pyridinehydroxamicacid; Pyridine-2-carbohydroxamicacid; N-Hydroxy-2-pyridinecarboxamide; 2-Pyridinecarboxamide,N-hydroxy-; 31888-72-9 |
Pyridine-2-boronic acid pinacol ester | 874186-98-8 | C11H16BNO2 | 205.06 | 2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE; Pyridine-2-boronic acid pinacol ester; Albb-006131 |
pyridine-2-aldoxime methyl methanesulfonate | 154-97-2 | |||
Pyridine-2,3-Dimethanol | 38070-79-0 | C7H9NO2 | 139.15 | PYRIDINE-2,3-DIMETHANOL; PYRIDINE-2,3-DIYLDIMETHANOL |
Pyridine,4-(iodomethyl)- | 138761-37-2 | C6H6 I N | 219.02 | 4-(iodomethyl)pyridine;Pyridine,4-(iodomethyl)-;138761-37-2;AC1LD5TV;pyridine,4-(iodomethyl)-;ACMC-1C1X6 |
Pyridine,3-chloro-4-fluoro- | 883107-69-5 | C5H3 Cl F N | 131.5354232 | 3-Cloro-4-fluoropyridine |
Pyridine,3-bromo-5-(2S)-2-pyrrolidinyl- | 83023-58-9 | C9H11 Br N2 | 227.1 | (2S)-5-BROMO-3-(2-PYRROLIDINYL)PYRIDINE |
Pyridine,3-(2R)-2-pyrrolidinyl- | 7076-23-5 | |||
Pyridine,2-methyl-3-[(5-nitro-2-pyridinyl)oxy]- | 200940-26-7 | C11H9 N3 O3 | 231.20746;g/mol | 2-methyl-3-(5-nitropyridin-2-yl)oxypyridine;200940-26-7;2-Methyl-3-((5-nitropyridin-2-yl)oxy)pyridine;PYRIDINE,2-METHYL-3-[(5-NITRO-2-PYRIDINYL)OXY]-;2-(2-Methylpyridin-3-yloxy)-5-nitropyridine;3-(5-nitropyridin-2-yloxy)-2-methylpyridine |
Punicalin | 65995-64-4 | C34H22O22 | ||
Punicalagin | 65995-63-3 | C48H28O30 | 2,3-(S)-hexahydroxydiphenoyl-4,6-(S,S)-gallagyl-D-glucose | |
Pungiolide A | 130430-97-6 | C29H34O9 | 526.57 | Pungiolide B |
Pungiolide A | 130395-54-9 | C30H36O7 | 508.611 | |
Puerarin 6''-O-xyloside | 114240-18-5 | C26H28O13 | 548.49 | |
Puerarin | 3681-99-0 | C21H20O9 | 416.38 | 8-b-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
PU 23 | 817635-93-1 | C21H19N3O3S2 | 425.52 | N-[[[4-[[(Phenylmethyl)amino]sulfonyl]phenyl]amino]thioxomethyl]benzamide |
PU 02 | 313984-77-9 | C16H12N4S | 292.36 | 6-[(1-Naphthalenylmethyl)thio]-9H-purine |
PTZ-343 | 101199-38-6 | C15H14NO3S2.Na | 343.4 | PTZ-343. |
PTZ-256 | 2095-21-8 | C15H16N2S | 256.37 | PTZ-256; phenothiazine derivative. |
PT-S58 | 1356497-92-1 | C17H22N2O5S2 | 398.49 | methyl 3-(N-(4-(tert-butylamino)-2-methoxyphenyl)sulfamoyl)thiophene-2-carboxylate |
p-Trimethylsiloxynitrobenzene | 1014-66-0 | C9H13NO3Si | 211.29 | P-TRIMETHYLSILOXYNITROBENZENE; trimethyl(4-nitrophenoxy)silane; p-trimethylsiloxynitrobenzene7%; p-Trimethylsiloxynitrobenzenemin97%; p-trimethylsiloxynitrobenzene min 97%; (4-Nitrophenyl)(trimethylsilyl) ether |
Ptp1B-In-2 | 1919853-46-5 | C34H36N2O9S2 | 680.787 | methyl 5-((4-((N-(4-(N-(2-methoxy-2-oxoethyl)methylsulfonamido)benzyl)-1-phenylmethyl)sulfonamido)phenoxy)methyl)-2-methylbenzoate |
PTP1B-IN-1 | 612530-44-6 | C8H8N2O3S | 212.23 | |
PTP1B Inhibitor | 765317-72-4 | C26H19Br2N3O7S3 | 741.5 | Protein Tyrosine Phosphatase 1B Inhibitor; FRJ; 3-(3,5-Dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide |
PTP Inhibitor IV | 329317-98-8 | C26H26F6N2O4S2 | 608.6 | Protein Tyrosine Phosphatase Inhibitor IV; Bis(4-Trifluoromethylsulfonamidophenyl)-1,4-diisopropylbenzene; 1,1,1-trifluoro-N-[4-[2-[4-[2-[4-(trifluoromethylsulfonylamino)phenyl]propan-2-yl]phenyl]propan-2-yl]phenyl]methanesulfonamide |
PT-2385 | 1672665-49-4 | C17H12F3NO4S | 383.34 | 3-[[(1S)-2,2-difluoro-1-hydroxy-7-methylsulfonyl-1,3-dihydroinden-4-yl]oxy]-5-fluorobenzonitrile PT-2385 SCHEMBL16555810 3-{[(1s)-2,2-Difluoro-1-Hydroxy-7-(Methylsulfonyl)-2,3-Dihydro-1h-Inden-4-Yl]oxy}-5-Fluorobenzonitrile 79A |
Pt(II) meso-tetra(pentafluorophenyl)porphine | 109781-47-7 | C44H8F20N4Pt | 1167.61 | PT(II) MESO-TETRA(PENTAFLUOROPHENYL)PORPHINE; 5,10,15,20-TETRAKIS-(2,3,4,5,6-PENTAFLUOROPHENYL)-PORPHYRIN-PT(II); 5,10,15,20-TETRAKIS(PENTAFLUOROPHENYL)-21H,23H-PORPHINE,PLATINUM(II) |
PT 1 | 331002-70-1 | C23H16ClN3O6S | 497.91 | 2-Chloro-5-[[5-[[5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-4-oxo-2-thiazolyl]amino]benzoic acid |
PSS-(3-Glycidyl)propoxy-Heptaisobutyl substituted | 444315-17-7 | C34H74O15Si8 | 931.63 | 1-(3-Glycidyl)propoxy-3,5,7,9,11,13,15-isobutylpentacyclo[9.5.1.13,9.15,15.17,13]octasiloxane, Glycidylisobutyl-POSS, POSS-Glycidyl-isobutyl substituted |
PSS-(3-CHLOROPROPYL)-HEPTACYCLOPENTYL S& | 308103-62-0 | C38H69ClO12Si8 | 978.08 | AC1MNSRF; 3-Chloropropyl-POSS® ; PSS-(3-Chloropropyl)-Heptacyclopentylsubstituted; 1-(3-Chloropropyl)-3,5,7,9,11,13,15-heptacyclopentylpentacyclo[9.5.1.13,9.15,15.17,13]octasiloxane; 308103-62-0 |
Psoromic acid | 7299-11-8 | C18H14O8 | 358.3 | NSC 92186; Parellic acid; 10-formyl-9-hydroxy-3-methoxy-4,7-dimethyl-6-oxobenzo[b][1,4]benzodioxepine-1-carboxylic acid |
Psoralidin | 18642-23-4 | C20H16O5 | 336.34 | 3,9-Dihydroxy-2-(3-methyl-2-butenyl)-6H-benzofuro[3,2-c][1]benzopyran-6-one, 3,9-Dihydroxy-2-prenylcoumestan |
Psoralenoside | 905954-17-8 | C17H18O9 | 366.3 | |
Psora 4 | 724709-68-6 | C21H18O4 | 334.37 | 4-(4-Phenylbutoxy)-7H-furo[3,2-g][1]benzopyran-7-one |
PSNCBAM-1 | 877202-74-9 | C22H21ClN4O | 392.88 | N-(4-Chlorophenyl)-N'-[3-[6-(1-pyrrolidinyl)-2-pyridinyl]phenyl]urea; PSNCBAM-1; PSNCBAM 1; PSNCBAM1 |
PSN632408 | 857652-30-3 | C18H24N4O4 | 360.41 | |
PSN 375963 hydrochloride | 388575-52-8 | C17H23N3O.HCl | 321.84 | 4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridine hydrochloride |
Psiguadial D | 1402066-95-8 | C30H34O5 | 474.597 | |
Psidial A | 1207181-35-8 | C30H34O5 | 474.6 | (2aR,4aR,10S,10aS,13aS)-7,9-Dihydroxy-2,2,4a-trimethyl-13-methyle ne-10-phenyl-1,2,2a,3,4,4a,10,10a,11,12,13,13a-dodecahydrocyclobu ta[6,7]cyclonona[1,2-b]chromene-6,8-dicarbaldehyde |
Psicose diacetonide | 205582-81-6 | 2,3:4,5-Di-O-isopropylidene-a-D-psicopyranose | ||
Psicofuranine | 1874-54-0 | C11H15N5O5 | 297.3 | Angustmycin C; NSC 53104; Psicofuranosyladenine; 1'-(Hydroxymethyl)adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-2,5-bis(hydroxymethyl)oxolane-3,4-diol |
PSI-6206 | 863329-66-2 | C10H13FN2O5 | 260.22 | RO-2433; RO 2433; RO2433; PSI6206; PSI 6206; GS331007; GS-331007; GS 331007; 2'-Deoxy-2'-fluoro-2'-C-methyluridine; 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidine-2,4-dione |
PSI-6130 | 817204-33-4 | C10H14FN3O4 | 259.23 | PSI-6130; PSI-6130; PSI-6130; R 1656; R-1656; R1656. |
Pseurotin A | 58523-30-1 | C22H25NO8 | 431.4 | |
Pseudouridine B | 10017-66-0 | C9H12N2O6 | 244.203 | |
pseudouridine | 1445-07-4 | C9H12N2O6 | 244.2 | 2,4(1H,3H)-Pyrimidinedione, 5-b-D-ribofuranosyl-; beta-Pseudouridine; psi-Uridine |
Pseudothymidine | 65358-15-8 | C10H14N2O5 | 242.23 | |
Pseudoprotogracillin | 637349-03-2 | C51H82O22 | Pseudoprotogracillin | |
Pseudoprotodioscin | 102115-79-7 | C51H82O21 | 1031.18 | Protogracellin |
Pseudopalmatine | 19716-66-6 | C21H22NO4 | 352.4 | 5,6-Dihydro-2,3,10,11-tetramethoxydibenzo[a,g]quinolizinium;5,6-Dihydro-8-desmethylcoralyne; 2,3,10,11-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium |
Mupirocin calcium EP impurity C sodium | 85178-60-5 | C26H41NaO9 | 520.59 | Pseudomonic Acid D Sodium |
Mupirocin | 12650-69-0 | C26H44O9 | 500.62 | (2E)-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-oxiranyl]methyl]-3-methyl-L-talo-non-2-enonic Acid 8-Carboxyoctyl Ester; BRL 4910A; Bactoderm; Bactroban; Bactroban Ointment; Mupirocin Neo-Sensitabs; Mupricin; Pseudomon |
Pseudolaric Acid C | 82601-41-0 | C21H26O7 | 390.4 | (3R,4R,4aS,9aR)-rel-3-[(1E,3E)-4-Carboxy-1,3-pentadienyl]-3,4,4a,5,6,9-hexahydro-4a-hydroxy-3-methyl-1-oxo-1H-4,9a-ethanocyclohepta[c]pyran-7-carboxylic acid 7-methyl ester; Deacetylpseudolaric acid B |
Pseudolaric acid B-O-beta-D-glucopyranoside | 98891-41-9 | C29H38O13 | 594.6 | Pseudolaric acid B-glucopyranoside; Pseudolaric acid B beta-D-glucoside |
Pseudolaric Acid B | 82508-31-4 | C23H28O8 | 432.46 | PLAB; 1H-4,9a-Ethanocyclohepta[c]pyran-7-carboxylicacid,4a-(acetyloxy)-3-[(1E,3E)-4-carboxy-1,3-pentadien-1-yl]-3,4,4a,5,6,9-hexahydro-3-methyl-1-oxo-,7-methyl ester, (3R,4S,4aS,9aR)-; Pseudolarix acid B; Pseudolaric acid |
Pseudolaric Acid A | 82508-32-5 | C22H28O6 | (2E,4E)-5-[(4aS)-4a-(acetyloxy)-3,7-dimethyl-1-oxo-3,4,4a,5,6,9-hexahydro-4,9a-ethanocyclohepta[c]pyran-3(1H)-yl]-2-methylpenta-2,4-dienoic acid | |
Pseudojervine | 36069-05-3 | C33H49NO8 | 587.7 | Pseudojervin; Jervin-3-glucoside; O-beta-D-Glucopyranosyljervine |
Pseudoisocytidine hydrochloride | 57100-20-6 | 279.73 | ||
Pseudohypericin | 55954-61-5 | C30H16O9 | 520.44 | PSEUDOHYPERICIN; Phenanthro[1,10,9,8-opqra]perylene-7,14-dione,1,3,4,6,8,13-hexahydroxy-10-(hydroxymethyl)-11-methyl-; 1,3,4,6,8,13-Hexahydroxy-10-(hydroxymethyl)-11-methylphenanthro[1,10,9,8-opqra]perylene-7,14-dione; 1,3,4,6,8,13-Hexahydroxy-10-hydroxym |
Pseudoginsenoside-RT5 | 98474-78-3 | C36H62O10 | (3beta,6alpha,12beta,24R)-20,24-Epoxy-3,12,25-trihydroxydammaran-6-yl beta-D-glucopyranoside; 24(R)-Pseudoginsenoside rt(5); b-D-Glucopyranoside, (3b,6a,12b,24R)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl | |
Pseudoginsenoside Rt1 | 98474-74-9 | C47H74O18 | 927.1 | |
Pseudoginsenoside Rh2 | 1370264-16-6 | C36H62O8 | 622.87 | (3b,12b,20E)-12,25-Dihydroxydammar-20(22)-en-3-yl b-D-glucopyranoside; Ginsenoside Rh10 |
Pseudoginsenoside Rg3(E) | 1012886-99-5 | C42H72O13 | 785.02 | |
Pseudoerythromycin A enol ether | 105882-69-7 | C37H65NO12 | 715.9 | |
Pseudoaspidin | 478-28-4 | C25H32O8 | 460.5 | 1-[3-[(3-butanoyl-2,6-dihydroxy-4-methoxy-5-methylphenyl)methyl]-2,4-dihydroxy-6-methoxy-5-methylphenyl]butan-1-one |
Pseudo Vardenafil | 224788-34-5 | C22H29N5O4S | 459.57 | 2-[2-Ethoxy-5-(1-piperidinylsulfonyl)phenyl]-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one; Piperidenafil; Pseudovardenafil |
PSEM 89S | 1336913-03-1 | C16H22N2O3·CF3CO2H | 404.38 | N-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,5-dimethoxybenzamide trifluoroacetate |
PSEUDO PHYTOL | 70851-60-4 | C20H36O | 292.50 | 6,10,14-Hexadecatrien-3-ol, 3,7,11,15-tetramethyl-, Dihydro Geranyl Linalool, Geranyl dihydrolinalool, PSEUDO PHYTOL |
Protriptyline-d3 Hydrochloride | 1435934-21-6 | C19H19D3ClN | 302.86 | N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine-d3 Hydrochloride; N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine-d3 Hydrochloride; N-Methyl-5H-Dibenzo[a,d]cycloheptene-5-propylamine-d3 Hydrochloride; Concordin-d3; MK-240-d3; Maximed-d3; Maximet-d3; |
PS-1145 | 431898-65-6 | C17H11ClN4O | 322.75 | N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)nicotinamide; PS-1145; PS 1145; PS1145 |
PSB 1115 | 152529-79-8 | C14H14N4O5S | 350.35 | 4-(2,3,6,7-Tetrahydro-2,6-dioxo-1-propyl-1H-purin-8-yl)-benzenesulfonic acid |
PSB-SB1202 | 1399049-60-5 | C23H26O4 | 366.5 | 5-Methoxy-3-[(2-methoxyphenyl)methyl]-7-pentylchromen-2-one |
PSB-12062 | 55476-47-6 | C19H15NO3S | 337.39 | 10-(4-methylphenyl)sulfonylphenoxazine; N-(p-methylphenylsulfonyl)phenoxazine; PSB-12062; 10-tosyl-10H-phenoxazine |
PSB 603 | 1092351-10-4 | C24H25ClN6O4S | 529.01 | 8-[4-[4-(4-Chlorophenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine |
PSB 36 | 524944-72-7 | C21H30N4O3 | 386.49 | 1-Butyl-8-(hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-3-(3-hydroxypropyl)-1H-purine-2,6-dione |
PSB 11 hydrochloride | 453591-58-7 | C16H17N5O.HCl | 331.8 | (8R)-8-Ethyl-1,4,7,8-tetrahydro-4-5H-imidazo[2,1-i]purin-5-one hydrochloride; (R)-8-ethyl-4-methyl-2-phenyl-7,8-dihydro-3H-imidazo[2,1-i]purin-5(4H)-one Hydrochloride |
PSB 10 hydrochloride | 591771-91-4 | C16H14Cl3N5O.HCl | 435.14 | 8-Ethyl-1,4,7,8-tetrahydro-4-methyl-2-(2,3,5-trichlorophenyl)-5H-imidazo[2,1-i]purin-5-one monohydrochloride |
Pleconaril | 153168-05-9 | C18H18F3N3O3 | 381.35 | 3-[3,5-dimethyl-4-[3-(3-methyl-1,2-oxazol-5-yl)propoxy]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole 3-(3,5-dimethyl-4((3-(3-methyl-5-isoxazolyl)propyl)phenyl)-5-trifluoromethyl)-1,2,4-oxadiazole Picovir pleconaril |
Plecanatide | 467426-54-6 | C65H104N18O26S4 | 1681.89 | |
PND-1186 (VS-4718) | 1061353-68-1 | C25H26F3N5O3 | 501.5 | SR-2156 |
PND-1186 | 1356154-94-3 | C25H26F3N5O3 | 537.968 | PND-1186; PND 1186; PND1186; SR 2516; SR-2516; SR2516. |
PN401 | 4105-38-8 | C15H18N2O9 | 370.314 | Uridine, 2',3',5'-triacetate; 2',3',5'-Tri-O-acetyluridine; 2',3',5'-Triacetyluridine; PN 401; RG 2133; Tri-O-acetyl uridine; Uridine triacetate; PN401, PN 401, PN-401, RG 2133, RG2133, RG-2133, Tri-O-acetyluridine, Triacetyluridine, Uridine triacetate, V |
p-Methoxyphenyl 1-thio-b-D-galactopyranoside | 41341-62-2 | |||
PMX 53 | 219639-75-5 | C47H65N11O7 | 896.1 | PMX 53; PMX 53; PMX53; Ac-Phe-cyclo(Orn-Pro-D-Cha-Trp-Arg); AcPhe(ornithine-Pro-cyclohexylamine-Trp-Arg. AcPhe(ornithine-Pro-cyclohexylamine-Trp-Arg) |
PMX 464 | 485842-97-5 | C13H9NO2S | 243.28 | 4-(2-Benzothiazolyl)-4-hydroxy-2,5-cyclohexadien-1-one |
Pitavastatin | 147511-69-1 | C25H24FNO4 | 421.46 | Zypitamag; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-3,5-Dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-6-heptenoic acid; Itavastatin; Livalo; NK 104; itavastatinn; NK-104; NK104; P 8 |
Pitavastatin Lactone | 141750-63-2 | C25H22FNO3 | 403.46 | Itavastatin Lactone; (4R,6S,E)-6-[2-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl] vinyl] tetrahydro-4-hydroxypyran-2-one |
Pitavastatin Impurity 8 | 1044518-75-3 | C13H22O5 | 258.32 | 3,5-Dideoxy-2,4-O-(1-methylethylidene)-D-erythro-hexuronic Acid 1,1-Dimethylethyl Ester |
Pitavastatin Impurity 5 | 147489-06-3 | C32H36FNO4 | 517.63 | t-Butyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate; (4R,6S)-6-[(1E)-2-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester; Pitavastatin Impurit |
Pitavastatin Ethyl Ester | 167073-19-0 | C27H28FNO4 | 449.51 | 5-dihydroxy-6-heptenoic acid ethyl ester; (3R,5S)-3,5-Dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-6-heptenoic acid ethyl ester; (E)-(3R,5S)-7-[2-Cyclopropyl-4-(4-fluoro-phenyl)-quinolin-3-yl]-3,5-dihydroxy-hept-6-enoic acid ethyl ester; (3 |
Pitavastatin Defuoro Impurity Calcium Salt | 1258947-30-6 | C50H48N2O8.Ca | 845.03 | |
Pitavastatin Calcium | 147526-32-7 | C50H46CaF2N2O8 | 880.98 | (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt; Flovas; Livalo; NK 104; NK 104 (acid); Pitava 1; Pitavastatin Hemicalcium; Pitavastatin Calcium Salt; calcium (E)-7-(2-cyclopropyl-4-(4-fluorophenyl) |
Pitavastatin 5-Oxo Impurity | 222306-15-2 | C25H22FNO4 | 419.46 | (3R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3-hydroxy-5-oxo-6-heptenoic Acid |
Pitavastatin 3-Oxo Ethyl Ester | 148901-69-3 | C27H26FNO4 | 447.51 | (E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoic Acid Ethyl Ester |
PIT 1 | 53501-41-0 | C14H10ClN3O4S | 351.76 | N-[[(3-Chloro-2-hydroxy-5-nitrophenyl)amino]thioxomethyl]benzamide |
PIT | 56583-49-4 | C13H8N2O2.C7H8O3S | 396.42 | 2-(2-Pyridinyl)-(3H)-indol-3-one-1-oxide 4-methylbenzenesulfonate; 2,2'-Pyridylisatogen tosylate |
p-Isobutyl Benzaldehyde | 4015-98-9 | C11H14O | 0 | 4-(2-methylpropyl)benzaldehyde; 4-Isobutylbenzaldehyde; 40150-98-9; p-Isobutylbenzaldehyde; 4-(2-Methylpropyl)benzaldehyde; p-isobutylbenzaldehyde |
Phosalone | 2310-17-0 | C12H15ClNO4PS2 | 367.81 | 6-chloro-3-(diethoxyphosphinothioylsulfanylmethyl)-1,3-benzoxazol-2-one fosalon fozalone phoazlone phosalone phozalone Zolone |
PHORWHITE REU | 82640-05-9 | 0 | acidmonosodiumsaltanddiethanolamine; azin-2-yl)amino]-,disodiumsalt,reactionproductswith2-aminoethanesulfonic; Benzenesulfonicacid,2,2'-(1,2-ethenediyl)bis[5-(4-chloro-6-methoxy-1,3,5-triazin-2-yl)amino]-,disodiumsalt,reactionproductswith2-aminoethanesulf | |
Phenyldiethoxysilane | 17872-93-4 | C10H16O2Si | 196.32 | PHENYLDIETHOXYSILANE |
PSB 0788 | 1027513-54-7 | C25H27ClN6O4S | 543.04 | 8-[4-[4-(4-Chlorobenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine |
PSB 0777 ammonium salt | 2122196-16-9 | C18H20N5O7S2.NH4 | 500.55 | 4-[2-[(6-Amino-9-b-D-ribofuranosyl-9H-purin-2-yl)thio]ethyl]benzenesulfonic acid ammonium salt |
PSB 0739 | 1052087-90-7 | C26H17N3Na2O8S2 | 609.54 | 1-Amino-9,10-dihydro-9,10-dioxo-4-[[4-(phenylamino)-3-sulfophenyl]amino]-2-anthracenesulfonic acid sodium salt; PSB-0739; PSB 0739; PSB0739 sodium |
PSB 069 | 78510-31-3 | C20H12N2O5ClSNa | 450.83 | 1-Amino-4-(4-chlorophenyl)aminoanthraquinone-2-sulfonic acid sodium salt |
PSB 06126 | 1052089-16-3 | C24H15N2NaO5S | 466.44 | 1-Amino-4-(1-naphthyl)aminoanthraquinone-2-sulfonic acid sodium salt |
Psammaplin A | 110659-91-1 | C22H24Br2N4O6S2 | 664.39 | PsammaplinA; 110659-91-1; Bisprasin; NSC614495; AC1O46WI; SCHEMBL364511 |
PS 48 | 1180676-32-7 | C17H15ClO2 | 286.75 | (Z)-5-(4-Chlorophenyl)-3-phenylpent-2-enoic acid |
PS 47 | 1180676-33-8 | C17H15ClO2 | 286.75 | (E)-5-(4-Chlorophenyl)-3-phenylpent-2-enoic acid |
PS 1145 dihydrochloride | 1049743-58-9 | C17H11ClN4O.2HCl | 395.67 | N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)nicotinamide; PS-1145; PS 1145; PS1145 |
Przewaquinone A | 76843-23-7 | C19H18O4 | 310.4 | 6,7,8,9-Tetrahydro-1-(hydroxymethyl)-6,6-dimethylphenanthro[1,2-b]furan-10,11-dione |
Przewalskinic acid A | 136112-75-9 | C18H14O8 | 358.3 | |
Prynachlor | 21267-72-1 | C12H12ClNO | 221.68 | 2903h; 2-chloro-n-(1-methyl-2-propynyl)-acetanilid; 2-chloro-n-(1-methyl-2-propynyl)-n-phenyl-acetamid; 2-chloro-n-(1-methyl-2-propynyl)-n-phenylacetamide; 2-chloro-n-(3-butynyl)-acetanilid; bas2900h |
PRX-08066 maleic acid | 866206-55-5 | C19H17ClFN5S·C4H4O4 | 517.96 | PRX-08066 maleate; 5-[[4-[(6-Chlorothieno[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl]methyl]-2-fluoro-benzonitrile (2Z)-2-Butenedioate |
PRX-07034 hydrochloride | 903580-39-2 | C21H28ClN3O4S·HCl | 490.44 | PRX-07034; PRX07034; PRX 07034; PRX-07034 HCl; N-(1-(5-Chloro-2,3-dimethoxyphenyl)ethyl)-2-(methylsulfonyl)-5-(piperazin-1-yl)aniline hydrochloride |
PRX 08066 | 866206-54-4 | C19H17ClFN5S | 401.89 | 5-[[4-[(6-chlorothieno[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]methyl]-2-fluorobenzonitrile |
Prunus serotina, ext. | 84604-07-9 | 0 | Prunus serotina, ext.; PRUNUS SEROTINA (WILD CHERRY) FRUIT EXTRACT; WILD CHERRY BARK EXTRACT; CHERRY BARK FLUID EXTRACT; CHERRY BARK SOLID EXTRACT | |
Prunus pygeum africana extract | 85865-74-3 | Prunus pygeum africana extract; Pygeum africanum extract | ||
PRUNUS INSITITIA SEED OIL | 216446-21-8 | |||
Prunetrin | 154-36-9 | C22H22O10 | 446.40 | Prunetin 4'-O-glucoside |
Prunetin 5-glucoside | 89595-66-4 | C22H22O10 | 446.40 | |
Prunetin | 552-59-0 | C16H12O5 | 284.26 | 4',5-Dihydroxy-7-methoxy-isoflavon;5-Hydroxy-3-(4-hydroxyphenyl)-7-metho xy-4-benzopyrone. |
Prunasin | 99-18-3 | C14H17NO6 | 295.3 | (r)-Alpha-(beta-d-glucopyranosyloxy)benzene-acetonitrile;(r)-Benzeneacetoni tril;(r)-Prunasin;d-Prunasin |
Prulifloxacin-d8 | 1246819-37-3 | C21H12FN3O6SD8 | 469.52 | 6-Fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-(piperazinyl-d8)]-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid; NM 441-d8; Quisunlabelled8; Sword-d8 |
Prulifloxacin | 123447-62-1 | C21H20FN3O6S | 461.46 | NM441; NM 441; NM-441 |
Prulifloxacin | 123447-63-2 | C21H20FN3O6S | 461.46 | |
Prudomestin | 3443-28-5 | C17H14O7 | 330.3 | 3,5,7-trihydroxy-4',8-dimethoxyflavone |
Prucalopride Succinate | 179474-85-2 | C18H26ClN3O3 C4H6O4 | 458.97 | 4-amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide succinate; R-108512; R 108512; R108512; Prucalopride Succinate; Resolor; Resotran |
Prucalopride N-Oxide | 1900715-98-1 | C18H26ClN3O4 | 383.88 | |
Prucalopride Impurity 6 | 1608459-56-8 | C18H27N3O3 | 333.43 | |
Prucalopride Impurity 4 | 1599434-55-5 | C17H24ClN3O3 | 353.85 | |
Prucalopride | 179474-81-8 | C18H26ClN3O3 | 367.87 | Resolor; 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide |
PRT4165 | 31083-55-3 | C15H9NO2 | 235.24 | PRT4165; PRT-4165; PRT 4165. |
PRT062607 | 1370261-96-3 | C19H23N9O | 393.45 | PRT-062607; P505-15; PRT-2607; BIIB-057 |
PRT-060318 | 1194961-19-7 | C18H24N6O | 340.431 | PRT-060318; PRT 060318; PRT060318; PRT318; P1426. |
PRP-194 | 596085-87-9 | C10H11ClN2 | 194.662 | PRP-194; 5-chloro-2,3,3-trimethyl-3H-pyrrolo[2,3-b]pyridine |
ProTx II | 484598-36-9 | C168H250N46O41S8 | 3826.59 | YCQKWMWTCDSERKCCEGMVCRLWCKKKLW |
Proxyphylline | 603-00-9 | C10H14N4O3 | 238.2 | NSC 163343; Proxiphylline; Purophyllin; Monophylline; 7-(2-hydroxypropyl)-1,3-dimethylpurine-2,6-dione |
Proxymetacaine hydrochloride | 5875-06-9 | C16H26N2O3.HCl | 330.85 | Proxymetacaine hydrochloride |
Proxyl fluorescamine | 216779-95-2 | C26H29N2O5K | 487.61 | PROXYL FLUORESCAMINE; PROXYL FLUORESCAMINE, POTASSIUM SALT; 5-(2-CARBOXYPHENYL)-5-HYDROXY-1-((2,2,5,5-TETRAMETHYL-1-OXYPYRROLIDIN-3-YL)-METHYL)-3-PHENYL-2-PYRROLIN-4-ONE, POTASSIUM SALT |
Proxyfan oxalate | 177708-09-7 | C13H16N2O.C2H2O4 | 306.32 | 4-[3-(Phenylmethoxy)propyl]-1H-imidazole oxalate |
Proxyfan oxalate | 1620017-81-3 | C13H16N2O·C2H2O4 | 306.32 | 4-[3-(Phenylmethoxy)propyl]-1H-imidazole oxalate |
Proxmethol | 27298-75-5 | C9H19NO2 | 173.26 | 3-(Hydroxymethyl)-1-oxy-2,2,5,5-tetramethylpyrrolidine; 3-(Hydroxymethyl)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy |
Proxibarbal | 2537-29-3 | C10H14N2O4 | ||
proxan-sodium | 140-93-2 | C4H7NaOS2 | 158.21 | SODIUM ISOPROPYLXANTHATE; sodium o-isopropyl dithiocarbonate; proxan sodium; Isopropylxanthic acid sodium salt; aeroxanthate343; carbonicacid,dithio-,o-isopropylester,sodiumsalt; carbonodithioicacid,o-(1methylethyl)ester,sodiumsalt; Carbonodithioicacid,O- |
provitamin C | 16533-48-5 | C6H10O7 | 0 | provitamin C; 36389-86-3 (Mono-hydrochloride salt); Xylo-2-hexulosonic acid |
ProTx I | 484598-35-8 | C171H245N53O47S6 | 3987.51 | ECRYWLGGCSAGQTCCKHLVCSRRHGWCVWDGTFS |
Protriptyline Hydrochloride | 1225-55-4 | C19H21N.HCl | 299.84 | PROTRIPTYLINE HCL;PROTRIPTYLINE HYDROCHLORIDE;5-(3-methylaminopropyl)-5h-dibenzo(a,d)cycloheptenehydrochloride;concordin;d)cyclohepten-5-propylamine,n-methyl-5h-dibenzo(hydrochloride;maximed;mk-240;n-methyl-5h-dibenzo(a,d)cycloheptene-5-propylaminehydroc |
Protease type viii bacterial | 9014-01-1 | |||
Protamines, sulfates | 9009-65-8 | angiociclan; dilangio; fluxema; Protamines,sulfates; usafd-4; vasorelax; CLUPEINE SULFATE; SALMINE | ||
Protamine sulfate | 53597-25-4 | |||
Protamine from salmon | 9012-00-4 | |||
proTAME | 1362911-19-0 | C34H38N4O12S | 726.75 | Pro-N-4-tosyl-L-arginine methyl ester; Methyl (2S)-5-[bis[(2-phenylacetyl)oxymethoxycarbonylamino]methylideneamino]-2-[(4-methylphenyl)sulfonylamino]pentanoate |
Propranolol-2-O-b-D-glucuronide | 66322-66-5 | C22H29NO8 | 435.47 | |
Prosulfuron | 94125-34-5 | C15H16F3N5O4S | 419.38 | PEAK; PROSULFURON; EXCEED; 1-(4-Methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea; N-((3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino)carbonyl)-2-(3,3,3-trifluoropropyl)benzone sulfnamide; PROSULFURON PESTANAL, 100 MG; p |
Prostephanaberrine | 105608-27-3 | C19H21NO5 | 343.38 | Prostephanaberrine |
Prostaglandin J2 | 60203-57-8 | C20H30O4 | 334.5 | PGJ2; 9-Deoxy-delta-9-prostaglandin D2; 9-Deoxy-delta-9-pgd2; (Z)-7-[(1S,5R)-5-[(E,3S)-3-hydroxyoct-1-enyl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid |
Prostaglandin I3 sodium salt | 68324-96-9 | C20H29O5·Na | 372.4 | PGI3; 6,9alpha-Epoxy-11alpha,15S-dihydroxy-prosta-5Z,13E,17Z-trien1-oic acid sodium salt |
Prostaglandin E2 ethanolamide | 194935-38-1 | C22H37NO5 | 395.5 | Dinoprostone ethanolamide; PGE2-EA; Prostamide E2; N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine |
Prostaglandin E2 | 363-24-6 | C20H32O5 | 352.47 | Dinoprostone; PGE2; Prostin E2; (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid |
Prostaglandin E1 alcohol | 21562-57-2 | C20H36O4 | 340.5 | 1-Hydroxy prostaglandin E1; PGE1 Alcohol; (2R,3R,4R)-4-hydroxy-2-(7-hydroxyheptyl)-3-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentan-1-one |
Prostaglandin E1 | 745-65-3 | C20H34O5 | 354.48 | l-PGE1; l-Prostaglandin E1; Lipoprost; Liprostin; Minprog; NSC 165559; ONO 1608; PGE-1; Promostan; Prostaglandin E1; Prostandin; Alprostadil; Topiglan; Vasaprostan. U 10136; U-10,136. |
Prostaglandin D2 | 41598-07-6 | C20H32O5 | 352.5 | PGD2; 11-Dehydroprostaglandin F2-alpha; (Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid |
Proscillaridin A | 466-06-8 | C30H42O8 | 530.65 | Scillarenin 3b-rhamnoside; 3-(6-Deoxy-a-L-mannopyranosyloxyl)-14-hydroxybufa-4,20,22-trienolide |
Prosaptide TX14(A) | 196391-82-9 | C69H110N16O26 | 1579.72 | H-Thr-D-Ala-Leu-Ile-Asp-Asn-Asn-Ala-Thr-Glu-Glu-Ile-Leu-Tyr-OH trifluoroacetate salt; Prosaptide trifluoroacetate salt; TX14(A) trifluoroacetate salt; TXLIDNNATEEILY (Modifications: Ala-2 = D-Ala) trifluoroacetate salt; TaLIDNNATEEILY trifluoroacetate sal |
Prosapogenin D | 103629-72-7 | C36H58O8 | 618.8 | |
Prosapogenin CP6 | 72629-76-6 | C46H74O16 | 882.5 | clematoside S; Saponin CP6 |
Prosaikogenin A | 99365-21-6 | C36H58O8 | 618.84 | |
Proroxan | 33743-96-3 | C21H23NO3 | 337.417 | Proroxan; 1-(7,10-dioxabicyclo[4.4.0]deca-2,4,11-trien-3-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one hydrochloride; 1-Propanone, 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenyl-1-pyrrolidinyl)-; 33025-33-1 (Hydrochloride); Proroxan [inn]; Proroxanum |
Proquazone | 22760-18-5 | C18H18N2O | 278.34832;g/mol | PROQUAZONE; Arthrex; Biarison; 22760-18-5; Proquazonum[INN-Latin]; Sandoz43-715 |
Propyphenazone-d3 (2-N-methyl-d3) | 162935-29-7 | C14H15D3N2O | 233.33 | 4-Isopropylantipyrine; 4-Isopropyl-2,3-dimethyl-1-phenyl-5-pyrazolone |
Propyphenazone EP impurity A | 60-80-0 | C11H12N2O | 188.23 | Antipyrine, Phenazone, Azophen, NSC 7945, NSC 7945, NSC 7945, Auralgan |
PROPYNYLLITHIUM | 4529-04-8 | |||
propynyl (r)-2-(4-((5-chloro-3-fluoro-2-pyridinyl)oxy)phenoxy)propanoate | 105512-06-9 | C17H13ClFNO4 | 349.74 | propynyl (r)-2-[4-[(5-chloro-3-fluoro-2-pyridinyl)oxy] phenoxy]propanoate; Topik; CLODINAFOP-PROPARGYL; CLODINAFOP-PROPARGYL ESTER; cga-184927; CLODINAFOP-PROPARGYL PESTANAL |
Propyltriacetoxysilane | 17865-07-5 | C9H16O6Si | 248.30524 | PROPYLTRIACETOXYSILANE MIN 97; propyl-silanetriotriacetate; Silanetriol,propyl-,triacetate; propyltriacetoxysilane min 97%; Propylsilanetriol triacetate; n-Propyltriacetoxysilane |
Propylthiouracil-d5 | 1189423-94-6 | C7H5N2OSD5 | 175.26 | 2,3-Dihydro-6-(propyl-d5)-2-thioxo-4(1H)pyrimidinone; 6-(Propyl-d5)-2-thiouracil; 2-Mercapto-4-hydroxy-6-n-propyl-d5-pyrimidine; 2-Mercapto-6-(propyl-d5)-pyrimidin-4-ol; Procasil-d5; Propacil-d5; Propycil-d5 |
Propylthiouracil N-b-D-glucuronide | 33987-24-5 | C13H18N2O7S | 346.36 | 1-Deoxy-1-(3,4-dihydro-4-oxo-6-propyl-2-thioxo-1(2H)-pyrimidinyl)- b-D-glucopyranuronic acid |
Propylthiouracil | 51-52-5 | C7H10N2OS | 170.23 | 6-n-Propylthiouracil; 6-Propyl-2-thiouracil; PTU |
Propylphosphonic dichloride | 4708-04-7 | C3H7Cl2OP | 160.966842;g/mol | Propylphosphonicdichloride; 4708-04-7; 1-PROPANEPHOSPHONICDICHLORIDE; 1-dichlorophosphorylpropane; ACMC-1ANRV; AC1Q3VGZ |
Propoxyphenyl-Thiosildenafil | 479073-87-5 | C23H32N6O3S2 | 504.68 | |
Propoxyphenyl Thiohomosidenafil | 479073-88-6 | C24H34N6O3S2 | 518.7 | |
Propoxyphenyl-Hydroxyhomosildenafil | 139755-87-6 | C24H34N6O5S | 518.63 | |
Propolis | 9009-62-5 | PROPOLIS; Bee bread; CUBANREDPROPOLIS | ||
Propoxyphenyl Thioaildenafil | 856190-49-3 | C24H34N6O3S2 | 518.7 | rel-5-[5-[[(3R,5S)-3,5-Dimethyl-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidine-7-thione; (3R,5S)-rel-1-[[3-(4,7-Dihydro-1-methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxyphenyl]sulfo |
Propoxyphenyl Sildenafil | 877777-10-1 | C23H32N6O4S | 488.61 | 1,6-Dihydro-1-methyl-5-[5-[(4-methyl-1-piperazinyl)sulfonyl]-2-propoxyphenyl]-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; 1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxyphenyl]sulfonyl]-4-methyl-piperazine; O-Desethy |
Propoxylated glycerin | 25791-96-2 | C3H8O3.(C3H6O)n | 0 | 2-ethanediyl),.alpha.,.alpha.',.alpha.''-1,2,3-propanetriyltris(.omega.-hydroxy-Poly[oxy(methyl-1; bypolet34; bypolet36; glycerolpoly(oxypropylene)triol; glycerolpropoxylate(1po/oh); glycerol-propylenoxidepolymer; glycols,polypropylene,1,2,3-propanetriyle |
Propoxycaine Hydrochloride | 550-83-4 | C16H27ClN2O3 | 330.85 | 4-Amino-2-propoxybenzoic Acid 2-(Diethylamino)ethyl Ester Monohydrochloride; 2-Diethylaminoethyl 4-Amino-2-propoxybenzoate Hydrochloride; 2'-Diethylaminoethyl 2-Propoxy-4-aminobenzoate Hydrochloride; Blockaine Hydrochloride; Pravocaine Hydrochloride; Prop |
Propoxycaine | 86-43-1 | C16H26N2O3 | 294.392 | |
Propofol-d17 | 1261393-54-7 | C12HOD17 | 195.38 | 2,6-Bis(1-methylethyl)phenol-d17; 2,6-Diisopropylphenol-d17; 2,6-Bis(isopropyl)phenol-d17; 2,6-Diisopropylphenol-d17; Ampofol-d17; Anepol-d17; Aquafol-d17; Diprifusor-d17; Diprivan-d17; Diprivan 10-d17; Diprofol-d17; Disoprivan-d17; Disoprofol-d17; Fresof |
PROPOFOL-4-HYDROXY-4-HYDROGENSULFATE | 114991-27-4 | C12H18O5S | 274.33 | PROPOFOL-4-HYDROXY-4-HYDROGENSULFATE |
Propofol Impurity O | 74663-48-2 | C12H18O | 178.28 | 2-(1-Methylethyl)-6-propylphenol; Propofol EP Impurity O; 2-Isopropyl-6-propylphenol |
Propofol Impurity N | 13423-73-9 | C13H18O3 | 222.29 | 4-Hydroxy-3,5-bis(1-methylethyl)benzoic Acid; 4-Hydroxy-3,5-diisopropylbenzoic Acid; Propofol EP Impurity N;Propofol 4-Carboxylic Acid |
Propofol Impurity L | 201166-22-5 | C12H16O2 | 192.26 | 2,2-Dimethyl-4-(1-methylethyl)-1,3-benzodioxole; Propofol EP Impurity L; |
Propofol Impurity K | 14366-59-7 | C12H18O | 178.28 | 1-(1-Methylethoxy)-2-(1-methylethyl)benzene; o-Cumenyl Isopropyl Ether; Propofol EP Impurity K; Isopropyl 2-Isopropylphenyl Ether |
Propofol Impurity J | 1988-11-0 | C12H16O2 | 192.26 | 2,6-Bis(1-methylethyl)-2,5-cyclohexadiene-1,4-dione; 2,6-Diisopropyl-p-benzoquinone; Propofol EP Impurity J; 2,6-Diisopropyl-1,4-benzoquinone |
Propofol Impurity G | 141214-18-8 | C15H24O | 220.36 | 2-(1-Methylethoxy)-1,3-bis(1-methylethyl)benzene; Propofol EP Impurity G; Propofol Isopropyl Ether |
Propofol Impurity E | 2416-95-7 | C24H34O2 | 354.54 | 3,3',5,5'-Tetrakis(1-methylethyl)-[1,1'-biphenyl]-4,4'-diol; 2,2',6,6'-Tetraisopropyl-p,p'-biphenol; 3,3',5,5'-Tetraisopropyl-4,4'-dihydroxybiphenyl; Propofol EP Impurity E; Dipropofol |
Propofol Impurity D | 35946-91-9 | C12H18O | 178.28 | 2,5-Bis(1-methylethyl)phenol; Propofol EP Impurity D; 2,5-Diisopropylphenol |
Propofol Impurity B | 74926-89-9 | C12H16O | 176.26 | 2-(1-Methylethenyl)-6-(1-methylethyl)phenol; Propofol EP Impurity B;2-Isopropenyl-6-isopropylphenol |
Propofol | 2078-54-8 | C12HOD17 | 195.38 | 2,6-di(propan-2-yl)phenol; 2,6 Diisopropylphenol; Diprivan; ICI35,868; Ivofol |
Propargyl alcohol propoxylate | 3973-17-9 | C6H10O2 | 114.14 | 1-(2-Propynyloxy)-2-propanol; 1-propynoxy-2-propanol; 4-Oxa-1-heptyn-6-ol; PAP; Propargyl alcohol propoxylate |
Propiverine N-Desmethyl Impurity HCl | 108640-64-8 | C22H27NO3. HCl | 389.93 | |
Propiverine Hydroxy Impurity | 3608-67-1 | C20H23NO3 | 325.41 | |
Propiverine Chloro Impurity HCl | 54556-99-9 | C20H22ClNO2. HCl | 380.32 | Chloro-diphenyl-acetic acid 1-methyl-piperidin-4-yl ester hydrochloride |
Propiophenone Impurity 2 | 111000-54-5 | C16H15ClO2 | 274.75 | 1-(4-(Benzyloxy)phenyl)-2-chloropropan-1-one; 2-Chloro-1-(4-phenylmethoxyphenyl)propan-1-one |
PROPIOPHENONE (RING-D5, 98%) | 54419-23-7 | C9H5D5O | 139.17 | |
Propionylpromazine-D6 hydrochloride | 1262770-67-1 | 1-[10-(3-Dimethyl-D6- amino-propyl)-10H- phenothiazin-2-yl]- propan-1-one hydrochloride | ||
Propionic Anhydride-d10 | 870471-31-1 | 130.14200 | ||
Propionic acid phenyl ester | 637-27-4 | C9H10O2 | 150.17 | propanoicacid,phenylester; PROPIONIC ACID PHENYL ESTER; PHENYL PROPIONATE; Propanoic acid phenyl; Propionic acid phenyl; phenyl propanoate |
PROPIONANILIDE | 620-71-3 | C9H11NO | 149.19 | PROPIONANILIDE; n-phenyl-propanamid; N-Phenylpropanamide; N-Phenylpropionamide; Propionamide, N-phenyl-; Propionic anilide |
Propenyl propyl disulfide | 5905-46-4 | C6H12S2 | 148.291 | 1 PROPENYL PROPYL DISULPHIDE; FEMA 3227; PROPENYL PROPYL DISULFIDE; PROPYL 1-PROPENYL DISULFIDE; Disulfide, 1-propenyl propyl; Propyl 1-propenyl disulfide, (E)-; Propyl 1-propenyl disulfide, (Z)-; prop-1-enyl propyl disulphide |
Propiconazole-4H-1,2,4-triazole (Mixture of Diastereomers) | 221132-58-7 | C15H17Cl2N3O2 | 342.23 | 4-[[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-4H-1,2,4-triazole; |
PPA | 13159-16-5 | C11H14O | 162.2 | |
PP242 | 1092351-67-1 | C16H16N6O | 308.345 | Pp242 |
PP-2206-d8 (deuterated) | 1403850-91-8 | C34H28FN5O7D8 | 653.74 | |
PP2 | 172889-27-9 | C15H16ClN5 | 301.77 | |
PP121 | 1092788-83-4 | C17H17N7 | 319.372 | PP121; PP 121; PP-121 |
PP1 | 172889-26-8 | C16H19N5 | 281.36 | 1-(tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; 1-tert-butyl-3-(4-methylphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine |
PP 3 | 5334-30-5 | C11H9N5 | 211.22 | 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
Piscidinol A | 100198-09-2 | C30H50O4 | 474.7 | Lanost-7-en-3-one,23,24,25-trihydroxy-, (13a,14b,17a,20S,23R,24S)- |
Phenylephrine-3-O-sulfate | 1242184-39-9 | C9H13NO5S | 247.27 | |
Phenylephrine Related Compound | 1217525-08-0 | C13H17NO6 | 283.28 | 2R,S-Hydroxy-4[[(2R)-2-hydroxy-2-(3-hydroxyphenyl)ethyl]methylamino]-4-oxo-butanoic Acid |
Phenylephrine Related Compound | 830346-80-0 | C13H17NO6 | 283.28 | 3-Hydroxy-4-[[(2R)-2-hydroxy-2-(3-hydroxyphenyl)ethyl]methylamino]-4-oxo-butanoic Acid |
Phenylephrine Impurity HCl (salt) | 23824-25-1 | C10H13NO2.HCl | 215.68 | 1,2,3,4-Tetrahydro-4,8-Dihydroxy-2-Methyl-Isoquinoline HCl |
Phenylephrine Impurity E | 71786-67-9 | C16H17NO2.HCl | 291.78 | 2-[Benzyl(methyl)amino]-1-(3-Hydroxyphenyl)ethanone Hydrochloride |
Phenylephrine Impurity C HCl | 94240-17-2 | C9H11NO2.HCl | 201.65 | 1-(3-Hydroxyphenyl)-2-(methylamino) ethanone HCl |
Phe-Met-Arg-Phe, amide | 64190-70-1 | C29H42N8O4S | 598.76 | H-Phe-Met-Arg-Phe-NH2; L-phenylalanyl-L-methionyl-L-arginyl-L-phenylalaninamide; (2S)-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanamide; FMR |
Phellopterin | 2543-94-4 | C17H16O5 | 300.31 | (5-Methoxy-8)-gama,gama-dimethylallyloxy(2',3',6,7-furanocoumarin) |
Phellodendrine chloride | 104112-82-5 | C20H24NO4.Cl | 377.85 | 6H-Dibenzo[a,g]quinolizinium,5,8,13,13a-tetrahydro-2,11-dihydroxy-3,10-dimethoxy-7-methyl-, chloride (1:1),(7S,13aS)- |
Phellodendrine | 6873-13-8 | C20H24NO4 | 342.4 | phellodendrine; Phellodendrine chloride |
propiomazine hydrogen maleate | 3568-23-8 | C24H28N2O5S | 456.55452 | |
Propiomazine Hydrochloride | 64-89-1 | C20H25ClN2OS | 376.98 | 1-(10-(2-(Dimethylamino)-1-methylethyl)phenothiazin-2-yl)-1-propanone hydrochloride;1-Propanone, 1-(10-(2-(dimethylamino)-1-methylethyl)-10H-phenothiazin-3-yl)-, monohydrochloride;Largon hydrochloride |
propiomazine | 362-29-8 | C20H24N2OS | 340.483 | propiomazine; 1-[10-[2-(Dimethylamino)propyl]-10H-phenothiazin-2-yl]propan-1-one; CB-1678; Wy-1359; 1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one |
propiolaldehyde | 624-67-9 | C3H2O | 54.04738 | PROPYNAL; 2-propynal; Propiolaldehyde; PROPIOALDEHYDE; PROPYNAL TECH.; 2-Propyn-1-al; 2-Propyne-1-one; Propiolic aldehyde |
Propineb | 12071-83-9 | C5H8N2S4Zn | 289.78 | |
Propidium Iodide | 25535-16-4 | C27H34I2N4 | 668.4 | PI; 3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenyl-phenanthridinium diiodide |
Propiconazole-d7 | 1246818-14-3 | C15H10Cl2N3O2D7 | 349.27 | Propiconazole-d7; Wocosen-d7; Bamper-d7; Desmel-d7 |
Propiconazole | 60207-90-1 | C15H17Cl2N3O2 | 342.23 | 1-[[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole; Bamper; Bamper 25EC; Banner Maxx; Binghuanzuo; Desmel; Dhan; Proconazole; Radar; Tilt; Wocosen; Wocosin 50TK; |
Propicillin potassium | 1245-44-9 | C18H21KN2O5S | 416.53 | PROPICILLIN POTASSIUM; baycillin; baycillinpotassium; brocillin; phenoxypropylpenicillinpotassium; potassiumphenoxypropylpenicillin; potassiumpropicillin; potassium (1-phenoxypropyl)penicillin |
Propericiazine | 2622-26-6 | C21H23N3OS | 365.49 | PROPERICIAZINE;PROPERICYAZINE;1-(3-(2-cyano-10-phenothiazinyl)propyl)-4-piperidino;10-(3-(4-hydroxypiperidino)propyl)-phenothiazine-2-carbonitril;10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile;10-[3-(4-Hydroxy-1-piperidinyl)propyl]-10H-ph |
Propentofylline | 55242-55-2 | C15H22N4O3 | 306.37 | 3,7-Dihydro-3-methyl-1-(5-oxohexyl)-7-propyl-1H-purine-2,6-dione; HWA-285; Albert-285; HOE-285; Hextol; Karsivan |
Propargylcholine bromide | 111755-76-1 | C7H14NO·Br | 208.10 | AOBT7378; AS-17070; N-(2-hydroxyethyl)-N,N-dimethyl-2-propyn-1-aminium monobromide; 2-hydroxyethyl-dimethyl-prop-2-ynylazanium bromide |
Propargyl a-D-galactopyranoside | 913074-13-2 | C9H14O6 | 218.21 | |
Propargite Impurity M | 682774-12-5 | C25H36O5S | 448.63 | |
Propargite | 2312-35-8 | C19H26O4S | 350.48 | Sulfurous Acid, 2-(p-Tert-butylphenoxy)cyclohexyl 2-Propynyl Ester (7CI,8CI); Sulfurous Acid, 2-[4-(1,1-Dimethylethyl)phenoxy]cyclohexyl 2-Propynyl Ester (9CI); 2-(p-tert-Butylphenoxy)cyclohexyl 2-Propynyl Sulfite; 2-(p-tert-Butylphenoxy)cyclohexyl Propar |
Propantheline-d3 Bromide (N-methyl-d3) | 64717-35-7 | C23H27D3NO3Br | 451.42 | (2-Hydroxyethyl)diisopropylmethylammonium Bromide Xanthene-9-carboxylate |
Propantheline Bromide | 50-34-0 | C23H30BrNO3 | 448.40 | Neometantyl; Neopepulsan; methyl-di(propan-2-yl)-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium;bromide |
Propanol, (2-ethoxymethylethoxy)- | 30025-38-8 | C8H18 O3 | 162.22672;g/mol | 1-(1-ethoxypropan-2-yloxy)propan-2-ol; SCHEMBL15973; dipropyleneglycolethylether; dipropyleneglycolmonoethylether; Jsp005675; CTK8J4800 |
Propanoic-d5 acid (9CI) | 60153-92-6 | C3H D5 O2 | 79.11 | PROPIONIC-D5 ACID; PROPIONIC ACID (D5) |
Propanoicacid,3-(triethoxysilyl)-,ethylester | 6439-39-0 | C11H24O5Si | 264.39076 | ((2-ethoxycarbonyl)ethyl)triethoxy-silan; (2-carbethoxyethyl)triethoxysilane; 2-carbethoxyethyltriethoxysilane; 3-(triethoxysilyl)-propionicaciethylester; Propanoicacid,3-(triethoxysilyl)-,ethylester; 2-ethoxycarbonylethyltriethoxysilane; ethyl 3-triethox |
Propanoicacid, 2-bromo-2-methyl-, 3-(ethoxydimethylsilyl)propyl ester | 265119-86-6 | C11H23 Br O3 Si | 311.28802;g/mol | 3-[ethoxy(dimethyl)silyl]propyl2-bromo-2-methylpropanoate;SCHEMBL4560373;MolPort-016-581-235;OR066577;OR250399;3-(Dimethylethoxysilyl)propyl2-bromoisobutyrate |
Propanoicacid, 2-[[(ethylthio)thioxomethyl]thio]-2-methyl- | 881037-62-3 | C7H12 O2 S3 | ||
Propanoic acid,3-mercapto-, 1,1'-[2,2-bis[(3-mercapto-1-oxopropoxy)methyl]-1,3-propanediyl]ester | 7575-23-7 | C17H28 O8 S4 | 488.6594 | propanoicacid,3-mercapto-,2,2-bis[(3-mercapto-1-oxopropoxy)methyl]-1,3-propa; PENTAERYTHRITOL TETRAKIS(3-MERCAPTOPROPIONATE); PENTAERYTHRITOL TETRA(3-MERCAPTOPROPIONATE); PROPANOIC ACID, 3-MERCAPTO, 2,2-BIS [(3-MERCAPTO-1-OXOPROPOXY) METHYL] -1,3-PROPANED |
Propanoic acid,3-amino-2-methyl- | 144-90-1 | C4H9 N O2 | 103.12 | |
Propanoic acid,3-[2-(2-heptyl-4,5-dihydro-1H-imidazol-1-yl)ethoxy]-, sodium salt (1:1) | 68877-55-4 | C15H28 N2 O3 . Na | ||
Propanoic acid,3,3,3-trifluoro-2-hydroxy-, (2S)- | 125995-00-8 | C3H3 F3 O3 | 144.05 | (S)-(-)-TRIFLUOROLACTIC ACID; S-TF-LA; (S)-(-)-3,3,3-TRIFLUORO-2-HYDROXYPROPANOIC ACID; (S)-(-)-3,3,3-TRIFLUOROLACTIC ACID; (S)-2-Hydroxy-3,3,3-trifluoropropionic acid; (S)-(-)-3,3,3-TRIFLUORO-2-HYDROXYPROPANOIC ACID (98% EE) |
Propanoic acid,3,3,3-trifluoro-, methyl ester | 18830-44-9 | C4H5 F3 O2 | 142.08 | METHYL 3,3,3-TRIFLUOROPROPIONATE |
Propanoic acid,3-(dodecylthio)-, 1,1'-[oxybis(2,1-ethanediyloxy-2,1-ethanediyl)] ester | 64253-30-1 | C38H74 O7 S2 | 707.24 | |
Propanoic acid,3-(benzoylthio)-2-methyl-, (R)- (9CI) | 74407-70-8 | C11H12 O3 S | 224.27618 | |
Prolintane hydrochloride | 1211-28-5 | C15H23N.HCl | 253.81100 | |
Prolinomethyltetracycline | 37106-99-3 | C28H33N3O10 | 571.58 | |
Prolactin-Releasing Peptide (1-31) (human) | 215510-22-8 | C160H252N56O42S | 3664.2 | Human PrRP-31; PrRP(1-31) |
Progesterone | 57-83-0 | C21H30O2 | 314.46 | Progestin; Lutren; Lutein; Flavolutan; Corporin; Luteal Hormone; 4-Pregnene-3,20-Dione |
ProgeninIII | 19057-67-1 | C39H64O13 | 740.92 | Prosapogenin A |
Progabide | 62666-20-0 | C17H16ClFN2O2 | 334.77 | 4-[[(4-Chlorophenyl)(5-fluoro-2-hydroxyphenyl)methylene]amino]butanamide;Gabren;Gabrene;Halogabide;SL76-002;SL76002;(E)-4-((4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methyleneamino)butanamide;4-[[(Z)-(4-Chlorophenyl)-(3-fluoro-6-oxo-1-cyclohexa-2,4-dienyli |
Proflavine Hemisulfate | 1811-28-5 | C26H24N6O4S | 516.58 | acridine-3,6-diamine;sulfuric acid 3,6 Diamino Acridine 3,6 Diaminoacridine 3,6-diamino acridine 3,6-diaminoacridine Acridine, 3,6-Diamino Hemisulfate, Proflavine Proflavin Proflavine Proflavine Hemisulfate |
PROFLAVINE DIHYDROCHLORIDE | 531-73-7 | C13H13Cl2N3 | 282.17 | 2 8-DIAMINOACRIDINE DIHYDROCHLORIDE; 3 6-DIAMINOACRIDINE DIHYDROCHLORIDE; SALOR-INT L204935-1EA; PROFLAVINE DIHYDROCHLORIDE; 2,8-diaminoacridiniumchloridehydrochloride; 3,6-acridinediamine,dihydrochloride; 3,6-diamino-acridindihydrochloride; 3,6-diaminoac |
proflavine | 92-62-6 | C13H11N3 | 209.2467 | |
ProFenoFos | 41198-08-7 | C11H15BrClO3PS | 373.63 | cga15324; phosphorothioicacid,o-(4-bromo-2-chlorophenyl)-o-ethyl-s-propylester; SANOFOS; Selecron; SELECRON(R); ROMIFOS |
Prochlorperazine-d3 Dimesylate | 753432-54-1 | C20H21D3ClN3S.CH4O3S.CH4O3S | 569.17 | 2-Chloro-10-[3-(4-methyl-d3-1-piperazinyl)propyl]-10H-phenothiazine Dimethanesulfonate; 3-Chloro-10-[3-(4-methyl-d3-1-piperazinyl)propyl]phenothiazine Dimesylate; Novamin-d3; Tementyl-d3; |
Prochlorperazine Sulfoxide | 10078-27-0 | C20H24ClN3OS | 389.95 | 2-Chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine 5-Oxide; |
Prochlorperazine Edisylate | 1257-78-9 | C22H30ClN3O6S3 | 564.14 | |
Prochlorperazine Dimaleate | 84-02-6 | C20H24ClN3S.C8H8O8 | 606.09 | Buccastem; Compazine; Emetiral; Meterazin Maleate; Pasotomin;Prochlorperazine Hydrogen Maleate; Prochloroperazine Dimaleate; Prochlorperazine Maleate; Stemetil; Stemetil Dimaleate; Vertigon |
Prochlorperazine D8 | 1215641-01-2 | C20H16ClD8N3S | 381.94 | |
Prochlorperazine | 58-38-8 | C20H24ClN3S | 373.943 | Prochlorperazin; Prochlorpromazine; Chlormeprazine; Chlorperazine; Procloperazine; 2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine |
Prochloraz Metabolite BTS 44595 | 139520-94-8 | 1-Propyl-1-[2-[2,4,6-tri- chloro phenoxy]ethyl]- urea | ||
Prochloraz Metabolite BTS 40348 | 67747-01-7 | N-Propyl-N-[2-(2,4,6-tri- chloro phenoxy)ethyl]- amine | ||
ProChloraz manganese | 75747-77-2 | C60H64Cl14MnN12O8 | 1632.51 | dichlorotetrakis(n-propyl-n-(2-(2,4,6-trichlorophenoxy)ethyl)-1h-imidazole-1-carboxamide)manganese; Prochloraz manganese; Prochloraz, manganese complex; Manganese, dichlorotetrakisN-propyl-N-2-(2,4,6-trichlorophenoxy)ethyl-1H-imidazole-1-carboxamide-; pro |
Prochloraz | 67747-09-5 | C15H16Cl3N3O2 | 376.7 | BTS-40542 |
Probenecid-d14 | 1189657-87-1 | C13H5NO4SD14 | 299.54 | 4[(Dipropylamino-d14)sulfonyl]benzoic Acid; p-(Dipropylsulfamoyl-d14)benzoic Acid; Apurina-d14; Benecid-d14; Benemid-d14; Benuryl-d14; Probecid-d14; NSC 18786-d14; Probenecid-d14 Acid |
Procaine Related Compound HCl (Diethyl (2-Hydroxyethyl)-Amino-p-[o-(Octyloxy)benzamido]benzoate hydrochloride) | 51444-52-1 | C28H40N2O4. HCl | 468.64 36.46 | |
Penicillin G. Procaine | 54-35-3 | C29H38N4O6S | 570.70 | Procaine penicillin; duphapen; depocillin; hostacillin; hydracillin; Procain Penicillin G; PROCAINE BENZYLPENICILLIN; benzylpenicillin procaine; Duphapen; Retardillin; Depocillin; Nopcaine; Vetspen; Jenacillin O; Micro-Pen; Benzilpenillina procainica [DCI |
Procaine HCl | 51-05-8 | C13H21ClN2O2 | 272.77 | Novocaine hydrochloride |
Procaine | 59-46-1 | C13H20N2O2 | 236.31 | Novocaine |
Procainamide Hydrochloride | 614-39-1 | C13H22ClN3O | 271.79 | 4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride; |
Probucol Disuccinate | 216168-45-5 | C39H56O8S2 | 716.989 | 4-[2,6-ditert-butyl-4-[2-[3,5-ditert-butyl-4-(3-carboxypropanoyloxy)phenyl]sulfanylpropan-2-ylsulfanyl]phenoxy]-4-oxobutanoic acid |
Probucol | 23288-49-5 | C31H48O2S2 | 516.84 | Lorelco |
Probenecid | 23795-03-1 | C13H18NNaO4S | 307.34 | |
PROANTHOCYANIDINS | 274678-42-1 | C31H28O12 | 592.56 | GRAPE SEED P E; PROANTHOCYANIDINS |
Proanthocyanidin A4 | 111466-29-6 | C30H24O12 | 576.51 | ent-Epigallocatechin-(2alpha-O-7,4alpha-8)-catechin |
Pristinamycin IIA | 21411-53-0 | C28H35N3O7 | 525.59 | virginiamycin M1; Streptogramin A; Mikamycin A; Ostreogrycin a |
Proadifen Hydrochloride | 62-68-0 | C23H32ClNO2 | 389.96 | 2-(diethylamino)ethyl 2,2-diphenylpentanoate;hydrochloride; SKF-525A, Hydrochloride; |
PRN1371 | 1802929-43-6 | C26H30Cl2N6O4 | 561.46 | 6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-8-[3-(4-prop-2-enoylpiperazin-1-yl)propyl]pyrido[2,3-d]pyrimidin-7-one |
PRMT3 inhibitor 1 | 1340875-03-7 | C15H18N4OS | 302.39 | |
PRL-3 Inhibitor | 893449-38-2 | C17H11Br2NO2S2 | 485.2 | BR-1; P0108; Phosphatase of Regenerating Liver 3 Inhibitor; PTP4A3 Inhibitor; 1-(2-Bromobenzyloxy)-4-bromo-2-benzylidene rhodanine |
Pristinamycin | 270076-60-3 | C73H89N11O17 | 866.96 | |
Pristimerin | 1258-84-0 | C30H40O4 | 464.64 | (9b,13a,14b,20a)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tertraen-29-oic acid methyl ester |
Pristane | 1921-70-6 | C19H40 | 268.52 | 2,6,10,14-Tetramethylpentadecane; Norphytane |
Prionitin | 117469-56-4 | C21H26O2 | 310.4 | (-)-2,2a,3,4-Tetrahydro-8-methoxy-2,2,5-trimethyl-9-(1-methylethyl)phenaleno[1,9-bc]furan |
Prionidipene A | 2199455-72-4 | C21H26O3 | 326.43 | |
Prion Protein 106-126 (human) | 148439-49-0 | C80H138N26O24S2 | 1912.26 | KTNMKHMAGAAAAGAVVGGLG |
Prinomastat | 192329-42-3 | C18H21N3O5S2 | 423.502 | AG3340; KB-R 9896 |
Prilocaine Related Compound B | 744961-76-0 | C13H20N2O | 220.32 | 2-(Propylamino)-p-propionotoluidide; N-(4-Methylphenyl)-2-(propylamino)propanamide; 2-Desmethyl 4-Methyl Prilocaine |
Prilocaine HCl (Propitocaine HCl) | 1786-81-8 | C13H20N2O.HCl | 256.77 | Citanest hydrochloride |
Prilocaine | 721-50-6 | C13H20N2O | 220.311 | |
Prifinium bromide | 4630-95-9 | C22H28N.Br | 386.37 | prifinium bromide; Prifinium; 3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidinium bromide (7CI); 3-(Diphenylmethylene)-1-ethyl-2-methylpyrrolidine ethyl bromide; Pyrodifenium bromide; Pyrrolidinium, 3-(diphenylmethylene)-1,1-diethyl-2-methyl-, bromide |
Pridopidine | 346688-38-8 | C15H23NO2S | 587.71 | 4-(3-Methylsulfonylphenyl)-1-propylpiperidine; 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine; ACR 16; 4-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine; |
PRI-724 | 847591-62-2 | C33H32N4O4 | 548.63 | PRI 724; ICG-001; ICG 001; (6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-8-(naphthalen-1-ylmethyl)-4,7-dioxo-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide |
Prezatide copper acetate | 130120-57-9 | C32H52CuN12O12 | 860.385 | |
Prexasertib mesylate | 1234015-55-4 | C19H23N7O5S | 461.49 | 2-Pyrazinecarbonitrile, 5-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)-, methanesulfonate; Prexasertib mesylate; LY2606368; LY-2606368; LY 2606368. |
Previtamin D2 | 21307-05-1 | C28H44O | 396.659 | Preergocalciferol; (6E,22E)-(3R)-9,10-Secoergosta-5(10),6,8,22-tetraen-3-ol |
Preskimmianine | 38695-41-9 | C17H21NO4 | 303.35 | 4,7,8-Trimethoxy-3-(3-methyl-2-butenyl)-2-quinolone |
Pre-schisanartanin B | 1033288-92-4 | C31H42O11 | 590.7 | 24,25-dihydropreschisanartanin; |
Presatovir | 1353625-73-6 | C24H30ClN7O3S | 532.06 | N-(2-((S)-2-(5-((S)-3-aminopyrrolidin-1-yl)-6-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl)-4-chlorophenyl)methanesulfonamide; GS-5806 |
Presapogenin CP4 | 75799-18-7 | C46H74O15 | 866.5 | Prosapogenin CP4 |
Prerubialatin | 1667718-89-9 | C27H20O7 | 456.45 | |
Prenylpiperitol | 157659-20-6 | C25H28O6 | 424.5 | 5-[(1S,3aR,4S,6aR)-4-{3-Methoxy-4-[(3-methyl-2-buten-1-yl)oxy]phe nyl}tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole |
Prednisolone steaglate | 5060-55-9 | C41H64O8 | 684.949 | Prednisolonesteaglate; 5060-55-9; UNII-OZQ2XN817F; Sintisone; Sintisone(TN); prednisolonesteaglate |
Prednisolone hydrate (2:3) | 52438-85-4 | C21H28O5.3/2H2O | 387.473 | |
Prednisolone EP Impurity E (14-Alpha-hydroxyprednisolone) | 95815-58-0 | C21H28O6 | 376.45 | |
Prednisolone Acetate | 52-21-1 | C23H30O6 | 402.48 | Omnipred |
Predocol | 630-67-1 | C28H31NaO9S | 566.59 | 11,17-Dihydroxy-21-[(3-sulfobenzoyl)oxy]-pregna-1,4-diene-3,20-dione Sodium Salt; ATL 2502; Cortico-Sol; Predenema; Predfoam; Prednisolone 21-m-sulfobenzoate sodium; Prednisolone 21-m-sulfobenzoate sodium salt; Prednisolone metasulfobenzoate sodium; Predn |
Precyasterone | 27335-85-9 | C29H44O8 | 520.65 | |
Precocene II | 644-06-4 | C13H16O3 | 220.27 | Ageratochromene |
PRE-084 hydrochloride | 75136-54-8 | C19H28NO3Cl | 353.88 | |
PRE-084 | 138847-85-5 | C19H27NO3 | 353.887 | 2-(4-Morpholinyl)ethyl 1-phenylcyclohexanecarboxylate hydrochloride; PRE-084 (hydrochloride) |
Prazosin-d8 | 1006717-55-0 | C19H13N5O4D8 | 391.46 | 4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl-d8]-2-furanylmethanone; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonxyl) piperazine-d8; Adversuten-d8; Adverszuten-d8; Alpress LP-d8; Furazosin-d8; Lentopres-d8; NSC 292810-d8; Peripres |
Prazosin HCl (Furazosin HCl) | 19237-84-4 | C19H21N5O4·HCl | 419.86 | cp-12299-1 |
Prazosin | 19216-56-9 | C19H21N5O4 | 383.40 | [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone Douglas Brand of Prazosin Hydrochloride Furazosin HCL, Prazosin Hydrochloride, Prazosin Minipress Pfizer Brand of Prazosin Hydrochloride Pratsiol Prazosin Prazosin HCL |
Prazobind | 107021-36-3 | C23H27N5O3 | 421.5 | SZL-49; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2-bicyclo[2.2.2]octa-2,5-dienyl)methanone |
Praziquantel-D11 | 1246343-36-1 | 2-Cyclohexane-D11- carbonyl-1,2,3,6,7,11b- hexahydro-pyrazino[2,1- a]isoquinolin-4-one | ||
Praziquantel Related Compound C | 125273-88-3 | C19H18N2O4 | 342.36 | |
Praziquantel Related Compound B | 125273-86-1 | C19H22N2O2 | 310.39 | 2-(Cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino[2,1-a]isoquinolin-4-one; USP Praziquantel Related Compound B; 1,2-Deshydro Praziquantel |
Praziquantel Related Compound A | 54761-87-4 | C19H18N2O2 | 306.37 | 2-Benzoyl-1,2,3,6,7,11b-hexahydro-4H-Pyrazino[2,1-a]isoquinolin-4-one; USP Praziquantel Related Compound A;2-(Descyclohexylcarbonyl)-2-benzoyl Praziquantel |
Praziquantel | 55268-74-1 | C19H24N2O2 | 312.41 | 2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one; (+/-)-Praziquantel; Azinox; Biltricide; Cesol; Cysticide; Distocide; Droncit; Embay 8440; Prazinon; Pyquiton; Warmnil; |
Pranlukast Impurity 2 | 136450-10-7 | C27H24N2O5 | 456.5 | 4-Oxo-8-[4-(4-phenylbutoxy)benzoylamino]-4H-1-benzopyran-2-carboxamide |
Prasugrel Metabolite R-95913 (Impurity IV, Mixture of Diastereomers) | 150322-38-6 | C18H18FNO2S | 331.41 | 5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one; R 95913; 2-Oxo-Prasugrel |
Prasugrel Metabolite R | 204204-73-9 | C18H20FNO3S | 349.42 | (2Z)-2-[1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-sulfanylpiperidin-3-ylidene]acetic acid; Prasugrel Metabolite R-138727 |
Prasugrel Metabolite Derivative-13C-d3 (cis R-138727MP, Mixture of Diastereomers) | 1217234-50-8 | C26H25FNO5S13CD3 | 501.6 | |
Prasugrel Metabolite Derivative (cis R-138727MP, Mixture of Diastereomers) | 929211-64-3 | C27H28FNO5S | 497.59 | (2Z)-2-[1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-[[2-(3-methoxyphenyl)-2-oxoethyl]thio]-3-piperidinylidene]acetic Acid; R 138727MP; |
Prasugrel Metabolite (R-106583) | 916599-27-4 | C19H22FNO3S | 363.45 | 2-[1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-(methylthio)-3-piperidinylidene]acetic Acid; R 106583; Prasugrel Metabolite M5; |
Prasugrel Maleic acid | 389574-20-3 | C24H24FNO7S | 489.51 | Save3DZoom 5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate (2Z)-2-butenedioate (1:1) |
Prasugrel Impurity III | 1391194-50-5 | C20H20FNO3S | 373.45 | |
Prasugrel Impurity II | 1391194-39-0 | C20H20FNO3S | 373.45 | |
Prasugrel Impurity I | 1391194-45-8 | C20H21NO3S | 355.46 | |
Prasugrel Impurity 8 (4-F-PM-A) | 1359829-52-9 | C11H10BrFO | 257.1 | 2-Bromo-1-cyclopropyl-2-(4-fluorophenyl)ethanone |
Prasugrel Impurity 7 (3-F-PM-A) | 1359829-72-3 | C11H10BrFO | 257.1 | 2-Bromo-1-cyclopropyl-2-(3-fluorophenyl)ethanone |
Prasugrel Impurity 17 | 1071842-61-9 | C11H11FO | 178.21 | 1-Cyclopropyl-2-(4-fluorophenyl)ethanone;Cyclopropyl 4-Fluorobenzyl Ketone |
Prasugrel Impurity 14 Maleate | 1373350-60-7 | C20H21BrFNO3S. C4H4O4 | 454.36 116.07 | 1-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-5-bromo-1-(2-fluorophenyl)-2-pentanone (2Z)-2-Butenedioate; 5-(5-Bromo-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl Acetate Maleate |
Prasugrel Impurity 13 hydrochloride | 1618108-01-2 | C18H18FNOS. HCl | 351.87 | |
Prasugrel Impurity (1-Bromo-5-chloro-1-(2-fluorophenyl)pentan-2-one) | 1373350-58-3 | C11H11BrClFO | 293.57 | 2-fluorophenyl)pentan-2-one |
Prasugrel Impurity | 204205-33-4 | C11H10BrFO | 257.1 | |
Prasugrel Hydrochloride | 389574-19-0 | C20H21ClFNO3S | 409.9 | [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride |
Prasugrel alpha-Hydroxy Impurity | 1100905-45-0 | C11H11FO2 | 194.21 | 1-Cyclopropyl-2-(2-fluorophenyl)-2-hydroxy-ethanone |
Prasugrel Acetyl Impurity | 1443034-67-0 | C18H18FNO3S | 347.41 | 5-(1-(2-Fluorophenyl)-2-oxopropyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)acetate; |
Prasugrel | 150322-43-3 | C20H20FNO3S | 373.442 | Effient; CS 747; LY640315; CS747; LY 640315; CS-747; LY-640315; |
Pranlukast Impurity 1 | 211116-98-2 | C27H23NO6 | 457.48 | 4-Oxo-8-[4-(4-phenylbutoxy)benzoylamino]-4H-1-benzopyran-2-carboxylic Acid |
Pranlukast hemihydrate | 150821-03-7 | C54H48N10O9 | 490.51 | 8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran |
Pranlukast | 103177-37-3 | C27H23N5O4 | 481.5 | Pranlukast; Ono-1078; ONO 1078; ONO-1078; ONO-RS 411; ONO-RS-411; SB 205312; |
Pranidipine | 99522-79-9 | C25H24N2O6 | 448.473 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl 5-[(2E)-3-phenyl-2-propen-1-yl] Ester; FRC 8411; OPC 13340; |
Pramoxine hydrochloride | 637-58-1 | C17H27NO3·HCl | 329.87 | Pramoxine HCl; Pramocaine hydrochloride; Prax Lotion; 4-[3-(4-butoxyphenoxy)propyl]morpholine hydrochloride |
Pramoxine | 140-65-8 | C17H27NO3 | 293.41 | |
Pramlintide | 151126-32-8 | C171H267N51O53S2 | 3949.42 | Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 |
Pramiracetam | 68497-62-1 | C14H27N3O2 | 269.38 | CP-945598 HCl |
Pralatrexate | 146464-95-1 | C23H23N7O5 | 477.47 | |
Praeruptorin C | 72463-77-5 | C24H28O7 | 428.48 | Wulongensin A; (2Z)-2-Methyl-2-butenoic acid (9R,10R)-9,10-dihydro-8,8-dimethyl-10-(3-methyl-1-oxobutoxy)-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl ester |
praeruptorin B | 81740-07-0 | C24H26O7 | 426.46 | anomalin; [8,8-Dimethyl-9-[(E)-2-methylbut-2-enoyl]oxy-2-oxo-9,10-dihydropyrano[6,5-h]chromen-10-yl] (E)-2-methylbut-2-enoate; Praeruptorin B; Paeruptorin B; (+)Pareruptorin B |
praeruptorin A | 73069-25-7 | C21H22O7 | 386.4 | PRAERUPTORIN A; 2-Butenoicacid, 2-methyl-, (9S, 10S)-10-(acetyloxy)-; 9,10-dihydro-8,8-dimethyl-2-oxo-2H, 8H-; DL-Praeruptorin A; Praeruptorin A DL-Praeruptorin A |
Praeroside II | 86940-46-7 | C20H24O10 | 424.399 | (9R,10R)-9-(beta-D-Glucopyranosyloxy)-9,10-dihydro-10-hydroxy-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one |
Practolol | 6673-35-4 | C14H22N2O3 | 266.34 | Teranol;Practololum;N-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide;rac Practolol;(±)-Practolol;1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol;Dalzic;Eraldin;4'-[2-Hydroxy-3-(isopropylamino)propoxy]acetanilide;ICI-50172;ICI50172 |
Pracinostat | 929016-96-6 | C20H30N4O2 | 358.486 | SB939; SB 939 |
PR-619 | 2645-32-1 | C7H5N5S2 | 223.272 | |
PR-104 | 851627-62-8 | C14H20BrN4O12PS | 579.268 | PR 104 |
PR 39 (porcine) | 139637-11-9 | C229H346N70O40 | 4719.7 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP; H-Arg-Arg-Arg-Pro-Arg-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Pro-Phe-Phe-Pro-Pro-Arg-Leu-Pro-Pro-Arg-Ile-Pro-Pro-Gly-Phe-Pro-Pro-Arg-Phe-Pro-Pro-Arg-Phe-Pro-NH2 |
PQR530 | 1927857-61-1 | C18H23F2N7O2 | 407.42 | (S)-4-(difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine |
PQR309 | 1225037-39-7 | C17H20F3N7O2 | 411.38 | 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine; PQR309; PQR-309; PQR309; Bimiralisib free base |
PQCA | 1144504-35-7 | C22H20N4O3 | 388.43 | 1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid,1401512-98-8 (sodium) |
PQ-10 | 927691-21-2 | C22H21N5O3 | 403.4 | 6,7-dimethoxy-4-[(3R)-3-(quinoxalin-2-yloxy)pyrrolidin-1-yl]quinazoline |
PQ 69 | 910045-32-8 | C20H19FN4O | 350.39 | 4-(Butylamino)-2-(3-fluorophenyl)-1,2-dihydro-3H-pyrazolo[4,3-c]quinolin-3-one; PQ-69; PQ 69; PQ69 |
PQ 401 | 196868-63-0 | C18H16ClN3O2 | 341.79 | |
PPY A | 875634-01-8 | C22H20N4O2 | 372.42 | 5-[3-(2-Methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethyl-3-pyridinecarboxamide |
PPA-904 | 30189-85-6 | C28H42BrN3S | 532.62 | dibutyl-[7-(dibutylamino)phenothiazin-3-ylidene]azanium;bromide; Phenothiazin-5-ium, 3,7-bis(dibutylamino)-, bromide |
PPT | 263717-53-9 | C24H22N2O3 | 386.45 | 4,4',4''-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol; Propyl pyrazole triol |
PPQ-102 | 931706-15-9 | C26H22N4O3 | 438.487 | |
PPPA | 113190-92-4 | C9H18NO5P | 251.22 | (2R*,4S*)-4-(3-Phosphonopropyl)-2-piperidinecarboxylic acid |
PPP hydrochloride | 21602-56-2 | C14H21N.HCl | 239.78 | 1-(2-phenylpropan-2-yl)piperidine hydrochloride; 1-(alpha,alpha-Dimethylbenzyl)piperidine hydrochloride |
PPOH | 206052-01-9 | C15H18O3 | 246.3 | 6-(2-propargyloxyphenyl)hexanoic acid |
PPNDS | 1021868-77-8 | C18H11N4Na4O14PS2 | 694.36 | Pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) tetrasodium salt |
PPM-18 | 65240-86-0 | C17H11NO3 | 277.3 | NSC 73233; n-(1,4-dioxo-1,4-dihydronaphthalen-2-yl)benzamide; NQN-1; 2-Benzoylamino-1,4-naphthoquinone |
PPIase-Parvulin Inhibitor | 64005-90-9 | C22H18N2O8 | 438.4 | HIC 016C; PiB; Diethyl-1,3,6,8-tetrahydro-1,3,6,8-tetraoxobenzo[lmn][3,8]phenanthroline-2,7-diacetate |
PPI-2458 | 431077-35-9 | C22H36N2O6 | 424.538 | PPI 2458; PPI2458 |
PPHT hydrochloride | 71787-90-1 | C21H27NO.HCl | 345.91 | (+/-)-PPHT hydrochloride; 6-[2-phenylethyl(propyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride |
PPDA | 684283-16-7 | C21H18N2O5 | 378.38 | (2S*,3R*)-1-(Phenanthren-2-carbonyl)piperazine-2,3-dicarboxylic acid |
Poziotinib | 1092364-38-9 | C23H21Cl2FN4O3 | 491.344 | HM781-36B; NOV120101; NOV-120101; NOV 120101; Poziotinib |
Pozanicline | 161417-03-4 | C11H16N2O | 192.26 | Pozanicline; Abt-089; ABT 089; UNII-CL2002R563; CHEMBL127071; Pozanicline (USAN); 2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine |
Povidone-iodine | 25655-41-8 | (C6H9NO)n.xI2 | 364.94 | |
POTASSIUMFERRATE | 13718-66-6 | |||
POTASSIUMDL-ASPARTATE | 923-09-1 | C4H8KNO5 | 189.20800 | |
POTASSIUM, (Z)-2-CYANO-1-ETHOXYCARBONYL-ETHENOLATE | 728897-00-5 | C6H6KNO3 | 179.21504 | POTASSIUM, (Z)-2-CYANO-1-ETHOXYCARBONYL-ETHENOLATE |
Potassium vinyltrifluoroborate | 13682-77-4 | C2H3BF3K | 133.94 | POTASSIUM VINYLTRIFLUOROBORATE; Vinyltrifluoroboric acid potassium salt; Borate(1-), ethenyltrifluoro-, potassium (1:1), (T-4)-; 3POTASSIUM VINYLTRIFLUOROBORATE; POTASSIUM VINYLTRIFLUOROBORATE, TECHNICAL; Vinylboronic acid trifluoroborate potassium salt |
Potassium tris(trifluoromethanesulfonyl)methide | 114395-69-6 | C4F9KO6S3 | 450.318 | |
Potassium triphosphate;Pentapotassium triphosphate | 13845-36-8 | K5O10P3 | 448.406786;g/mol | pentapotassium; [oxido(phosphonatooxy)phosphoryl]phosphate; Pentapotassiumtriphosphate; 13845-36-8; potassiumtriphosphate; Triphosphoricacid,pentapotassiumsalt |
POTASSIUM TRIOXALATOFERRATE(III) | 5936-11-8 | C6H6FeK3O15 | 491.24 | POTASSIUM FERRIC OXALATE TRIHYDRATE; POTASSIUM TRIS(OXALATO)FERRATE(III) TRIHYDRATE; POTASSIUM TRIOXALATOFERRATE(III); POTASSIUM TRIS(OXALATE)FERRATE (III) TRIHYDRATE; FERRIC POTASSIUM OXALATE; IRON (III) TRIPOTASSIUM OXALATE; IRON(III) TRIPOTASSIUM OXALA |
Potassium trihydrogen dioxalate dihydrate | 6100-20-5 | 254.19 | POTASSIUM TETRAOXALATE; POTASSIUM TETRAOXALATE DIHYDRATE; POTASSIUM OXALATE (2:1) DIHYDRATE; POTASSIUM HYDROGEN OXALATE-OXALIC ACID-WATER; POTASSIUM TETRAOXALATE-2-HYDRATE R. G. &; Potassium trihydrogen dioxalate dihydrate, 99.5%; Potassiumtetra-Oxalate2- | |
potassium thiosulfate | 10294-66-3 | K2O3S2 | 190.31 | thiosulfuricacid(h2s2o3),dipotassiumsalt; Thiosulfuricacid,dipotassiumsalt; POTASSIUM THIOSULFATE; POTASSIUM HYPOSULFITE; potassium thiosulphate; POTASSIUM THIOSULFATE, 75% SOLUTION IN W ATER |
Potassium thioglycolate | 34452-51-2 | C2H3KO2S | 130.21 | Potassium thioglycolate; Pottassium thioglycolate solution |
POTASSIUM TETRAMETHYLCYCLOPENTADIENIDE | 150239-39-7 | C9H13K | 160.3 | POTASSIUM TETRAMETHYLCYCLOPENTADIENIDE |
POTASSIUM TETRAKIS(PENTAFLUOROPHENYL)BORATE | 89171-23-3 | C24BF20K | 718.13 | POTASSIUM TETRAKIS(PENTAFLUOROPHENYL)BORATE; Kaliumtetrakis(pentafluorophenyl)borat |
Potassium tetrafluoroborate | 14075-53-7 | KBF4 | 125.90 | POTASSIUM TETRAFLUOROBORATE; POTASSIUM BOROFLUORIDE; POTASSIUM BOROFULUORIDE; POTASSIUM FLUOROBORATE; POTASSIUM FLUOBORATE; Avogadrite |
potassium tetrafluoroaluminate | 14484-69-6 | KAlF4 | 142.07 | Aluminate(1-), tetrafluoro-, potassium, (T-4)-; potassium,(beta-4)-aluminate(1-tetrafluoro-; potassiumaluminiumfluoride; potassiumaluminumtetrafluoride; tetrafluoro-,potassium,(T-4)-Aluminate(1-); POTASSIUM ALUMINUM FLUORIDE |
POTASSIUM TETRABROMOPLATINATE(II) | 13826-94-3 | Br4K2Pt | 592.89 | dipotassium,(sp-4-1)-platinate(2-tetrabromo-; dipotassiumtetrabromoplatinate; potassiumbromoplatinate(ii); potassiumtetrabromoplatinate; tetrabromo-platinate(2-dipotassium; tetrabromo-platinum(2-dipotassium; POTASSIUM TETRABROMOPLATINATE(II); POTASSIUM PL |
POTASSIUM TARTRATE | 304655-91-2 | C4H4K2O6 | 226.27 | L-(+)TARTARIC ACID DIPOTASSIUM SALT; L(+)TARTARIC ACID DIPOTASSIUM |
potassium sulfite | 10117-38-1 | K2O3S | 158.2382 | POTASSIUM SULFITE; POTASSIUM SULPHITE; dipotassiumsulfite; potassiumsulfite(k2so3); Potassiumsulfite,anhydrous; Sulfurousacid,dipotassiumsalt; Potassium sulfite solution; POTASSIUM SULFITE SOLUTION, ~43% IN WATE R |
Potassium sulfate | 7778-80-5 | K2SO4 | 174.24 | Arcanum duplicatum; arcanumduplicatum; dipotassiumsulfate; Glazier's salt; K2SO4; kaliumsulphuricum; Potassium sulfate, alpha; potassiumsulfate(2:1) |
Potassium stearate | 593-29-3 | C18H35KO2 | 322.574 | Octadecanoic acid potassium salt; Stearic Acid Potassium Salt |
Potassium sorbate | 590-00-1 | C6H7KO2 | 150.21 | |
Pomalidomide Impurity 8 | 2635-64-5 | C13H13N3O5 | 291.26 | 5-amino-2-(4-amino-1,3-dioxoisoindol-2-yl)-5-oxopentanoic acid; CC-8017; CC 8017; CC8017; SCHEMBL2168383; XSKMMEVRGHPMSJ-UHFFFAOYSA-N; M11(CC-8017) |
Pomalidomide-d5 | 1377838-49-7 | C13H6N3O4D5 | 278.28 | 4-Amino-2-(2,6-dioxo-3-piperidinyl)isoindole-1,3-dione-D5; Actimid-D5; CC 4047-D5; IMiD 3-D5 |
Pomalidomide-d4 (deuterated) | 1416575-78-4 | C13H7N3O4D4 | 277.27 | 4-Amino-2-(2,6-dioxo-3-piperidinyl)isoindole-1,3-dione-d4; 4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione-d4; Actimid-d4; CC 4047-d4; IMiD 3-d4 |
Pirlindole mesylate | 207572-66-5 | C15H18N2.CH3SO3H | 322.42 | 2,3,3a,4,5,6-Hexahydro-8-methyl-1H-pyrazino[3,2,1-j,k]carbazole mesylate |
Pirlindole | 60762-57-4 | C15H18FN2 | 226.32 | |
Pirlimycin hydrochloride | 78822-40-9 | C17H32Cl2N2O5S | 447.4 | U 57930E |
Piritrexim | 72732-56-0 | C17H19 N5 O2 | 325.36 | |
Piriprost potassium salt | 88851-62-1 | C26H34NO4·K | 463.7 | U-60257B; 5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-1-phenyl-5,6-dihydro-4H-cyclopenta[b]pyrrol-2-yl]pentanoate potassium salt |
Pirinixic acid aminothiazole | 1492060-44-2 | C25H25ClN4O2S2 | 513.1 | 2-[4-Chloro-6-[4-(2-naphthyl)-2-thiazolylamino]-2-pyrimidinylthio]octanoic acid |
Pirinixic Acid | 50892-23-4 | C14H14ClN3O2S | 323.8 | WY-14643 |
Pirimiphos-methyl | 29232-93-7 | C11H20N3O3PS | 305.33 | ACTELLIC; ACTELLIC(R); ACTELLIFOG; O-(2-Diethylamino-6-methyl-4-pyrimidinyl)-O,O-dimethyl phosphorothioate; O-2-DIETHYLAMINO-6-METHYLPYRIMIDINE-4-YL O,O-DIMETHYL PHOSPHOROTHIOATE; PIRIMPHOS-METHYL ESTER; PIRIMIPHOS-METHYL; PP511 |
Pirimicarb-D6 | 1015854-66-6 | Dimethyl-D6-carbamic acid (2-dimethylamino- 5,6-dimethyl pyrimidin-4- yl) ester | ||
Piracetam Impuirty D | 53934-76-2 | C6H9NO3 | 143.14 | (2-Oxopyrrolidin-1-yl)acetic Acid |
Piracetam-d8 | 1329799-64-5 | C6H2D3N2O2 | 150.21 | 2-Oxo-1-pyrrolidineacetamide-d8; (2-Oxopyrrolidino)acetamide-d8; 2-(2-Oxopyrrolidin-1-yl)acetamide-d8; Avigilen-d8; Axonyl-d8; Cerebroforte-d8; Piramem-d8; Pyracetam-d8; UCB 6215-d8; |
Piracetam Impuirty C | 61516-73-2 | C8H13NO3 | 171.2 | Ethyl (2-Oxopyrrolidin-1-yl)acetate |
Pinaverium bromide | 53251-94-8 | C26H41Br2NO4 | 591.42 | Icosapentaenoic acid; Dicetel; 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-2-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium bromide |
Pinane Thromboxane A2 | 71111-01-8 | C24H40O3 | 376.6 | 15(S)-Pinane Thromboxane A2; Pinane TXA2; PTA2; 7-[3-(3-hydroxyoct-1-enyl)-6,6-dimethyl-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid |
Pinane Hydroperoxide | 5405-84-5 | C10H18O2 | 170.24872;g/mol | Pinanehydroperoxide; 5405-84-5; NSC5238; pinanylhydroperoxide; 2-Hydroperoxypinane; AC1Q7DKL |
Pinacyanol bromide | 2670-67-9 | C25H25BrN2 | 433.38 | 2,2'-TRIMETHINEQUINOCYANINE BROMIDE; 2,2'-CARBOCYANINE BROMIDE, 1,1'-DIETHYL-; 1-ETHYL-2-[3-(1-ETHYL-2(1H)-QUINOLYLIDENE)PROPENYL]QUINOLINIUM BROMIDE; 1-ETHYL-2-(3-[1-ETHYL-2(1H)-QUINOLINYLIDENE]-1-PROPENYL)QUINOLINIUM BROMIDE; 1,1'-DIETHYL-2,2'-CARBOCYAN |
PINACOL-D12 | 75160-24-6 | C6H2D12O2 | 130.248101336 | PINACOL-D12 |
Pinacidil monohydrate | 85371-64-8 | C13H19N5·H2O | 263.34 | Pinacidil hydrate; 1-cyano-2-(3,3-dimethylbutan-2-yl)-3-pyridin-4-ylguanidine hydrate |
Pimprinine | 13640-26-1 | C12H10N2O | 198.2 | 5-(3-Indolyl)-2-methyloxazole, WS 30581C, APHE 3 |
Pimpinellin | 131-12-4 | C13H10O5 | 246.2 | 5,6-Dimethoxy-2H-furo[2,3-h]chromen-2-one |
Phosphoric aciddiphenyl ethylhexyl ester | 1241-94-7 | C20H27O4P | 362.4 | 2-ETHYLHEXYL DIPHENYL PHOSPHATE; Diphenyl-2-ethylhexyl phosphate; OCTYL DIPHENYL PHOSPHATE; PHOSPHORIC ACID OCTYL DIPHENYL ESTER; PHOSPHORIC ACID DIPHENYL 2-ETHYLHEXYL ESTER; PHOSPHORIC ACID 2-ETHYLHEXYL DIPHENYL ESTER; (2-Ethylhexyl)-difenylfosfat; 1-Hex |
Phosphoric acid,silver(1+) sodium zirconium(4+) salt (9CI) | 265647-11-8 | Ag. x H3 O4 P . x Na . x Zr | 412.024693;g/mol | silver;sodium;zirconium(4+);diphosphate;Phosphoricacid,silver(1+)sodiumzirconium(4+)salt(9CI);265647-11-8 |
Phenyl-(4-butoxy-phenyl)-iodonium hexafluorophosphate | 204781-59-9 | C16H18F6IOP | 498.19 | |
phenyl(1h-pyrrol-2-yl)methanone | 7697-46-3 | C11H9NO | 171.19 | 2-BENZOYLPYRROLE; 2-Benzoylpyrroline; Phenyl(1H-pyrrol-2-yl)methanone; (1H-Pyrrole-2-yl)phenyl ketone; 2-Benzoyl-1H-pyrrole; Phenyl(1H-pyrrol-2-yl) ketone; Nsc75585 |
Obinutuzumab | 949142-50-2 | C6512H10060N1712O2020S44 | 146100 | GA101 |
obiltoxaximab | 1351337-07-9 | C6444H9994N1734O2022S44 | 145500 | Anthim |
OBIDOXIME CHLORIDE | 114-90-9 | C14H16Cl2N4O3 | 359.21 | BIS(4-FORMYLPYRIDINIOMETHYL) ETHER DIOXIME; 1,1'[OXYBIS(METHYLENE)]-BIS[4-(HYDROXYIMINO)METHYL]PYRIDINIUM DICHLORIDE; 1,1'-(OXYDIMETHYLENE)BIS(PYRIDINIUM-4-CARBALDOXIME) DICHLORIDE; OBIDOXIME CHLORIDE; TOXOGONIN; 1,1'-(oxybis(methylene))bis(4-((hydroxyimi |
Obeticholic Acid | 459789-99-2 | C26H44O4 | 420.634 | 6-ECDCA; 6-Ethylchenodeoxycholic acid; (4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid |
Obestatin (rat) | 869705-22-6 | C114H174N34O31 | 2516.84 | |
O-(2-Azido-4,6-O-benzylidene-2-deoxy-a-D-galactopyranosyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-threonine tert-Butyl Ester | 195976-07-9 | C36H40N4O9 | 672.72 | O-(2-Azido-4,6-O-benzylidene-2-deoxy-a-D-galactopyranosyl)-N-Fmoc-L-threonine tert-Butyl Ester; Fmoc-Thr[GalN3[46Bzd]-a]-OtBu |
O-(2-Azido-4,6-O-benzylidene-2-deoxy-a-D-galactopyranosyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine tert-Butyl Ester | 878483-02-4 | C35H38N4O9 | 658.70 | O-(2-Azido-4,6-O-benzylidene-2-deoxy-a-D-galactopyranosyl)-N-Fmoc-L-serine tert-Butyl Ester; Fmoc-Ser[GalN3[46Bzd]-a]-OtBu |
Pomalidomide Impurity 5 | 19171-18-7 | C13H9N3O6 | 303.23 | |
Pomalidomide Impurity 4 | 585-21-7 | C5H10N2O3 | 146.15 | DL-GLUTAMINE |
Pomalidomide Impurity 3 | 498-25-9 | C5H10N2O3 | 146.15 | |
POM 1 | 314075-43-9 | Na6O39W12·H2O | 2986.1 | Sodium Metatungstate; Sodium Polyoxotungstate |
POM 1 | 12141-67-2 | H2O40Na6W12 | 2986.01 | Sodium metatungstate; Tungstate (W12(OH)2O386-) Hexasodium; Tungstic Acid (H8W12O40) Hexasodium Salt; SPT; POM 1 |
Polyvinylimidazole | 25232-42-2 | (C5H6N2)n | 1-Vinylimidazole; 1-Vinyl-1H-imidazole; N-Vinylimidazole; 1H-Imidazole, 1-ethenyl-; Lufixan | |
POLYVINYLCYCLOHEXANE | 25498-06-0 | |||
Polyvinyl chloride | 93050-82-9 | C2H3Cl | 62.4979 | |
Polyvinyl alcohol-polyethylene glycol graft-copolymer | 96734-39-3 | Kollicoat IR; Macrogol-poly(vinyl alcohol) graft-copolymer | ||
Polyvinyl Alcohol | 9002-89-5 | PVA | ||
Polyvinyl acetate | 9003-20-7 | (C4H6O2)n | Poly(vinyl acetate); PVA | |
Polyurethane rubber | 61789-63-7 | C45H55N3O8 | 765.93300 | |
Poly-tribromostyrene | 57137-10-7 | (C8H5Br3)x | 343.863 | Benzene,ethenyl-,tribromo-,deriv.,homopolymer; benzene,ethenyl-,tribromoderiv.,homopolymer; benzeneethenyl-,homopolymer,brominated; ethenylbenzenetribromoderiv.homopolymer; pyro-chek63pb; pyro-cheklm; TRIBROMINATED POLYSTYRENE; Benzene, tribromoethenyl-, |
Poly-TPD | 472960-35-3 | |||
Polysulfone | 25135-51-7 | (C27H22O4S)n | ||
POLYSULFONE | 25154-01-2 | C81H66O12S3X2 | 1327.58 | 1,1'-Sulfonylbis[4-chlorobenzene],bisphenolApolymer; nzene]; Phenol,4,4'-(1-methylethylidene)bis-,polymerwith1,1'-sulfonylbis(4-chlorobenzene); SULFONE RESIN; POLYSULFONE; POLYSULFONE RESIN; 4,4''-(1-METHYLETHYLIDENE)BISPHENL-1,1''-SULFONYLBIS(4-CHLOROBEN |
Polysucrose 400 | 26873-85-8 | 400K | ||
Polysucrose | 25702-74-3 | C12H22O11 | 342.30 | |
Polysorbate 80 | 9005-65-6 | Polyethoxylated Sorbitan Monooleate; Tween 80 | ||
Polysorbate 60 | 9005-67-8 | Pegnol T 60 | ||
Polysorbate 40 | 9005-66-7 | Tween 40 | ||
Polysorbate 20 | 9005-64-5 | Tween 20; Ahco 7596T; Nissa | ||
Polysiloxanes,polyether- | 94469-32-6 | |||
Polysiloxanes,di-Me, vinyl group-terminated | 68083-19-2 | C8H18OSi2 | 0 | dowcorning3-4939; dowcorning6646; ge3175; Polydimethylsiloxane,vinylendblocked; ps441; ps442; ps448; SiloxanesandSilicones,di-Me,vinylgroup-terminated |
Polysiloxanes,di-Me, 3-hydroxypropyl Me, ethers with polyethylene-polypropylene glycolmono-Me ether | 67762-85-0 | C2H10OSi2 | 106.2712 | lypropyleneglycolmono-meether; organosilicone,polyoxyalkyleneethercopolymer; siloxanesandsilicones,di-me,3-hydroxypropylme,etherswithpolyethylene-po; SiloxanesandSilicones,di-Me,3-hydroxypropylMe,etherswithpolyethylene-polypropyleneglycolmono-Meether; PRO |
Polysiloxanes,di-Me, [(trimethoxysilyl)oxy]-terminated | 142982-20-5 | |||
Polysiloxanes, Me3-mercaptopropyl | 102783-03-9 | 0 | (MERCAPTOPROPYL)METHYLSILOXANE, DIMETHYLSILOXANE COPOLYMER; (MERCAPTOPROPYL)METHYLSILOXANE - DIMETHYLSILOXANE COPOLYMERS; (2-3% MERCAPTOPROPYL)METHYLSILOXANE) - DIMETHYLSILOXANE COPOLYMER: VISCOSITY 120-180 CST.; (4-6% MERCAPTOPROPYL)METHYLSILOXANE) - DIM | |
Polysiloxanes, di-Me,hydroxy-terminated, ethoxylated propoxylated | 64365-23-7 | |||
Polysiloxanes | 63148-53-8 | 0 | POLYPHENYLMETHYLDIMETHYLSILOXANE; POLYPHENYLMETHYLSILOXANE; POLYMETHYLPHENYLSILOXANE; SILICONE DC 550 FLUID; SILICONE FLUID; SILICONE FLUID DC 550; SILICONE OIL AR 200; EMALEX MTS-30E | |
Polysiloxane | 9011-19-2 | |||
Polysalicylate | 25496-36-0 | (C7H4O2)n | 0 | Polysalicylate; poly(salicylic acid); salicylic acid polyesters; 2-Hydroxybenzoic acid homopolymer |